var title_f40_33_41488="Esophageal perforation CT";
var content_f40_33_41488=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F81791&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F81791&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Esophageal perforation",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 312px; height: 288px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    CT scan of the chest in a patient with spontaneous esophageal perforation. There is widening of the mediastinum, air in the mediastinum (appearing as black dots, arrows), and bilateral pleural effusions.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert E Mindelzun, MD, Department of Radiology, Stanford University.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41488=[""].join("\n");
var outline_f40_33_41488=null;
var title_f40_33_41489="Patient information: Mono, the “kissing disease” (The Basics)";
var content_f40_33_41489=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15446\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/5/36948\">",
"         Organs inside the abdomen",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?39/40/40578\">",
"         Patient information: Fever in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"mobipreview.htm?0/57/914\">",
"         Patient information: Sore throat in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"mobipreview.htm?0/11/176\">",
"         Patient information: Infectious mononucleosis (mono) in adults and adolescents (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Mono, the &ldquo;kissing disease&rdquo; (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/mono-the-kissing-disease-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H475485619\">",
"      <span class=\"h1\">",
"       What is mono?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Mono is a viral infection that causes fever, sore throat, tiredness, and swelling of the neck glands. Some people call mono \"the kissing disease.\" That&rsquo;s because kissing is one of the ways you can catch mono. It usually affects children, teenagers and young adults. &ldquo;Mono&rdquo; is short for mononucleosis.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H475485626\">",
"      <span class=\"h1\">",
"       How did I get mono?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The virus that causes mono lives in saliva. You can catch it from someone who has mono if you:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Kiss",
"       </li>",
"       <li>",
"        Share a fork, spoon, or knife",
"       </li>",
"       <li>",
"        Drink from the same glass",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H475485633\">",
"      <span class=\"h1\">",
"       Is there a test for mono?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Your doctor or nurse can give you a blood test to check for mono. But even if you do have mono, the test may not show the infection during the first 2 weeks of symptoms.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H475485640\">",
"      <span class=\"h1\">",
"       How is mono treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;There is no treatment that cures mono. But medicines like",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?19/35/20021?source=see_link\">",
"       acetaminophen",
"      </a>",
"      (sample brand name: Tylenol&reg;) or",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?14/17/14614?source=see_link\">",
"       ibuprofen",
"      </a>",
"      (sample brand names: Advil&reg; and Motrin&reg;) can relieve the pain and fever mono causes. If you take these medicines, be sure to follow the directions on the label.",
"     </p>",
"     <p>",
"      Antibiotics do not work on mono.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H475485647\">",
"      <span class=\"h1\">",
"       What can I do to feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Get plenty of rest. And drink enough fluids so that your urine",
"      <strong>",
"      </strong>",
"      is pale yellow instead of dark yellow. Drinking fluids is really important if you are taking",
"      <a class=\"drug drug_patient\" href=\"mobipreview.htm?14/17/14614?source=see_link\">",
"       ibuprofen",
"      </a>",
"      . That&rsquo;s because ibuprofen can cause problems with your kidneys.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H475485654\">",
"      <span class=\"h1\">",
"       When can I go back to work or school?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You can go back to school or work when you feel better. But you may need to avoid sports or other physical activities for at least a month. That's because mono can cause one of the organs in your body to become bigger than it should be. This organ is called the spleen (",
"      <a class=\"graphic graphic_figure graphicRef61816 \" href=\"mobipreview.htm?36/5/36948\">",
"       figure 1",
"      </a>",
"      ). When it is too big, it can get damaged during physical activity.",
"     </p>",
"     <p>",
"      If your spleen gets big when you have mono, you will have to avoid physical activity until your doctor or nurse says you can go back to it.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H475485661\">",
"      <span class=\"h1\">",
"       When will I feel better?",
"      </span>",
"      &nbsp;&mdash;&nbsp;You will probably start to feel better in 1 to 2 weeks. But it can be a month or more before you get back to normal. Most people get over mono with no lasting problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H475485668\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/40/40578?source=see_link\">",
"       Patient information: Fever in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/57/914?source=see_link\">",
"       Patient information: Sore throat in adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/11/176?source=see_link\">",
"       Patient information: Infectious mononucleosis (mono) in adults and adolescents (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"mobipreview.htm?40/33/41489?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15446 Version 3.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0503-122.72.80.101-E34D2EC933-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41489=[""].join("\n");
var outline_f40_33_41489=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H475485619\">",
"      What is mono?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H475485626\">",
"      How did I get mono?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H475485633\">",
"      Is there a test for mono?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H475485640\">",
"      How is mono treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H475485647\">",
"      What can I do to feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H475485654\">",
"      When can I go back to work or school?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H475485661\">",
"      When will I feel better?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H475485668\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15446\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?36/5/36948\">",
"      Organs inside the abdomen",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?39/40/40578?source=related_link\">",
"      Patient information: Fever in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?0/11/176?source=related_link\">",
"      Patient information: Infectious mononucleosis (mono) in adults and adolescents (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?0/57/914?source=related_link\">",
"      Patient information: Sore throat in adults (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_33_41490="Small pulmonary artery";
var content_f40_33_41490=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F66276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F66276&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary hypertension histology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Photomicrograph of a small pulmonary artery demonstrating medial hypertrophy and intimal proliferation.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Colleen L Bailey, MD and Lewis J Rubin, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41490=[""].join("\n");
var outline_f40_33_41490=null;
var title_f40_33_41491="Metaxalone: Patient drug information";
var content_f40_33_41491=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Metaxalone: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/61/41940?source=see_link\">",
"     see \"Metaxalone: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F193793\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Skelaxin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F193794\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Skelaxin&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10014502\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691274",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to calm muscles.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10014501\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702481",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to metaxalone or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703232",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Anemia, kidney disease, or liver disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10014506\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10014507\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10014509\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698658",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling very tired or weak.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10014504\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug is used with rest, PT (physical therapy), pain drugs, and other therapies.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10014505\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10014510\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10014511\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10847 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.247-9F1D191359-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41491=[""].join("\n");
var outline_f40_33_41491=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193793\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193794\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014502\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014501\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014506\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014507\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014509\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014504\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014505\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014510\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10014511\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?40/61/41940?source=related_link\">",
"      Metaxalone: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_33_41492="Loperamide: Patient drug information";
var content_f40_33_41492=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Loperamide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/53/16214?source=see_link\">",
"     see \"Loperamide: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/31/8692?source=see_link\">",
"     see \"Loperamide: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F189683\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Anti-Diarrheal [OTC];",
"     </li>",
"     <li>",
"      Diamode [OTC];",
"     </li>",
"     <li>",
"      Imodium&reg; A-D EZ Chews [OTC];",
"     </li>",
"     <li>",
"      Imodium&reg; A-D for children [OTC];",
"     </li>",
"     <li>",
"      Imodium&reg; A-D [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F189684\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Loperamide&reg;;",
"     </li>",
"     <li>",
"      Diarr-Eze;",
"     </li>",
"     <li>",
"      Dom-Loperamide;",
"     </li>",
"     <li>",
"      Imodium&reg;;",
"     </li>",
"     <li>",
"      Loperacap;",
"     </li>",
"     <li>",
"      Novo-Loperamide;",
"     </li>",
"     <li>",
"      PMS-Loperamine;",
"     </li>",
"     <li>",
"      Rhoxal-loperamide;",
"     </li>",
"     <li>",
"      Rho&reg;-Loperamine;",
"     </li>",
"     <li>",
"      Riva-Loperamide;",
"     </li>",
"     <li>",
"      Sandoz-Loperamide",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10015775\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691815",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691342",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to lower ostomy output.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10015774\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702406",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to loperamide or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703410",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Bloody loose stools, high fever, or pseudomembranous colitis.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703877",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you need to avoid hard stools (constipation).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10015779\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696611",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, mixed drinks, or other drugs and natural products that slow your actions.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10015780\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698060",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling lightheaded, sleepy, having blurred eyesight, or a change in thinking clearly. Avoid driving and doing other tasks or actions that call for you to be alert or have clear eyesight until you see how this drug affects you.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697975",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10015782\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699091",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling of belly.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698679",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High fever.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10015777\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694871",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow what your doctor has told you to do.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694286",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       There is a liquid (solution) if you cannot swallow pills.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696107",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Those who have feeding tubes may also use the liquid. Flush the feeding tube before and after this drug is given.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694818",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink lots of noncaffeine liquids unless told to drink less liquid by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10015778\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10015783\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699264",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Protect from light.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10015784\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11173 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-BFBE39938F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41492=[""].join("\n");
var outline_f40_33_41492=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189683\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F189684\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015775\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015774\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015779\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015780\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015782\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015777\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015778\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015783\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10015784\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?15/53/16214?source=related_link\">",
"      Loperamide: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?8/31/8692?source=related_link\">",
"      Loperamide: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_33_41493="Diflunisal: Patient drug information";
var content_f40_33_41493=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Diflunisal: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/41/25240?source=see_link\">",
"     see \"Diflunisal: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F159980\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Diflunisal&reg;;",
"     </li>",
"     <li>",
"      Novo-Diflunisal;",
"     </li>",
"     <li>",
"      Nu-Diflunisal",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10029632\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700782",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of very bad and sometimes deadly heart and blood vessel side effects like heart attack and stroke. The risk may be greater if you have heart disease or risks for heart disease. The risk may be greater with long-term use. Do not use this drug right before or after bypass heart surgery.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700792",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may raise the chance of ulcers or bleeding from the stomach or bowel. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700454",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug comes with an extra patient fact sheet called a Medication Guide. Read it with care. Read it again each time this drug is refilled.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10029634\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691600",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to ease pain and swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691733",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat arthritis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10029633\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701947",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to diflunisal or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701061",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are more than 24 weeks pregnant.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10029638\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have asthma, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697265",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood pressure, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have had an ulcer or bleeding from your stomach or bowel, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a weak heart, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697622",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using products that have aspirin, blood thinners, garlic, ginseng, ginkgo, ibuprofen or like products, pain drugs, or vitamin E.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell dentists, surgeons, and other doctors that you use this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697795",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may bleed more easily. Be careful and avoid injury. Use a soft toothbrush and an electric razor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696862",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take colestipol or cholestyramine within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696618",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Avoid beer, wine, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10029639\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10029641\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698626",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Chest pain or pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698619",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Change in strength on 1 side is greater than the other, trouble speaking or thinking, change in balance, or blurred eyesight.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699050",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad swelling or pain of hands or feet.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699062",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A big weight gain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black, tarry, or bloody stools.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698609",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Blood in the urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699105",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any bruising or bleeding.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10029636\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with food to stop an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swallow tablet whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10029637\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696540",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Many times this drug is taken on an as needed basis.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10029642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10029643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12381 Version 35.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-58.240.98.179-AEB5EC0217-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41493=[""].join("\n");
var outline_f40_33_41493=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F159980\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029632\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029634\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029633\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029638\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029639\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029641\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029636\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029637\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029642\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10029643\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?24/41/25240?source=related_link\">",
"      Diflunisal: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_33_41494="Small vessel disease in HCM";
var content_f40_33_41494=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F73467&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F73467&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Small vessel disease in hypertrophic cardiomyopathy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 382px; height: 252px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Patients with hypertrophic cardiomyopathy often have small vessel disease which may be associated with symptoms of ischemia. The small intramural vessels often demonstrate apparent lumenal narrowing, caused by hypertrophy of the tunica media.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Professor Michael Davies, St. George's Hospital, London.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41494=[""].join("\n");
var outline_f40_33_41494=null;
var title_f40_33_41495="Classification and genetics of multiple endocrine neoplasia type 2";
var content_f40_33_41495=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Classification and genetics of multiple endocrine neoplasia type 2",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/33/41495/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41495/contributors\">",
"     Cornelis J Lips, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/33/41495/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41495/contributors\">",
"     Marc K Drezner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/33/41495/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41495/contributors\">",
"     Jean E Mulder, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/33/41495/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 13, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple endocrine neoplasia type 2 (MEN2) is characterized by medullary thyroid carcinoma (MTC), pheochromocytoma (PC), and primary parathyroid hyperplasia (PPH). It is an autosomal dominant disorder with an estimated prevalence of 1 per 30,000 in the general population. Although these syndromes are rare, recognition is important both for treatment and for evaluation of family members. A MEN syndrome is often first suspected when a patient is found to have one or more of the tumors, but molecular DNA testing is now available for detecting asymptomatic patients with MEN2 and familial medullary cancer of the thyroid (FMTC).",
"   </p>",
"   <p>",
"    This topic will review the classification and genetics of the MEN type 2 syndromes. The clinical manifestations, diagnosis, and therapy of MEN type 2 and MEN type 1 syndrome are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22794?source=see_link\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/42/8872?source=see_link\">",
"     \"Approach to therapy in multiple endocrine neoplasia type 2\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/49/17174?source=see_link\">",
"     \"Multiple endocrine neoplasia type 1: Definition and genetics\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/14/43240?source=see_link\">",
"     \"Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38871?source=see_link\">",
"     \"Multiple endocrine neoplasia type 1: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLASSIFICATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;MEN2 is subclassified into three distinct syndromes: MEN2A, MEN2B, and familial medullary thyroid cancer (FMTC). In all three syndromes, there is an occurrence of multicentric tumor formation in all organs where the RET proto-oncogene is expressed. The thyroid, parathyroid and adrenal glands, and accessory adrenals are at risk for developing tumors that may reduce life expectancy and quality of life.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Multiple endocrine neoplasia type 2A",
"    </span>",
"    &nbsp;&mdash;&nbsp;MEN2A is a heritable predisposition to medullary thyroid cancer, pheochromocytoma, and primary parathyroid hyperplasia. The respective frequency of these tumors in MEN2 is over 90 percent for medullary thyroid cancer, approximately 40 to 50 percent for pheochromocytoma, and 10 to 20 percent for multigland parathyroid hyperplasia (",
"    <a class=\"graphic graphic_table graphicRef53057 \" href=\"mobipreview.htm?19/40/20108\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Cutaneous lichen amyloidosis (also known as lichen planus amyloidosis) has been described in some families with MEN2A [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. This disorder is now considered a component of the syndrome [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to MEN1, in which the long-term benefit of early diagnosis via genetic screening is not well established, early diagnosis via screening of \"at-risk\" family members in MEN2A kindreds is essential because medullary thyroid cancer is a life-threatening disease that can be cured or prevented by early thyroidectomy. In the past, screening was performed with intravenous pentagastrin or calcium, which stimulates calcitonin secretion from malignant or hyperplastic parafollicular cells. However, DNA testing has been the best screening test for this disorder since it was recognized that affected patients have germ-line mutations in the RET proto-oncogene on chromosome 10 (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Molecular genetics'",
"    </a>",
"    below) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22794?source=see_link&amp;anchor=H1590678#H1590678\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\", section on 'Indications for genetic testing'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Multiple endocrine neoplasia type 2B",
"    </span>",
"    &nbsp;&mdash;&nbsp;The frequency of MEN2B is 8 to 15 percent of all MEN2 patients. MEN2B shares the inherited predisposition to medullary thyroid cancer and pheochromocytoma that occurs in MEN2A. There are, however, important clinical differences. Patients with MEN2B also tend to have mucosal neuromas, typically involving the lips and tongue, and intestinal ganglioneuromas. Disturbances of colonic function are common, including chronic constipation and megacolon. Many of these patients have development abnormalities, a Marfanoid habitus, and myelinated corneal nerves. On the other hand, parathyroid hyperplasia is not a feature of this disorder.",
"   </p>",
"   <p>",
"    Medullary thyroid cancer is the most common component of the MEN2B syndrome. Furthermore, the tumor is often more aggressive and of earlier onset than in MEN2A; as a result, early diagnosis and prevention are particularly critical.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Familial medullary thyroid cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;FMTC is a variant of MEN2A, in which there is a strong predisposition to medullary thyroid cancer but not the other clinical manifestations of MEN2A (or 2B). The clinical distinction of FMTC from MEN2A may be difficult on statistical grounds in small families; even in some large kindreds the clinical designation of FMTC has been changed to MEN2A after the diagnosis of pheochromocytoma or hyperparathyroidism in a family member. Because FMTC is the most limited variant of MEN2, making the wrong diagnosis of FMTC could result in missing a pheochromocytoma in a patient with MEN2. Therefore, a FMTC kindred should be defined using the following rigorous criteria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/4\">",
"     4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      More than 10 carriers in the kindred",
"     </li>",
"     <li>",
"      Multiple carriers or affected members over the age of 50 years",
"     </li>",
"     <li>",
"      An adequate medical history, particularly in older family members",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Why pheochromocytomas and hyperparathyroidism infrequently develop in these families is still unknown, since many FMTC and MEN2A families carry identical RET mutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. In rare families, both Hirschsprung disease (HSCR) and FMTC appear to segregate.",
"   </p>",
"   <p>",
"    In some populations, the prevalence of the FMTC phenotype among RET mutation carriers is higher than MEN2A and MEN2B (57 verus 34 and 6.8 percent, respectively) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/7\">",
"     7",
"    </a>",
"    ]. This may be related to the introduction of RET screening in the work-up of apparently sporadic MTC and the more extensive search for RET mutations in non-hot spot regions of the gene.",
"   </p>",
"   <p>",
"    A detailed discussion of sporadic medullary thyroid cancer (ie, not part of a MEN syndrome) is found elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link\">",
"     \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/23/38263?source=see_link\">",
"     \"Medullary thyroid cancer: Treatment and prognosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     MOLECULAR GENETICS",
"    </span>",
"    &nbsp;&mdash;&nbsp;MEN2A, MEN2B, and FMTC are inherited in an autosomal dominant pattern with very high penetrance. The genetic defect in these disorders involves the RET proto-oncogene on chromosome 10 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/5,6,8,9\">",
"     5,6,8,9",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H392452\">",
"    <span class=\"h2\">",
"     Structure and function of the normal RET proto-oncogene and its product",
"    </span>",
"    &nbsp;&mdash;&nbsp;The RET protein is a receptor tyrosine kinase that appears to transduce growth and differentiation signals in several developing tissues including those derived from the neural crest [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/6\">",
"     6",
"    </a>",
"    ]. The protein consists of an extracellular part with a ligand-binding domain, a cadherin (Ca++-dependent cell adhesion)-like domain and a cysteine-rich domain close to the cell membrane. It has a single transmembrane domain and an intracellular part with two tyrosine kinase subdomains, TK1 and TK2.",
"   </p>",
"   <p>",
"    Activation of RET occurs by the binding of one of its four ligands, glial-cell-line-derived neurotrophic factor (GDNF), neurturin (TNT), artemin or persephin, which require their specific co-receptors GDNF-receptor-family-a-1, -2, -3, and -4 (GFR-a-1, GFR-a-2, GFR-a-3, and GFR-a-4), respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/10-14\">",
"     10-14",
"    </a>",
"    ]. Interaction of these molecules results in dimerization of RET, cross-autophosphorylation, and subsequent phosphorylation of intracellular substrates (",
"    <a class=\"graphic graphic_figure graphicRef75557 \" href=\"mobipreview.htm?31/48/32515\">",
"     figure 1",
"    </a>",
"    ). RET is expressed in the C-cells of the thyroid gland, adrenal medulla, neurons, and in other tissues. In mice, GDNF or RET play crucial roles in the differentiation and survival of central nervous system neurons, the development of the peripheral nervous system, and the development of the kidneys and ureters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/15-18\">",
"     15-18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H392467\">",
"    <span class=\"h2\">",
"     Structure and function of the mutated RET proto-oncogene and its product",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are differences but much overlap in the specific RET gene mutations underlying MEN2A and FMTC [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/5,6,19,20\">",
"     5,6,19,20",
"    </a>",
"    ]; on the other hand, MEN2B is caused by specific RET mutations (",
"    <a class=\"graphic graphic_figure graphicRef71594 \" href=\"mobipreview.htm?40/28/41415\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/8,19,21\">",
"     8,19,21",
"    </a>",
"    ]. Several studies, including one from the International RET Mutation Consortium [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/19\">",
"     19",
"    </a>",
"    ], have described the relationships between the site of mutation and the type of disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Germline mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;The germline RET mutations in MEN2 and FMTC result in a",
"    <strong>",
"     gain",
"    </strong>",
"    of function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/22\">",
"     22",
"    </a>",
"    ]. This is different from almost all other inherited predispositions to neoplasia which are due to heritable \"loss of function\" mutations that inactivate tumor suppressor proteins. The functional constraints for such activating lesions are probably responsible for the small number of sites at which RET mutations are found, a limitation that is of great benefit for molecular diagnosis in this disorder. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22794?source=see_link\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h4\">",
"     Germline mutations in the extracellular domain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The majority of mutations in MEN2A kindreds and most in FMTC kindreds involve one of five cysteine residues in the cysteine-rich region of the RET protein's extracellular domain encoded in RET exons 10 (codons 609, 611, 618, and 620) or 11 (codons 630 or 634) (",
"    <a class=\"graphic graphic_figure graphicRef71594 \" href=\"mobipreview.htm?40/28/41415\">",
"     figure 2",
"    </a>",
"    ). These extracellular",
"    <span class=\"nowrap\">",
"     MEN2A/FMTC",
"    </span>",
"    cysteine mutations lead to a ligand-independent dimerization of receptor molecules and constitutive activation of intracellular signaling pathways (",
"    <a class=\"graphic graphic_figure graphicRef52243 \" href=\"mobipreview.htm?28/7/28787\">",
"     figure 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A mutation in codon 634 in exon 11 is associated with hyperparathyroidism and pheochromocytoma (PC) in MEN2A and is the most common genetic defect in this disorder (",
"    <a class=\"graphic graphic_figure graphicRef71594 \" href=\"mobipreview.htm?40/28/41415\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/23\">",
"     23",
"    </a>",
"    ]. The penetrance of hyperparathyroidism in those with mutations at this site is about 20 percent. Even with the same mutation, the penetrance of hyperparathyroidism within families varies from 9 to 34 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/24\">",
"     24",
"    </a>",
"    ]. Specific RET mutations have been detected in sporadic MTCs and PCs, whereas such mutations have not been detected in sporadically-occurring parathyroid adenomas.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h4\">",
"     Germline mutations in the intracellular tyrosine kinase domains",
"    </span>",
"    &nbsp;&mdash;&nbsp;Germline mutations in codons 768 (exon 13), 804 (exon 14), and 891 (exon 15) are found only in FMTC, but account for only a minority of cases of this disorder. These sites are part of the intracellular tyrosine kinase (TK) domain (",
"    <a class=\"graphic graphic_figure graphicRef71594 \" href=\"mobipreview.htm?40/28/41415\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Less common mutations in MEN2A and FMTC occur in exon 13 (codons 790 and 791) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MEN2B-associated tumors are caused by mutations in the intracellular TK2 domain. A single 918 Met to Thr mutation in exon 16 is responsible for over 95 percent of cases of MEN2B and is found only in this disorder (",
"    <a class=\"graphic graphic_figure graphicRef52243 \" href=\"mobipreview.htm?28/7/28787\">",
"     figure 3",
"    </a>",
"    ). Met 918 is a critical component of the substrate recognition pocket in the tyrosine kinase catalytic core of the RET protein. In more than 50 percent of cases of MEN2B with codon 918 affected, mutations occur as new (de novo) germline mutations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/26\">",
"     26",
"    </a>",
"    ]. Another mutation, alanine to phenylalanine at codon 883 in exon 15, has been found in some unrelated MEN2B kindreds [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/21,27,28\">",
"     21,27,28",
"    </a>",
"    ]. Atypical MEN2B may occur by dual (tandem) mutations 804 and 806 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/29\">",
"     29",
"    </a>",
"    ] or 804 and 904 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other mutations in the RET gene can produce disorders seemingly unrelated to MEN2, further illustrating the importance of the site of the mutation, its functional consequence (eg, gain versus loss of function), and perhaps the influence of other genes upon the ultimate phenotype. In humans, inactivating mutations of RET have been associated with Hirschsprung disease (congenital megacolon) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/32-34\">",
"     32-34",
"    </a>",
"    ]. Mutations in the RET coding sequence account for up to 50 percent or 7 to 20 percent of familial and sporadic cases, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/35\">",
"     35",
"    </a>",
"    ]. In MEN2A and FMTC, codon 609, 611, 618, and 620 are involved. The RET mutations are inactivating and occur throughout the gene.",
"   </p>",
"   <p>",
"    In mice, RET inactivation leads to a similar loss of enteric neurons and to renal agenesis or dysgenesis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/15\">",
"     15",
"    </a>",
"    ]. In rare families, both Hirschsprung disease and MEN2 appear to segregate with the germline RET mutation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/14\">",
"     14",
"    </a>",
"    ]. A similar situation, in which a particular human RET mutation is apparently inactive during development but active and tumorigenic in postnatal life, is suggested by the description of renal agenesis in a family with FMTC and a RET mutation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?15/58/16296?source=see_link\">",
"     \"Prenatal diagnosis of renal agenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Somatic mutations",
"    </span>",
"    &nbsp;&mdash;&nbsp;About 75 percent of all MTCs are sporadic. In these sporadic MTCs, RET mutations were detected in about 65 percent. Most of these mutations are in exon 16 (codon 918), but other exons have also been affected (",
"    <a class=\"graphic graphic_figure graphicRef71594 \" href=\"mobipreview.htm?40/28/41415\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/37-43\">",
"     37-43",
"    </a>",
"    ]. These mutations are present only in the patients' tumor cells, and are not genetically transmitted. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link&amp;anchor=H1589190#H1589190\">",
"     \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\", section on 'Genetic screening in sporadic MTC'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Genotype-phenotype correlation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Extensive studies on large families reveal that there is a clear genotype-phenotype correlation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/44\">",
"     44",
"    </a>",
"    ]. In four large MEN2A families with a RET-codon 634 mutation, before clinical screening started, the average life span of obligate disease gene carriers (who died of extensive MTC metastases) was 48 years compared with 60 years in FMTC families with a cysteine codon 618 mutation of the RET gene [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/45\">",
"     45",
"    </a>",
"    ]. Thus, although the distinct clinical course of the disease in a family (frequency of pheochromocytoma and parathyroid gland adenoma, and life expectancy) primarily depends upon the specific RET gene germline mutation that is present, screening for other endocrinopathies is mandatory in all families with MTC.",
"   </p>",
"   <p>",
"    Periodic examination of family members has shown that the age of conversion from normal to elevated plasma calcitonin (CT) levels during a C-cell stimulation test was 18 to 31 years (mean 23 years) in FMTC families compared with 6 to 33 years (mean 16 years) in MEN2 families [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/46\">",
"     46",
"    </a>",
"    ]. The age at initial diagnosis of MTC also correlates with the genotype (",
"    <a class=\"graphic graphic_table graphicRef58578 \" href=\"mobipreview.htm?0/38/620\">",
"     table 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although the course of disease in FMTC families with a cysteine codon 618 mutation in the RET proto-oncogene is milder than in MEN2A families with a cysteine codon 634 mutation, patients with extensive metastases and an aggressive and unfavorable course of the disease occur in all such families, irrespective of the nature of the RET mutation. Progression of the disease probably depends on additional somatic mutations in other proto-oncogenes,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    tumor suppressor genes. Individual habits like diet and smoking, as well as the environment and pollution, may promote the occurrence of these additional mutations.",
"   </p>",
"   <p>",
"    There is greater morbidity and mortality in MEN2B than in MEN2A. The survival curves of patients with MEN2B are similar to those of patients with sporadic MTC who have somatic RET mutations identical with the most common germline mutations causing MEN2B [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/19\">",
"     19",
"    </a>",
"    ]. The clinical manifestations of MEN2 and the role of genetic screening are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22794?source=see_link\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/42/8872?source=see_link\">",
"     \"Approach to therapy in multiple endocrine neoplasia type 2\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The outcomes of patients with familial medullary cancer also vary with genotype. As an example, among carriers of the RET oncogene who had thyroidectomy, all 11 patients with mutations in codons 790, 791, 804 or 891 were cured, while 5 of 35 patients with mutations in codons 618, 620, 630 or 634 (which are associated with more aggressive disease) failed to be cured [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in the molecular genetics underlying the MEN2 syndromes have resulted in DNA testing becoming the optimal test for their detection. In contrast to MEN1, in which the long-term benefit of early diagnosis by genetic screening is not well established, early diagnosis by screening of \"at-risk\" family members in MEN2 kindreds is essential because MTC is a life-threatening disease that can be cured or prevented by early thyroidectomy. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/42/8872?source=see_link\">",
"     \"Approach to therapy in multiple endocrine neoplasia type 2\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The topic of genetic testing in families with suspected MEN2 and in patients with apparently sporadic medullary thyroid cancer is discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22794?source=see_link&amp;anchor=H1590678#H1590678\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\", section on 'Indications for genetic testing'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=see_link&amp;anchor=H1589190#H1589190\">",
"     \"Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging\", section on 'Genetic screening in sporadic MTC'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Multiple endocrine neoplasia type 2 (MEN2) is an autosomal dominant disorder with an estimated prevalence of 1 per 30,000 in the general population. Although these syndromes are rare, recognition is important both for treatment and for evaluation of family members.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Classification",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      MEN2 is subclassified into three distinct syndromes: MEN2A, MEN2B, and familial medullary thyroid cancer (FMTC) (",
"      <a class=\"graphic graphic_table graphicRef53057 \" href=\"mobipreview.htm?19/40/20108\">",
"       table 1",
"      </a>",
"      ) (see",
"      <a class=\"local\" href=\"#H2\">",
"       'Classification'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      MEN2A is a heritable predisposition to medullary thyroid cancer, pheochromocytoma, and primary parathyroid hyperplasia. The respective frequency of these tumors in MEN2A is over 90 percent for medullary thyroid cancer, approximately 40 to 50 percent for pheochromocytoma, and 10 to 20 percent for multigland parathyroid hyperplasia. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Multiple endocrine neoplasia type 2A'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      MEN2B shares the inherited predisposition to medullary thyroid cancer and pheochromocytoma that occurs in MEN2A. Patients with MEN2B also tend to have mucosal neuromas, intestinal ganglioneuromas, and in some instances, a Marfanoid habitus; on the other hand, parathyroid hyperplasia is not a feature of this disorder. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Multiple endocrine neoplasia type 2B'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      FMTC is a variant of MEN2A, in which there is a strong predisposition to medullary thyroid cancer but not the other clinical manifestations of MEN2A (or 2B). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Familial medullary thyroid cancer'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Genetics",
"    </span>",
"    &nbsp;&mdash;&nbsp;MEN2A, MEN2B, and FMTC are inherited in an autosomal dominant pattern with very high penetrance. The genetic defect in these disorders involves the RET proto-oncogene on chromosome 10. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Molecular genetics'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The germline RET mutations in MEN2 and FMTC result in a",
"      <strong>",
"       gain",
"      </strong>",
"      of function (",
"      <a class=\"graphic graphic_figure graphicRef52243 \" href=\"mobipreview.htm?28/7/28787\">",
"       figure 3",
"      </a>",
"      ) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?40/33/41495/abstract/22\">",
"       22",
"      </a>",
"      ]. This is different from almost all other inherited predispositions to neoplasia which are due to heritable \"loss of function\" mutations that inactivate tumor suppressor proteins. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Germline mutations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of mutations in MEN2A kindreds and most in FMTC kindreds involve one of five cysteine residues in the cysteine-rich region of the RET protein's extracellular domain encoded in RET exons 10 (codons 609, 611, 618, and 620) or 11 (codon 634) (",
"      <a class=\"graphic graphic_figure graphicRef71594 \" href=\"mobipreview.htm?40/28/41415\">",
"       figure 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Germline mutations in the extracellular domain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A single Met to Thr mutation in exon 16 is responsible for over 95 percent of cases of MEN2B and is found only in this disorder. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Germline mutations in the intracellular tyrosine kinase domains'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clinical manifestations and treatment of MEN2 are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22794?source=see_link\">",
"     \"Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/42/8872?source=see_link\">",
"     \"Approach to therapy in multiple endocrine neoplasia type 2\"",
"    </a>",
"    .)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/1\">",
"      Donovan DT, Levy ML, Furst EJ, et al. Familial cutaneous lichen amyloidosis in association with multiple endocrine neoplasia type 2A: a new variant. Henry Ford Hosp Med J 1989; 37:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/2\">",
"      Verga U, Fugazzola L, Cambiaghi S, et al. Frequent association between MEN 2A and cutaneous lichen amyloidosis. Clin Endocrinol (Oxf) 2003; 59:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/3\">",
"      Mathew CG, Chin KS, Easton DF, et al. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature 1987; 328:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/4\">",
"      Brandi ML, Gagel RF, Angeli A, et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 2001; 86:5658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/5\">",
"      Mulligan LM, Eng C, Healey CS, et al. Specific mutations of the RET proto-oncogene are related to disease phenotype in MEN 2A and FMTC. Nat Genet 1994; 6:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/6\">",
"      Mulligan LM, Ponder BA. Genetic basis of endocrine disease: multiple endocrine neoplasia type 2. J Clin Endocrinol Metab 1995; 80:1989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/7\">",
"      Romei C, Mariotti S, Fugazzola L, et al. Multiple endocrine neoplasia type 2 syndromes (MEN 2): results from the ItaMEN network analysis on the prevalence of different genotypes and phenotypes. Eur J Endocrinol 2010; 163:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/8\">",
"      Hofstra RM, Landsvater RM, Ceccherini I, et al. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature 1994; 367:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/9\">",
"      Donis-Keller H, Dou S, Chi D, et al. Mutations in the RET proto-oncogene are associated with MEN 2A and FMTC. Hum Mol Genet 1993; 2:851.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/10\">",
"      Trupp, M, Arenas, E, Fainzilber, M, et al. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 1996; 381:785.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/11\">",
"      Durbec P, Marcos-Gutierrez CV, Kilkenny C, et al. GDNF signalling through the Ret receptor tyrosine kinase. Nature 1996; 381:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/12\">",
"      Kotzbauer PT, Lampe PA, Heuckeroth RO, et al. Neurturin, a relative of glial-cell-line-derived neurotrophic factor. Nature 1996; 384:467.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/13\">",
"      Treanor JJ, Goodman L, de Sauvage F, et al. Characterization of a multicomponent receptor for GDNF. Nature 1996; 382:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/14\">",
"      Hansford JR, Mulligan LM. Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis. J Med Genet 2000; 37:817.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/15\">",
"      Schuchardt A, D'Agati V, Larsson-Blomberg L, et al. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature 1994; 367:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/16\">",
"      S&aacute;nchez MP, Silos-Santiago I, Fris&eacute;n J, et al. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature 1996; 382:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/17\">",
"      Pichel JG, Shen L, Sheng HZ, et al. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature 1996; 382:73.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/18\">",
"      Moore MW, Klein RD, Fari&ntilde;as I, et al. Renal and neuronal abnormalities in mice lacking GDNF. Nature 1996; 382:76.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/19\">",
"      Eng C, Clayton D, Schuffenecker I, et al. The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis. JAMA 1996; 276:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/20\">",
"      Bolino A, Schuffenecker I, Luo Y, et al. RET mutations in exons 13 and 14 of FMTC patients. Oncogene 1995; 10:2415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/21\">",
"      Gimm O, Marsh DJ, Andrew SD, et al. Germline dinucleotide mutation in codon 883 of the RET proto-oncogene in multiple endocrine neoplasia type 2B without codon 918 mutation. J Clin Endocrinol Metab 1997; 82:3902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/22\">",
"      Santoro M, Carlomagno F, Romano A, et al. Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B. Science 1995; 267:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/23\">",
"      Raue F, Frank-Raue K. Genotype-phenotype relationship in multiple endocrine neoplasia type 2. Implications for clinical management. Hormones (Athens) 2009; 8:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/24\">",
"      Schuffenecker I, Virally-Monod M, Brohet R, et al. Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs &agrave; Calcitonine. J Clin Endocrinol Metab 1998; 83:487.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/25\">",
"      Berndt I, Reuter M, Saller B, et al. A new hot spot for mutations in the ret protooncogene causing familial medullary thyroid carcinoma and multiple endocrine neoplasia type 2A. J Clin Endocrinol Metab 1998; 83:770.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/26\">",
"      Carlson KM, Bracamontes J, Jackson CE, et al. Parent-of-origin effects in multiple endocrine neoplasia type 2B. Am J Hum Genet 1994; 55:1076.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/27\">",
"      Smith DP, Houghton C, Ponder BA. Germline mutation of RET codon 883 in two cases of de novo MEN 2B. Oncogene 1997; 15:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/28\">",
"      Jasim S, Ying AK, Waguespack SG, et al. Multiple endocrine neoplasia type 2B with a RET proto-oncogene A883F mutation displays a more indolent form of medullary thyroid carcinoma compared with a RET M918T mutation. Thyroid 2011; 21:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/29\">",
"      Miyauchi A, Futami H, Hai N, et al. Two germline missense mutations at codons 804 and 806 of the RET proto-oncogene in the same allele in a patient with multiple endocrine neoplasia type 2B without codon 918 mutation. Jpn J Cancer Res 1999; 90:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/30\">",
"      Menko FH, van der Luijt RB, de Valk IA, et al. Atypical MEN type 2B associated with two germline RET mutations on the same allele not involving codon 918. J Clin Endocrinol Metab 2002; 87:393.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/31\">",
"      Cranston AN, Carniti C, Oakhill K, et al. RET is constitutively activated by novel tandem mutations that alter the active site resulting in multiple endocrine neoplasia type 2B. Cancer Res 2006; 66:10179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/32\">",
"      Edery P, Lyonnet S, Mulligan LM, et al. Mutations of the RET proto-oncogene in Hirschsprung's disease. Nature 1994; 367:378.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/33\">",
"      Amiel J, Lyonnet S. Hirschsprung disease, associated syndromes, and genetics: a review. J Med Genet 2001; 38:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/34\">",
"      Brooks AS, Oostra BA, Hofstra RM. Studying the genetics of Hirschsprung's disease: unraveling an oligogenic disorder. Clin Genet 2005; 67:6.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/35\">",
"      Amiel J, Sproat-Emison E, Garcia-Barcelo M, et al. Hirschsprung disease, associated syndromes and genetics: a review. J Med Genet 2008; 45:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/36\">",
"      Lor&eacute; F, Di Cairano G, Talidis F. Unilateral renal agenesis in a family with medullary thyroid carcinoma. N Engl J Med 2000; 342:1218.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/37\">",
"      Romei C, Elisei R, Pinchera A, et al. Somatic mutations of the ret protooncogene in sporadic medullary thyroid carcinoma are not restricted to exon 16 and are associated with tumor recurrence. J Clin Endocrinol Metab 1996; 81:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/38\">",
"      Marsh DJ, Learoyd DL, Andrew SD, et al. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinoma. Clin Endocrinol (Oxf) 1996; 44:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/39\">",
"      Eng C, Mulligan LM. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes, related sporadic tumours, and hirschsprung disease. Hum Mutat 1997; 9:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/40\">",
"      Elisei R, Cosci B, Romei C, et al. Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study. J Clin Endocrinol Metab 2008; 93:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/41\">",
"      Dvorakova S, Vaclavikova E, Sykorova V, et al. Somatic mutations in the RET proto-oncogene in sporadic medullary thyroid carcinomas. Mol Cell Endocrinol 2008; 284:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/42\">",
"      Zedenius J. Is somatic RET mutation a prognostic factor for sporadic medullary thyroid carcinoma? Nat Clin Pract Endocrinol Metab 2008; 4:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/43\">",
"      Moura MM, Cavaco BM, Pinto AE, et al. Correlation of RET somatic mutations with clinicopathological features in sporadic medullary thyroid carcinomas. Br J Cancer 2009; 100:1777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/44\">",
"      Yip L, Cote GJ, Shapiro SE, et al. Multiple endocrine neoplasia type 2: evaluation of the genotype-phenotype relationship. Arch Surg 2003; 138:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/45\">",
"      Lips CJ, Landsvater RM, H&ouml;ppener JW, et al. Clinical screening as compared with DNA analysis in families with multiple endocrine neoplasia type 2A. N Engl J Med 1994; 331:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/46\">",
"      Moers AM, Landsvater RM, Schaap C, et al. Familial medullary thyroid carcinoma: not a distinct entity? Genotype-phenotype correlation in a large family. Am J Med 1996; 101:635.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/47\">",
"      de Groot JW, Links TP, Plukker JT, et al. RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr Rev 2006; 27:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41495/abstract/48\">",
"      Frank-Raue K, Buhr H, Dralle H, et al. Long-term outcome in 46 gene carriers of hereditary medullary thyroid carcinoma after prophylactic thyroidectomy: impact of individual RET genotype. Eur J Endocrinol 2006; 155:229.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 7869 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-D8D1174216-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41495=[""].join("\n");
var outline_f40_33_41495=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H13\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLASSIFICATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Multiple endocrine neoplasia type 2A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Multiple endocrine neoplasia type 2B",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Familial medullary thyroid cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      MOLECULAR GENETICS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H392452\">",
"      Structure and function of the normal RET proto-oncogene and its product",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H392467\">",
"      Structure and function of the mutated RET proto-oncogene and its product",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Germline mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Germline mutations in the extracellular domain",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Germline mutations in the intracellular tyrosine kinase domains",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Somatic mutations",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Genotype-phenotype correlation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Screening",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Classification",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ENDO/7869\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7869|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?31/48/32515\" title=\"figure 1\">",
"      Normal activation of RET",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?40/28/41415\" title=\"figure 2\">",
"      RET TK receptor mutations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/7/28787\" title=\"figure 3\">",
"      Effect activat mutation RET",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ENDO/7869|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/40/20108\" title=\"table 1\">",
"      MEN syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/38/620\" title=\"table 2\">",
"      MEN2 genotype timing progression",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/42/8872?source=related_link\">",
"      Approach to therapy in multiple endocrine neoplasia type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?22/16/22794?source=related_link\">",
"      Clinical manifestations and diagnosis of multiple endocrine neoplasia type 2",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?9/21/9560?source=related_link\">",
"      Medullary thyroid cancer: Clinical manifestations, diagnosis, and staging",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/23/38263?source=related_link\">",
"      Medullary thyroid cancer: Treatment and prognosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/14/43240?source=related_link\">",
"      Multiple endocrine neoplasia type 1: Clinical manifestations and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/49/17174?source=related_link\">",
"      Multiple endocrine neoplasia type 1: Definition and genetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/61/38871?source=related_link\">",
"      Multiple endocrine neoplasia type 1: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/58/16296?source=related_link\">",
"      Prenatal diagnosis of renal agenesis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_33_41496="Acute side effects of adjuvant chemotherapy for early stage breast cancer";
var content_f40_33_41496=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Acute side effects of adjuvant chemotherapy for early stage breast cancer",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/33/41496/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41496/contributors\">",
"     Charles L Shapiro, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/33/41496/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41496/contributors\">",
"     Daniel F Hayes, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/33/41496/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41496/contributors\">",
"     Don S Dizon, MD, FACP",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/33/41496/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 11, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Adjuvant chemotherapy results in an improvement in both disease-free and overall survival and is routinely administered for women with early stage breast cancer. However, treatment is associated with both acute and long-term complications for the breast cancer survivor.",
"   </p>",
"   <p>",
"    The acute complications of adjuvant chemotherapy will be reviewed here. Long-term complications and the treatment of breast cancer subsets are discussed separately. Hypersensitivity reactions and dermatologic toxicity associated with chemotherapy, including radiation recall dermatitis, are also presented elsewhere.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8202?source=see_link\">",
"       \"Patterns of relapse and long-term complications of therapy in breast cancer survivors\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?19/40/20106?source=see_link\">",
"       \"Adjuvant endocrine therapy for hormone receptor-positive breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11384?source=see_link\">",
"       \"Adjuvant medical therapy for HER2-positive breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37961?source=see_link\">",
"       \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?42/57/43930?source=see_link\">",
"       \"Infusion reactions to systemic chemotherapy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/7/36986?source=see_link\">",
"       \"Cutaneous complications of conventional chemotherapy agents\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     OVERVIEW OF THE ISSUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number, nature, and costs of severe adverse effects experienced by women receiving adjuvant chemotherapy for breast cancer are relatively unknown, but may be more common than suspected from what has been reported from clinical trials.",
"   </p>",
"   <p>",
"    This was illustrated in a series of 12,239 women aged 63 or younger with newly diagnosed breast cancer between 1998 and 2002, 4075 of whom were treated with adjuvant chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/1\">",
"     1",
"    </a>",
"    ]. Women who were treated with chemotherapy were significantly more likely to visit emergency rooms for all causes (61 versus 42 percent) and for serious adverse effects (16 versus 5 percent). For patients receiving chemotherapy, the major reasons prompting hospitalization or an emergency room visit during the year after their breast cancer diagnosis were:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Fever or infection",
"     </li>",
"     <li>",
"      Neutropenia or thrombocytopenia",
"     </li>",
"     <li>",
"      Dehydration or electrolyte disorders",
"     </li>",
"     <li>",
"      Nausea, emesis, or diarrhea",
"     </li>",
"     <li>",
"      Anemia",
"     </li>",
"     <li>",
"      Constitutional symptoms",
"     </li>",
"     <li>",
"      Deep venous thrombosis or pulmonary embolus &nbsp;",
"     </li>",
"     <li>",
"      Malnutrition",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following sections will focus on individual toxicities with the exceptions of treatment-related alopecia and venous thromboembolism. Toxicities that may arise following chemotherapy, including cardiovascular toxicity and secondary malignancies, are covered separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/12/44232?source=see_link\">",
"     \"Chemotherapy-induced alopecia\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/36/6730?source=see_link&amp;anchor=H6#H6\">",
"     \"Drug-induced thrombosis and vascular disease in patients with malignancy\", section on 'Treatment of breast cancer'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8202?source=see_link&amp;anchor=H6#H6\">",
"     \"Patterns of relapse and long-term complications of therapy in breast cancer survivors\", section on 'Long-term adverse effects of primary therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MYELOSUPPRESSION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most patients receiving combination chemotherapy experience a small to moderate reduction in the white blood cell count, 10 to 14 days after each cycle. It usually resolves prior to the next course of chemotherapy. However, if severe or prolonged, it can result in fever or life-threatening infection.",
"   </p>",
"   <p>",
"    For most regimens used in breast cancer therapy, the risk of febrile neutropenia is less than two percent. However, there are two groups of regimens associated with at least a 20 percent risk of neutropenia:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?40/59/41913?source=see_link\">",
"       Docetaxel",
"      </a>",
"      -containing regimens (both TAC and TC)",
"     </li>",
"     <li>",
"      Treatment every two weeks (ie, dose-dense, eg, ACT)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients receiving either",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    -containing regimens or dose-dense chemotherapy, and those who experienced neutropenic fever with their previously administered cycle, should receive granulocyte colony stimulating factors (G-CSF) to reduce the duration of neutropenia and the risk of neutropenic fever [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33945?source=see_link&amp;anchor=H523774212#H523774212\">",
"     \"Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia\", section on 'Primary prophylaxis'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3001?source=see_link&amp;anchor=H875811271#H875811271\">",
"     \"Prophylaxis of infection during chemotherapy-induced neutropenia in high-risk adults\", section on 'Antibacterial prophylaxis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     GASTROINTESTINAL SIDE EFFECTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H985144536\">",
"    <span class=\"h2\">",
"     Nausea and vomiting",
"    </span>",
"    &nbsp;&mdash;&nbsp;All patients receiving adjuvant chemotherapy require antiemetic therapy tailored to the risk of the specific treatment regimen [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/18/39210?source=see_link\">",
"     \"Prevention and treatment of chemotherapy-induced nausea and vomiting\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Few side effects of cancer treatment are more feared by patients than nausea and vomiting. Although significant progress has been made, chemotherapy-induced nausea and vomiting remains an important adverse effect of treatment. Of the regimens used in the adjuvant setting, regimens that contain",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    are considered highly emetogenic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556222257\">",
"    <span class=\"h2\">",
"     Mucositis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients at risk for mucositis and those who experienced mucositis with a prior cycle should receive oral cryotherapy (ice chips swished around the mouth for 30 minutes) around the time of drug administration. The use of systemic antifungal therapy (ie,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/53/32592?source=see_link\">",
"     nystatin",
"    </a>",
"    suspension or",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/12/16586?source=see_link\">",
"     fluconazole",
"    </a>",
"    ) is not recommended. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/22/38250?source=see_link\">",
"     \"Oral toxicity associated with chemotherapy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Oral mucositis is the inflammation of the buccal mucosa or soft palate. It typically begins as a burning sensation in the mouth, but as it increases in severity, it can result in ulceration with an inability to eat or drink. Fortunately, severe oral mucositis is uncommon with all adjuvant regimens. Milder symptoms are more likely with 5-fluorouracil (5-FU)",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    containing regimens (eg, CAF) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556222264\">",
"    <span class=\"h2\">",
"     Hepatotoxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormalities in liver function tests are common during adjuvant chemotherapy but are usually mild in severity. Up to 75 percent of patients receiving CAF may develop a transaminitis, which may take up to one year to normalize. No interventions are required for mild liver function abnormalities. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44074?source=see_link&amp;anchor=H55#H55\">",
"     \"Chemotherapy hepatotoxicity and dose modification in patients with liver disease\", section on 'Combination chemotherapy regimens'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556222309\">",
"    <span class=\"h2\">",
"     Weight gain",
"    </span>",
"    &nbsp;&mdash;&nbsp;Up to 96 percent of women gain weight during treatment, and this appears to be particularly problematic among premenopausal women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/7\">",
"     7",
"    </a>",
"    ]. Potential mechanisms may involve energy imbalances provoked by chemotherapy, such as poor treatment tolerance, hormonal alterations, and changes in adiposity that may induce insulin resistance [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because obesity has been associated with inferior outcomes in women treated for breast cancer, all patients receiving chemotherapy should meet with a nutritionist about diet and exercise program during and after completion of chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     NEUROTOXICITY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Taxanes such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    are associated with both a motor and sensory neuropathy that is dose and schedule-dependent and cumulative [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/6\">",
"     6",
"    </a>",
"    ]. Early recognition and subsequent treatment delay or dose reduction may alleviate or prevent the worsening of symptoms in most cases. Symptoms usually improve slowly after discontinuation of treatment (over weeks to months); if severe, recovery may be incomplete. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/32/43530?source=see_link&amp;anchor=H12#H12\">",
"     \"Neurologic complications of non-platinum cancer chemotherapy\", section on 'Taxanes'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556222188\">",
"    <span class=\"h1\">",
"     MUSCULOSKELETAL SIDE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dose-related myalgias and arthralgias are a particular problem with",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"     paclitaxel",
"    </a>",
"    ; they typically develop between 72 to 96 hours of treatment and are much less common with weekly compared to every three weekly regimens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/11\">",
"     11",
"    </a>",
"    ]. The pathophysiologic mechanism is unknown; however, accumulating evidence supports the view that this is a manifestation of acute neurotoxicity (it is referred to as paclitaxel-associated acute pain syndrome). The onset of symptoms is associated with individual doses and does not appear to be a cumulative effect [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?42/32/43530?source=see_link&amp;anchor=H14#H14\">",
"     \"Neurologic complications of non-platinum cancer chemotherapy\", section on 'Manifestations and incidence'",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    There is a paucity of data on prevention and treatment of this complication, but options for management include the use of non-steroidal anti-inflammatory drugs,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    , glutamine, and antihistamines [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     FATIGUE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Moderate to severe fatigue is a common complaint during adjuvant chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/13-15\">",
"     13-15",
"    </a>",
"    ]. Possible contributory factors include anemia, vasomotor symptoms that lead to sleep disturbance and depression [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/16\">",
"     16",
"    </a>",
"    ]. For most patients, fatigue generally resolves following the completion of treatment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/17\">",
"     17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/62/11242?source=see_link\">",
"     \"Cancer-related fatigue: Prevalence, screening and clinical assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment of fatigue during therapy should begin with an evaluation for potentially correctable etiologic factors, including anemia, pain, depression, hypoxia, or",
"    <span class=\"nowrap\">",
"     fluid/electrolyte",
"    </span>",
"    imbalances. In many cases, fatigue will not be attributable to a correctable condition, and treatment should be directed towards symptomatic relief. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27098?source=see_link\">",
"     \"Cancer-related fatigue: Treatment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556218392\">",
"    <span class=\"h2\">",
"     Anemia",
"    </span>",
"    &nbsp;&mdash;&nbsp;A common side effect of chemotherapy is myelosuppression, including the onset of anemia. Anemia can impair a patient&rsquo;s functional status, diminish physiologic reserve, and result in significant fatigue.",
"   </p>",
"   <p>",
"    While erythropoietin-stimulating agents (ESAs) are available for the treatment of anemia, their administration has been associated with increased risks for thromboembolic events and worse clinical outcomes, including survival. For women with early stage breast cancer receiving chemotherapy with curative intent, we recommend not administering ESAs. For patients with a symptomatic anemia, we recommend red blood cell transfusions to a baseline hemoglobin &ge;10",
"    <span class=\"nowrap\">",
"     mg/dL.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/15/38138?source=see_link&amp;anchor=H13#H13\">",
"     \"Role of erythropoiesis-stimulating agents in the treatment of anemia in patients with cancer\", section on 'Effect on disease control and survival'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     VASOMOTOR SYMPTOMS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vasomotor symptoms may develop because of premature cessation of ovarian function caused by the administration of adjuvant chemotherapy (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Chemotherapy-induced amenorrhea'",
"    </a>",
"    below) or the use of adjuvant hormone therapy (",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?21/49/22294?source=see_link\">",
"     anastrozole",
"    </a>",
"    , oophorectomy, gonadotropin releasing hormone agonists) in women with hormone receptor-positive tumors.",
"   </p>",
"   <p>",
"    The major clinical manifestations of vasomotor symptoms are hot flashes, sleep disturbance, headache, and irritability. The use of estrogen replacement is generally prohibited because data from randomized trials suggest that estrogen therapy may be associated with excessive risk. Therefore, we recommend the use of non-estrogen therapies for controlling symptoms before considering estrogen therapy in these women. This is consistent with guidelines from the North American Menopause Society [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/18\">",
"     18",
"    </a>",
"    ]. The risks of postmenopausal hormonal therapy in women with a prior history of breast cancer are covered separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/11/11449?source=see_link&amp;anchor=H22#H22\">",
"     \"Postmenopausal hormone therapy and the risk of breast cancer\", section on 'Personal history of breast cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Several non-estrogenic treatments such as",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?19/19/19768?source=see_link\">",
"     gabapentin",
"    </a>",
"    and the selective serotonin reuptake inhibitors (SSRIs) may provide symptomatic benefit for women with troublesome vasomotor symptoms. However, SSRIs are inhibitors of the 2D6 enzyme that is responsible for converting",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    to its active metabolite endoxifen. Whether tamoxifen is less effective in breast cancer patients receiving SSRIs is unknown, but there is clear evidence that endoxifen levels are reduced, particularly in the presence of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/50/15146?source=see_link\">",
"     paroxetine",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?14/49/15130?source=see_link\">",
"     fluoxetine",
"    </a>",
"    . Thus, these drugs should be used with caution and possibly avoided altogether in patients receiving tamoxifen. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/2/7210?source=see_link&amp;anchor=H7#H7\">",
"     \"Mechanisms of action of selective estrogen receptor modulators\", section on 'Intrinsic resistance'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to pharmacologic treatments, cognitive behavioral therapy (CBT) and exercise may alleviate the burden of vasomotor symptoms. In one trial, 422 women were randomly assigned to CBT, exercise, CBT plus exercise, or to a control group (no interventions) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/19\">",
"     19",
"    </a>",
"    ]. CBT consisted of six weekly group sessions that incorporated relaxation techniques. The exercise program was a 12 week individualized, home-based program that required 2.5 to 3 hours of activity per week. Of those who participated, 64 percent were &le;3 years out from completion of chemotherapy and 93 percent were still taking adjuvant endocrine therapy. High levels of noncompliance were reported (58, 64, and 70 percent in the CBT, exercise, and CBT plus exercise groups, respectively). When outcomes were analyzed using data from women who were compliant (n= 219), all three interventions resulted in significantly lower endocrine symptoms compared to controls at 12 weeks and 6 months. In addition, CBT with or without exercise significantly reduced the perceived burden associated with hot flashes or night sweats, which was sustained at six months. However, the frequencies of night sweats or hot flashes in the intervention groups were not significantly different compared to controls.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CHEMOTHERAPY-INDUCED AMENORRHEA",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chemotherapy-induced amenorrhea is a well-recognized side effect of cytotoxic chemotherapy. These drugs appear to have a greater effect on follicular development than on oocytes, with variable degrees of subsequent ovarian dysfunction. Some women develop complete follicular depletion and permanent ovarian failure during chemotherapy, while others may become amenorrheic during therapy, but then have subsequent return of ovarian function, menstrual cycles, and fertility, months to years after the cessation of therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556222552\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are well-recognized risk factors for chemotherapy-induced amenorrhea or ovarian failure, such as age, chemotherapy regimen, subsequent use of endocrine therapy, and genetics. These are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556219635\">",
"    <span class=\"h3\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;The risk of amenorrhea is greater in women who are over the age of 40 at the time of treatment initiation (",
"    <a class=\"graphic graphic_table graphicRef51143 \" href=\"mobipreview.htm?24/61/25563\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/20-22\">",
"     20-22",
"    </a>",
"    ]. In addition, ovarian failure is less often reversible in older women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/6,22,23\">",
"     6,22,23",
"    </a>",
"    ]. This was illustrated in a combined analysis of three trials of women (n=796) treated with adjuvant",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    -containing chemotherapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/24\">",
"     24",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Women under 39 years did not experience chemotherapy-induced amenorrhea.",
"     </li>",
"     <li>",
"      Chemotherapy-induced amenorrhea occurred in 96 percent of women age 40 to 49 years.",
"     </li>",
"     <li>",
"      Ovarian function (evidenced by resumption of menses) returned in 50 percent of women younger than 40 years, but only in 10 percent of women over 40 years.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556219856\">",
"    <span class=\"h3\">",
"     Chemotherapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;The incidence of chemotherapy induced ovarian failure differs with the type of chemotherapy regimen. In a study evaluating amenorrhea following adjuvant chemotherapy in the National Surgical Adjuvant Breast and Bowel Project (NSABP) B30 trial, the rates of prolonged amenorrhea (&ge;6 months) were lowest in the group treated with a regimen that did not contain",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    (38 percent) and highest in those receiving a cyclophosphamide-containing treatment (70 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In general, rates of both transient and prolonged amenorrhea are higher with CMF or",
"    <span class=\"nowrap\">",
"     CEF/CAF-type",
"    </span>",
"    regimens as compared to AC (",
"    <a class=\"graphic graphic_table graphicRef51143 \" href=\"mobipreview.htm?24/61/25563\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/20,21,26\">",
"     20,21,26",
"    </a>",
"    ]. Although some trials evaluating the addition of taxanes report higher rates of prolonged amenorrhea than expected with AC alone, others suggest that rates are similar or even lower [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/27-33\">",
"     27-33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1447?source=see_link\">",
"     \"Ovarian failure due to anticancer drugs and radiation\"",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    The relative intensity of the chemotherapy regimen, including higher doses, longer duration, and the use of multi-agent regimens, all confer higher rates of amenorrhea [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/34\">",
"     34",
"    </a>",
"    ]. However, the impact of dose-dense therapy on rates of amenorrhea has not been well studied. The available data come from one prospective study of FEC administered on an every 14 or 21 day basis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/35\">",
"     35",
"    </a>",
"    ]. The incidence of amenorrhea was identical in both arms (64 percent). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37961?source=see_link&amp;anchor=H32#H32\">",
"     \"Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer\", section on 'Dose density'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556219904\">",
"    <span class=\"h3\">",
"     Genetic factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inherited genetic factors may play a role in determining which women will develop chemotherapy induced amenorrhea or ovarian failure. Although not well studied, it is possible that genetic changes that have been associated with spontaneous premature menopause might also predict this complication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/36\">",
"     36",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/40/7817?source=see_link\">",
"     \"Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)\"",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"    One category of candidate genes includes those involved in drug transport and metabolism [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/37\">",
"     37",
"    </a>",
"    ]. CYP2C19 is an enzyme of the cytochrome P450 family that is involved in the metabolism of many drugs, including",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/20/9546?source=see_link\">",
"     cyclophosphamide",
"    </a>",
"    . Although prospective studies have not been carried out, individuals receiving single agent cyclophosphamide for lupus nephritis, who are homozygous or heterozygous for a CYP2C19 variant (CYP2C19*2), had a lower risk of ovarian failure (relative risk 0.10, 95% CI 0.02-0.52) after adjustment for age and total number of cyclophosphamide pulses [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/37\">",
"     37",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/32/25098?source=see_link&amp;anchor=H8#H8\">",
"     \"General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases\", section on 'Gonadal toxicity'",
"    </a>",
"    .)",
"    <br/>",
"    <br/>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556216763\">",
"    <span class=\"h2\">",
"     Consequences of chemotherapy-induced amenorrhea",
"    </span>",
"    &nbsp;&mdash;&nbsp;Women who develop chemotherapy-induced amenorrhea during or soon after treatment experience significant side effects, including the following:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556218357\">",
"    <span class=\"h3\">",
"     Menopausal symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hot flashes, vaginal dryness, dyspareunia, depression, and sleep disturbance are often reported by postmenopausal women with breast cancer and can result in disruptions in quality of life during adjuvant therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. Successful management includes careful symptom assessment, education, counseling, and behavioral or pharmacologic interventions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/39\">",
"     39",
"    </a>",
"    ]. The treatment of menopausal symptoms is similar to the treatment of vasomotor symptoms, which is discussed above. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Vasomotor symptoms'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H556219926\">",
"    <span class=\"h3\">",
"     Infertility",
"    </span>",
"    &nbsp;&mdash;&nbsp;Amenorrhea is a poor surrogate for ovarian function and should not be considered as proof of ovarian failure. In addition, the return of menstrual cycles is not a good marker of normal ovarian function [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    For women who are concerned about fertility during and after chemotherapy, testing for ovarian reserve is available. Serum measurement of anti-M&uuml;llerian hormone and inhibin B were found to correlate with chemotherapy-induced amenorrhea in a study of 127 patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/41\">",
"     41",
"    </a>",
"    ]. Because chemotherapy-induced amenorrhea is often transient and reversible (up to 24 months posttreatment), especially in younger women, sexually active women should be prescribed non-hormonal methods of birth control even if they are not menstruating because they may still ovulate and become pregnant. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5322?source=see_link&amp;anchor=H269850350#H269850350\">",
"     \"Approach to the long-term survivor of breast cancer\", section on 'Contraception after breast cancer'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Reducing the incidence of ovarian toxicity",
"    </span>",
"    &nbsp;&mdash;&nbsp;For women at risk for ovarian toxicity, administration of gonadotropin-releasing hormone (GnRH) agonists or oral contraceptives may diminish ovarian function and prevent damage to ovarian tissue. However, the efficacy of GnRH agonists to prevent ovarian toxicity remains unproven. In one prospective trial, 60 women with hormone-receptor negative breast cancer were randomly allocated to neoadjuvant chemotherapy with or without the GnRH agonist",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?9/22/9574?source=see_link\">",
"     goserelin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/42\">",
"     42",
"    </a>",
"    ]. There was no difference in the reappearance of menstruation at six months following the end of chemotherapy. More data establishing the safety of ovarian suppression in cancer patients and its long-term efficacy in preserving fertility (not just resumption of menses) are needed. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/7/38010?source=see_link&amp;anchor=H12#H12\">",
"     \"Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection\", section on 'Gonadal suppression'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The alternative approach to the use of GnRH agonists would be to choose an adjuvant chemotherapy regimen with a lower risk of ovarian failure. As an example, in the analysis of posttreatment long-term amenorrhea in the NSASBP B-30 trial described above, the lowest rates of long-term amenorrhea were in women who received",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?35/37/36440?source=see_link\">",
"     doxorubicin",
"    </a>",
"    plus",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?40/59/41913?source=see_link\">",
"     docetaxel",
"    </a>",
"    with or without",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?32/27/33208?source=see_link\">",
"     tamoxifen",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41496/abstract/25\">",
"     25",
"    </a>",
"    ]. This information might prove useful for younger women who are interested in preserving fertility. (See",
"    <a class=\"local\" href=\"#H556219856\">",
"     'Chemotherapy'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/56/12167?source=see_link\">",
"       \"Patient information: Breast cancer guide to diagnosis and treatment (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/53/25426?source=see_link\">",
"       \"Patient information: Adjuvant medical therapy for HER2-positive breast cancer (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10809655\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Adjuvant chemotherapy represents a significant advance in the management of early stage breast cancer, resulting in many lives being saved. Although the acute toxicities must be considered when assessing the relative risk benefit ratio of adjuvant chemotherapy, in general, the survival benefit gained exceeds the negative impact of side effects on quality of life (QOL) in both premenopausal and postmenopausal women. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Nausea, vomiting, stomatitis (mucositis), and bone marrow suppression are acute and reversible side effects of systemic chemotherapy. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Gastrointestinal side effects'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Myelosuppression'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Taxanes such as",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"       paclitaxel",
"      </a>",
"      are associated with both a motor and sensory neuropathy that is dose and schedule-dependent and cumulative. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Neurotoxicity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dose-related myalgias and arthralgias may develop within 72 hours of",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?16/58/17320?source=see_link\">",
"       paclitaxel",
"      </a>",
"      and are much less common with weekly compared to every three weekly schedule. (See",
"      <a class=\"local\" href=\"#H556222188\">",
"       'Musculoskeletal side effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Moderate to severe fatigue is a common complaint during adjuvant chemotherapy; contributory factors include anemia, vasomotor symptoms, and depression. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Fatigue'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Vasomotor symptoms may develop because of premature cessation of ovarian function caused by the administration of adjuvant chemotherapy or the use of adjuvant hormone therapy (see",
"      <a class=\"local\" href=\"#H12\">",
"       'Vasomotor symptoms'",
"      </a>",
"      above) in women with hormone receptor-positive tumors.",
"     </li>",
"     <li>",
"      Chemotherapy-induced amenorrhea (CIA) is a well-recognized side effect of cytotoxic chemotherapy. The frequency and duration varies according to age, the specific chemotherapy regimen, and use of endocrine therapy. The consequences of premature ovarian failure include menopausal symptoms and bone loss. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Chemotherapy-induced amenorrhea'",
"      </a>",
"      above.) &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/1\">",
"      Hassett MJ, O'Malley AJ, Pakes JR, et al. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 2006; 98:1108.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/2\">",
"      Smith TJ, Khatcheressian J, Lyman GH, et al. 2006 update of recommendations for the use of white blood cell growth factors: an evidence-based clinical practice guideline. J Clin Oncol 2006; 24:3187.",
"     </a>",
"    </li>",
"    <li>",
"     NCCN Clinical Practice Guidelines in Oncology: Myeloid Growth Factors, Version 1.2012 file://www.nccn.org/professionals/physician_gls/pdf/myeloid_growth.pdf (Accessed on May 21, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/4\">",
"      Hesketh PJ. Chemotherapy-induced nausea and vomiting. N Engl J Med 2008; 358:2482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/5\">",
"      Basch E, Prestrud AA, Hesketh PJ, et al. Antiemetics: American Society of Clinical Oncology clinical practice guideline update. J Clin Oncol 2011; 29:4189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/6\">",
"      Shapiro CL, Recht A. Side effects of adjuvant treatment of breast cancer. N Engl J Med 2001; 344:1997.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/7\">",
"      Vance V, Mourtzakis M, McCargar L, Hanning R. Weight gain in breast cancer survivors: prevalence, pattern and health consequences. Obes Rev 2011; 12:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/8\">",
"      Gad&eacute;a E, Thivat E, Planchat E, et al. Importance of metabolic changes induced by chemotherapy on prognosis of early-stage breast cancer patients: a review of potential mechanisms. Obes Rev 2012; 13:368.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/9\">",
"      Pekmezi DW, Demark-Wahnefried W. Updated evidence in support of diet and exercise interventions in cancer survivors. Acta Oncol 2011; 50:167.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/10\">",
"      Rock CL, Doyle C, Demark-Wahnefried W, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 2012; 62:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/11\">",
"      Akerley W 3rd. Paclitaxel in advanced non-small cell lung cancer : an alternative high-dose weekly schedule. Chest 2000; 117:152S.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/12\">",
"      Garrison JA, McCune JS, Livingston RB, et al. Myalgias and arthralgias associated with paclitaxel. Oncology (Williston Park) 2003; 17:271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/13\">",
"      Sadler IJ, Jacobsen PB. Progress in understanding fatigue associated with breast cancer treatment. Cancer Invest 2001; 19:723.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/14\">",
"      Berger AM. Patterns of fatigue and activity and rest during adjuvant breast cancer chemotherapy. Oncol Nurs Forum 1998; 25:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/15\">",
"      Fan HG, Hou&eacute;d&eacute;-Tchen N, Yi QL, et al. Fatigue, menopausal symptoms, and cognitive function in women after adjuvant chemotherapy for breast cancer: 1- and 2-year follow-up of a prospective controlled study. J Clin Oncol 2005; 23:8025.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/16\">",
"      Broeckel JA, Jacobsen PB, Horton J, et al. Characteristics and correlates of fatigue after adjuvant chemotherapy for breast cancer. J Clin Oncol 1998; 16:1689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/17\">",
"      Bower JE, Ganz PA, Desmond KA, et al. Fatigue in breast cancer survivors: occurrence, correlates, and impact on quality of life. J Clin Oncol 2000; 18:743.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/18\">",
"      North American Menopause Society. Estrogen and progestogen use in postmenopausal women: 2010 position statement of The North American Menopause Society. Menopause 2010; 17:242.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/19\">",
"      Duijts SF, van Beurden M, Oldenburg HS, et al. Efficacy of cognitive behavioral therapy and physical exercise in alleviating treatment-induced menopausal symptoms in patients with breast cancer: results of a randomized, controlled, multicenter trial. J Clin Oncol 2012; 30:4124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/20\">",
"      Walshe JM, Denduluri N, Swain SM. Amenorrhea in premenopausal women after adjuvant chemotherapy for breast cancer. J Clin Oncol 2006; 24:5769.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/21\">",
"      Petrek JA, Naughton MJ, Case LD, et al. Incidence, time course, and determinants of menstrual bleeding after breast cancer treatment: a prospective study. J Clin Oncol 2006; 24:1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/22\">",
"      Schmid P, Untch M, Koss&eacute; V, et al. Leuprorelin acetate every-3-months depot versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant treatment in premenopausal patients with node-positive breast cancer: the TABLE study. J Clin Oncol 2007; 25:2509.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/23\">",
"      Bernard-Marty C, Mano M, Paesmans M, et al. Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) with an anthracycline-based regimen in adjuvant treatment of node-positive breast cancer patients. Ann Oncol 2003; 14:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/24\">",
"      Hortobagyi GN, Buzdar AU, Marcus CE, Smith TL. Immediate and long-term toxicity of adjuvant chemotherapy regimens containing doxorubicin in trials at M.D. Anderson Hospital and Tumor Institute. NCI Monogr 1986; :105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/25\">",
"      Ganz PA, Land SR, Geyer CE Jr, et al. Menstrual history and quality-of-life outcomes in women with node-positive breast cancer treated with adjuvant therapy on the NSABP B-30 trial. J Clin Oncol 2011; 29:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/26\">",
"      Parulekar WR, Day AG, Ottaway JA, et al. Incidence and prognostic impact of amenorrhea during adjuvant therapy in high-risk premenopausal breast cancer: analysis of a National Cancer Institute of Canada Clinical Trials Group Study--NCIC CTG MA.5. J Clin Oncol 2005; 23:6002.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/27\">",
"      Martin M, Pienkowski T, Mackey J, et al. Adjuvant docetaxel for node-positive breast cancer. N Engl J Med 2005; 352:2302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/28\">",
"      Swain SM, Land SR, Ritter MW, et al. Amenorrhea in premenopausal women on the doxorubicin-and-cyclophosphamide-followed-by-docetaxel arm of NSABP B-30 trial. Breast Cancer Res Treat 2009; 113:315.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/29\">",
"      Tham YL, Sexton K, Weiss H, et al. The rates of chemotherapy-induced amenorrhea in patients treated with adjuvant doxorubicin and cyclophosphamide followed by a taxane. Am J Clin Oncol 2007; 30:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/30\">",
"      Abusief ME, Missmer SA, Ginsburg ES, et al. The effects of paclitaxel, dose density, and trastuzumab on treatment-related amenorrhea in premenopausal women with breast cancer. Cancer 2010; 116:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/31\">",
"      Davis AL, Klitus M, Mintzer DM. Chemotherapy-induced amenorrhea from adjuvant breast cancer treatment: the effect of the addition of taxanes. Clin Breast Cancer 2005; 6:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/32\">",
"      Fornier MN, Modi S, Panageas KS, et al. Incidence of chemotherapy-induced, long-term amenorrhea in patients with breast carcinoma age 40 years and younger after adjuvant anthracycline and taxane. Cancer 2005; 104:1575.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/33\">",
"      Berliere M, Dalenc F, Malingret N, et al. Incidence of reversible amenorrhea in women with breast cancer undergoing adjuvant anthracycline-based chemotherapy with or without docetaxel. BMC Cancer 2008; 8:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/34\">",
"      Hulvat MC, Jeruss JS. Fertility preservation options for young women with breast cancer. Curr Opin Obstet Gynecol 2011; 23:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/35\">",
"      Venturini M, Del Mastro L, Aitini E, et al. Dose-dense adjuvant chemotherapy in early breast cancer patients: results from a randomized trial. J Natl Cancer Inst 2005; 97:1724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/36\">",
"      Stearns V, Schneider B, Henry NL, et al. Breast cancer treatment and ovarian failure: risk factors and emerging genetic determinants. Nat Rev Cancer 2006; 6:886.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/37\">",
"      Takada K, Arefayene M, Desta Z, et al. Cytochrome P450 pharmacogenetics as a predictor of toxicity and clinical response to pulse cyclophosphamide in lupus nephritis. Arthritis Rheum 2004; 50:2202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/38\">",
"      Schover LR. Premature ovarian failure and its consequences: vasomotor symptoms, sexuality, and fertility. J Clin Oncol 2008; 26:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/39\">",
"      Bordeleau L, Pritchard K, Goodwin P, Loprinzi C. Therapeutic options for the management of hot flashes in breast cancer survivors: an evidence-based review. Clin Ther 2007; 29:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/40\">",
"      Su HI. Measuring ovarian function in young cancer survivors. Minerva Endocrinol 2010; 35:259.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/41\">",
"      Su HI, Sammel MD, Green J, et al. Antimullerian hormone and inhibin B are hormone measures of ovarian function in late reproductive-aged breast cancer survivors. Cancer 2010; 116:592.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41496/abstract/42\">",
"      Gerber B, von Minckwitz G, Stehle H, et al. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol 2011; 29:2334.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 745 Version 21.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-118.195.65.248-E01451B0F0-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41496=[""].join("\n");
var outline_f40_33_41496=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10809655\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      OVERVIEW OF THE ISSUE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MYELOSUPPRESSION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      GASTROINTESTINAL SIDE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H985144536\">",
"      Nausea and vomiting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H556222257\">",
"      Mucositis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H556222264\">",
"      Hepatotoxicity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H556222309\">",
"      Weight gain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      NEUROTOXICITY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H556222188\">",
"      MUSCULOSKELETAL SIDE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      FATIGUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H556218392\">",
"      Anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      VASOMOTOR SYMPTOMS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CHEMOTHERAPY-INDUCED AMENORRHEA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H556222552\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H556219635\">",
"      - Age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H556219856\">",
"      - Chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H556219904\">",
"      - Genetic factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H556216763\">",
"      Consequences of chemotherapy-induced amenorrhea",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H556218357\">",
"      - Menopausal symptoms",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H556219926\">",
"      - Infertility",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Reducing the incidence of ovarian toxicity",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10809655\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/745\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/745|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?24/61/25563\" title=\"table 1\">",
"      Chemotherapy induced amenorrhea by age and specific regimen",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/4/37961?source=related_link\">",
"      Adjuvant chemotherapy for hormone receptor-positive or negative, HER2-negative breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/40/20106?source=related_link\">",
"      Adjuvant endocrine therapy for hormone receptor-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/7/11384?source=related_link\">",
"      Adjuvant medical therapy for HER2-positive breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/12/5322?source=related_link\">",
"      Approach to the long-term survivor of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/62/11242?source=related_link\">",
"      Cancer-related fatigue: Prevalence, screening and clinical assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/29/27098?source=related_link\">",
"      Cancer-related fatigue: Treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/2/44074?source=related_link\">",
"      Chemotherapy hepatotoxicity and dose modification in patients with liver disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/12/44232?source=related_link\">",
"      Chemotherapy-induced alopecia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/7/36986?source=related_link\">",
"      Cutaneous complications of conventional chemotherapy agents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/36/6730?source=related_link\">",
"      Drug-induced thrombosis and vascular disease in patients with malignancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/7/38010?source=related_link\">",
"      Fertility preservation in patients undergoing gonadotoxic treatment or gonadal resection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/32/25098?source=related_link\">",
"      General toxicity of cyclophosphamide and chlorambucil in inflammatory diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/57/43930?source=related_link\">",
"      Infusion reactions to systemic chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/2/7210?source=related_link\">",
"      Mechanisms of action of selective estrogen receptor modulators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?42/32/43530?source=related_link\">",
"      Neurologic complications of non-platinum cancer chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/22/38250?source=related_link\">",
"      Oral toxicity associated with chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/26/1447?source=related_link\">",
"      Ovarian failure due to anticancer drugs and radiation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/40/7817?source=related_link\">",
"      Pathogenesis and causes of spontaneous primary ovarian insufficiency (premature ovarian failure)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?24/53/25426?source=related_link\">",
"      Patient information: Adjuvant medical therapy for HER2-positive breast cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?11/56/12167?source=related_link\">",
"      Patient information: Breast cancer guide to diagnosis and treatment (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/0/8202?source=related_link\">",
"      Patterns of relapse and long-term complications of therapy in breast cancer survivors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/11/11449?source=related_link\">",
"      Postmenopausal hormone therapy and the risk of breast cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/18/39210?source=related_link\">",
"      Prevention and treatment of chemotherapy-induced nausea and vomiting",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/59/3001?source=related_link\">",
"      Prophylaxis of infection during chemotherapy-induced neutropenia in high-risk adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/15/38138?source=related_link\">",
"      Role of erythropoiesis-stimulating agents in the treatment of anemia in patients with cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33945?source=related_link\">",
"      Use of granulocyte colony stimulating factors in patients with chemotherapy-induced neutropenia",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_33_41497="Management of smoking cessation in adolescents";
var content_f40_33_41497=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of smoking cessation in adolescents",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/33/41497/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41497/contributors\">",
"     Joseph B Rosen, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41497/contributors\">",
"     Marianna Sockrider, MD, DrPH",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/33/41497/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41497/contributors\">",
"     George B Mallory, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41497/contributors\">",
"     Amy B Middleman, MD, MPH, MS Ed",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?40/33/41497/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?40/33/41497/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?40/33/41497/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 14, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Long-term tobacco smoking can have adverse effects in nearly every organ of the body and cause a variety of diseases. In the United States, the adverse health effects from cigarette smoking account for more than 400,000 deaths among adults, or nearly one of every five deaths; more deaths are caused each year by tobacco use than by all deaths from human immunodeficiency virus (HIV), illegal drug use, alcohol use, motor vehicle injuries, suicides, and murders combined [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Cancer was among the first diseases causally linked to smoking. Smoking causes cancers of the bladder, oral cavity, pharynx, larynx, esophagus, cervix, kidney, lung, pancreas, and stomach, and acute myeloid leukemia (",
"    <a class=\"graphic graphic_table graphicRef57169 \" href=\"mobipreview.htm?0/41/668\">",
"     table 1",
"    </a>",
"    ). Smoking causes about 90 percent of lung cancer deaths in men and almost 80 percent of lung cancer deaths in women [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/1\">",
"     1",
"    </a>",
"    ]. The epidemiology of smoking and the benefits of smoking cessation in adults are discussed in separate topic reviews. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/34997?source=see_link\">",
"     \"Patterns of tobacco use\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12298?source=see_link\">",
"     \"Cigarette smoking and other risk factors for lung cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of tobacco smoking among adolescents in the United States has gradually declined since the late 1990s. In 2011, 23 percent of 12th grade students reported smoking in the past 30 days, as compared with 37 percent in 1997 (",
"    <a class=\"graphic graphic_figure graphicRef79503 \" href=\"mobipreview.htm?18/63/19454\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Regional variations, prevalence and trends in smoking among adolescents are discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/13/37081?source=see_link\">",
"     \"Prevention of smoking initiation in children and adolescents\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Smoking cessation is particularly important in the adolescent population, because intervention at this time may prevent nicotine dependence and severe health consequences later in life. Smoking in adulthood is closely associated with smoking during adolescence: 90 percent of adult smokers smoked their first cigarette before the age of 18 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Smoking among adolescents is often clustered with other risk behaviors, including use of alcohol or drugs, earlier initiation of sexual activity, and unhealthy dieting techniques [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/5-8\">",
"     5-8",
"    </a>",
"    ]. These associated behaviors pose additional health risks and may impede smoking cessation, so it is important that providers examine health behaviors in multiple domains, in concert with efforts to support smoking cessation. (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Smoking cessation in the setting of other risky behaviors'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/35/19000?source=see_link\">",
"     \"Guidelines for adolescent preventive services\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Motivation to quit smoking, as well as methods to help adolescent patients stop smoking, including smoking bans, adolescent smoking cessation programs, and pharmacological interventions are reviewed here.",
"   </p>",
"   <p>",
"    Behavioral and pharmacological interventions to support smoking cessation in adults are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/38/12904?source=see_link\">",
"     \"Smoking cessation counseling strategies in primary care\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/3/23609?source=see_link\">",
"     \"Overview of smoking cessation management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATTERNS OF SMOKING CESSATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A minority of adolescent smokers quit without intervention. In a national survey in the United States, 12.2 percent of adolescents who had ever smoked daily and tried to quit smoking were successful (defined as not smoking during the 30 days prior to the survey) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In most populations, the overall prevalence of smoking increases from early to late adolescence, and is fairly stable thereafter, with approximately equal numbers of individuals initiating smoking and quitting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/10\">",
"     10",
"    </a>",
"    ]. As an example, a study prospectively followed regular and occasional smokers in Finland from early adolescence until age 28 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/11\">",
"     11",
"    </a>",
"    ]. By age 21, 22 percent of daily smokers and 35 percent of occasional smokers had ceased smoking. This yields an annual quitting rate of 4.1 percent between ages 15 and 21. By the age of 28, 26 percent of those who were daily smokers and 46 percent of those who were occasional smokers at age 15 years had quit. The cessation rate was higher among those who were female, married, employed,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    white collar workers.",
"   </p>",
"   <p>",
"    However, this overall pattern is made up of several groups with independent trajectories (",
"    <a class=\"graphic graphic_figure graphicRef56174 \" href=\"mobipreview.htm?12/42/12975\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/10\">",
"     10",
"    </a>",
"    ]. The risk factors for those who remained stable high smokers (alcohol use, deviance from rules, peer smoking, and drug use) are remarkably similar to those who quit or remained stable light smokers after adolescence. Moreover, a distinct group initiates smoking during early adulthood (\"late escalators\"), and these individuals tend to have few of the risk factors that are associated with initiating smoking earlier in adolescence. A possible exception is that novice smokers who escalate rapidly during early adolescence are particularly likely to remain heavy smokers; it has been suggested that this pattern is a marker for nicotine dependence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/12\">",
"     12",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Nicotine dependence'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Thus, clinical risk factors do not reliably identify individual adolescent smokers who are most likely to quit independently, suggesting that intervention to support smoking cessation is appropriate for all adolescents who smoke, regardless of smoking frequency.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     READINESS TO QUIT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most adolescent smokers report that they want to quit smoking. In a study of adolescents caught smoking at school, 71 percent reported that they had attempted to quit in the last year, and two thirds intended to quit in the next six months [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/13\">",
"     13",
"    </a>",
"    ]. Similar rates of attempts to quit smoking were found in a national survey study in the United States [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, the majority of adolescents who smoke are interested in quitting, suggesting readiness for intervention.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     ESTABLISHED INTERVENTIONS FOR ADULTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among adults, the long-term success rate of an unaided quit attempt is less than 7 percent, whereas the likelihood of success can be increased as much as four-fold with optimal treatment. A variety of studies and meta-analyses have established that both psychosocial counseling and pharmacotherapy are effective, and that combinations of the two methods achieve the best results. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/3/23609?source=see_link\">",
"     \"Overview of smoking cessation management in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is considerably less information about the outcomes of related interventions in adolescent smokers, but existing data support the use of similar approaches, as discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     FOSTERING MOTIVATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Understanding the adolescent's motivations provides an important basis for an effective counseling interaction. Exploring the individual's incentives to smoke or to quit is the first step in effective problem solving. Some of the most common motivations that prompt adolescents to smoke or to want to quit are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Incentives to quit",
"    </span>",
"    &nbsp;&mdash;&nbsp;In surveys of adolescents who smoke, concerns about future and current health, as well as physical appearance, cost of cigarettes, and athletic performance are the most common reasons given for making an attempt to quit smoking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/14,15\">",
"     14,15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Adverse health effects",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among adolescents who are considering quitting, the long term adverse health consequences are the most important motivating factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]. As an example, in a survey of adolescents who smoked, 75 percent said that future health was a motivation for quitting smoking, and 35 percent identified this concern as the most motivating factor [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/15\">",
"     15",
"    </a>",
"    ]. Most of the respondents were older adolescents (average age 16 years); the frequency of this concern did not vary by age or gender. This may not be as strong a factor for those who are not already considering quitting.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Monetary costs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many adolescents cite the cost of cigarettes as a reason to quit. The cost of regular smoking is considerable. In 2010, the average cost of a pack of cigarettes in the United States was $4.80, and was as high as $11.90 in some states [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/16\">",
"     16",
"    </a>",
"    ]. Thus, the cost of buying one pack of cigarettes daily averages $1750 per year and can be as high as $4300 per year. Legislative and regulatory strategies that raise prices on tobacco products are effective in reducing smoking initiation and consumption levels, especially among youth and young adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Helping an adolescent calculate the costs of regular smoking may be motivating as they consider the current and future costs of their habit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/15\">",
"     15",
"    </a>",
"    ]. Adolescents may derive more motivation to quit if they realize this money could be put towards music, movies, clothes, or even a car.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Athletic performance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Concerns about athletic performance are commonly cited as reasons for attempting to quit. In one study, this was cited as the most important motivator by 16 percent of participants, and was only slightly more common among boys than girls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Adolescents involved in sports may not be aware of the effects of smoking on current lung function and performance. A discussion of their goals for athletic performance and how smoking may limit their achievements in the future may boost their motivation to quit.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Barriers to quitting",
"    </span>",
"    &nbsp;&mdash;&nbsp;A variety of physiologic and psychosocial forces may impede smoking cessation in adolescents, including nicotine dependence, efforts to boost social standing among peers, or assertion of independence from parents or authority figures. Eliciting the adolescent's own reasons for starting or continuing smoking in a nonjudgmental way promotes insight and can help formulate a quitting strategy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Nicotine dependence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nicotine dependence is characterized by tolerance to nicotine, and psychobehavioral symptoms that are triggered by nicotine withdrawal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/18\">",
"     18",
"    </a>",
"    ]. These include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Craving for cigarettes",
"     </li>",
"     <li>",
"      Dysphoria or depressed mood",
"     </li>",
"     <li>",
"      Sleep disturbances",
"     </li>",
"     <li>",
"      Irritability and anger",
"     </li>",
"     <li>",
"      Anxiety",
"     </li>",
"     <li>",
"      Difficulty concentrating",
"     </li>",
"     <li>",
"      Restlessness",
"     </li>",
"     <li>",
"      Increased appetite",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Youth are particularly vulnerable to becoming dependent on nicotine, as compared to adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/17\">",
"     17",
"    </a>",
"    ]. Nicotine dependence can develop after as few as 100 cigarettes. The first symptoms of nicotine dependence can appear within days to weeks of the onset of occasional cigarette use, and often appear before the onset of daily smoking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/19\">",
"     19",
"    </a>",
"    ]. With increasing nicotine exposure, smokers progress through a sequence of symptoms of addiction, characterized by &ldquo;wanting,&rdquo; then &ldquo;craving,&rdquo; then &ldquo;needing&rdquo; tobacco [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/20\">",
"     20",
"    </a>",
"    ]. Adolescents who report early emergence of symptoms of nicotine dependence are significantly more likely to be smokers two years later, as compared to those who do not report early symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/21\">",
"     21",
"    </a>",
"    ]. &nbsp;",
"   </p>",
"   <p>",
"    The likelihood of nicotine dependence increases with the quantity and duration of smoking: smokers who smoke more than 10 cigarettes per day report greater severity of withdrawal symptoms. One study found that 66 percent of adolescents who smoked daily for the past two to six months displayed symptoms of nicotine dependence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/22\">",
"     22",
"    </a>",
"    ]. Genetic factors also may influence an individual&rsquo;s predisposition to become dependent on nicotine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/17,23\">",
"     17,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a survey of adolescent smokers, about 20 percent of adolescents were substantially dependent on nicotine, as assessed by a modified Fagerstrom Tolerance Questionnaire (a survey tool to measure symptoms of nicotine dependence), and 42 percent had moderate dependence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/24\">",
"     24",
"    </a>",
"    ]. Those with greater evidence of nicotine dependence were less likely to be successful with a quit attempt. Thus, nicotine dependence and nicotine withdrawal can interfere with an adolescent's success in quitting smoking, suggesting a potential role for nicotine replacement therapy in the treatment of tobacco use and dependence among adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H26\">",
"     'Nicotine replacement'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Weight control",
"    </span>",
"    &nbsp;&mdash;&nbsp;Many teens view smoking as a means of weight control. These concerns may be particularly relevant because of the increasing prevalence of obesity in youth.",
"   </p>",
"   <p>",
"    Contemplation of and experimentation with smoking have been found to be related to weight concerns [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/26\">",
"     26",
"    </a>",
"    ]. A survey found that girls in sixth and seventh grade who reported dieting up to one time per week were almost twice as likely to be smokers as girls who had not dieted [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/27\">",
"     27",
"    </a>",
"    ]. The odds ratio increased to 3.9 for girls who dieted more than once per week. They did not find such a relationship for boys.",
"   </p>",
"   <p>",
"    Among adults, smoking cessation is associated with a long-term average weight gain of about 7 kg [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/28\">",
"     28",
"    </a>",
"    ]. Weight patterns after smoking cessation in adolescents are not well characterized, but the 2012 Surgeon General&rsquo;s report concludes that there is no evidence that young smokers weigh less or lose weight because of their smoking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    If concerns about weight gain present a barrier to smoking cessation, the clinician should offer advice about other ways to control weight, such as limiting high calorie foods and sodas, and increasing physical activity. Other strategies include identifying oral cravings and substituting them with healthy snacks, and finding new activities to occupy the hands after cessation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/29\">",
"     29",
"    </a>",
"    ]. Although there is little evidence that these strategies attenuate weight gain in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/28\">",
"     28",
"    </a>",
"    ], they have not been studied in adolescents. Adolescent patients who are motivated to quit smoking by an interest in improving athletic performance may be particularly willing to increase their physical activity. A separate topic review discusses eating habits and misconceptions that are commonly seen in adolescents, and counseling strategies to address these. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?16/24/16778?source=see_link\">",
"     \"Adolescent eating habits\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Depression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Depressed adolescents are significantly more likely to start smoking than those without depression. Symptoms of depression and anxiety increase the likelihood of smoking initiation during adolescence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/10,30\">",
"     10,30",
"    </a>",
"    ]. Therefore, treatment of depression may facilitate smoking cessation in this population. Although",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?38/11/39096?source=see_link\">",
"     bupropion",
"    </a>",
"    , an antidepressant, has been shown to assist with smoking cessation in adults, there is minimal data on the use of bupropion for smoking cessation in adolescents, so decisions about antidepressants should be based on considerations of efficacy and safety for depression rather than for smoking cessation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/52/30538?source=see_link\">",
"     \"Psychopharmacological treatment for adolescent depression\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/3/23609?source=see_link\">",
"     \"Overview of smoking cessation management in adults\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H29\">",
"     'Other drugs'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/13/17626?source=see_link&amp;anchor=H13311180#H13311180\">",
"     \"Pharmacotherapy for smoking cessation in adults\", section on 'Bupropion'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Stress and coping behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;Compared to adolescent smokers who had quit, current adolescent smokers have greater levels of perceived stress, and are less likely to use cognitive coping methods [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/31\">",
"     31",
"    </a>",
"    ]. Therefore, it may be helpful to incorporate stress reduction techniques and training in problem solving skills into interventions to support cessation efforts. Recreational physical activity is associated with higher success rates of smoking cessation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/11\">",
"     11",
"    </a>",
"    ]. It is not clear if this effect is related to stress reduction, positive social influences, or other motivators [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     OTHER INFLUENCES ON SMOKING BEHAVIOR",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Peer/social influences",
"    </span>",
"    &nbsp;&mdash;&nbsp;Peer habits have a powerful influence on smoking initiation and cessation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/17\">",
"     17",
"    </a>",
"    ]. In a report of teens caught smoking at school, half reported that all five of their five best friends smoked, and most were daily smokers [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/13\">",
"     13",
"    </a>",
"    ]. Among individuals who started smoking by age 15 years, only 20 percent had quit by age 28 if their best friend was a smoker, whereas 52 percent had quit if their best friend was not a smoker [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The cross-sectional studies cited above could be explained by self-selection of friends with like habits, rather than causation. However, longitudinal studies suggest that peer smoking has a causal influence on smoking initiation and cessation. In a study of youth who smoked occasionally but not daily in eighth grade, progression to daily smoking was predicted by their parents' and peers' smoking habits [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/32\">",
"     32",
"    </a>",
"    ]. Furthermore, smoking among parents was the most important influence on smoking initiation in younger adolescents, but smoking among peers became the more important influence in older adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Peers are often willing to support smoking cessation, particularly if they are a nonsmoker themselves. In a survey of college students, 54 percent reported that they \"definitely would\" be interested in helping an acquaintance quit smoking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/34\">",
"     34",
"    </a>",
"    ]. Characteristics significantly associated with willingness to help included being a nontobacco user, and whether they had a close relationship with the smoker (a boyfriend, girlfriend, or spouse). Similar degrees of altruism might not be expected in a sample of younger smokers.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Parental smoking and cessation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Parental smoking has a large influence on adolescent smoking. Children whose parents smoke are more likely to smoke, particularly if both parents smoke.",
"   </p>",
"   <p>",
"    Conversely, smoking cessation efforts by parents can have an impact on their children's efforts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/35\">",
"     35",
"    </a>",
"    ]. In one study, adolescents whose parents quit smoking were almost one-third less likely to smoke than those whose parents still smoked [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/36\">",
"     36",
"    </a>",
"    ]. The earlier in the child's life the parent quits, the less likely their children will become smokers. Furthermore, adolescents whose parents quit smoking were twice as likely to quit themselves, compared with those whose parents continued to smoke.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Smoking bans",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several studies have shown that household or workplace smoking bans are associated with reduced rates of smoking among adolescents [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/17,37-39\">",
"     17,37-39",
"    </a>",
"    ]. Household smoking bans can be helpful even when parents are smokers. However, a no-smoking ban must be strictly enforced in order to be effective [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h1\">",
"     INTERVENTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a growing number of studies examining methods to promote and support adolescent smoking cessation. Some programs are school based, while others have been offered in community. Health care providers can provide support in quitting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/40\">",
"     40",
"    </a>",
"    ] through direct counseling,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    by directing patients to cessation programs or to self-help resources [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/13,41-45\">",
"     13,41-45",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One report used a survey to collect suggestions from smoking and nonsmoking teens for smoking cessation support [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/46\">",
"     46",
"    </a>",
"    ]: Sixty percent of the teens surveyed supported having a friend as a quitting partner. Peer educators were considered a preferred source of information. Twenty-eight percent thought that medication would make quitting easier. Forty-two percent of nonsmoking respondents thought that seeing pictures of diseases causes by smoking would help encourage cessation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Health care provider interventions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pediatricians and other pediatric health care providers have an important role to play in helping teens with smoking cessation. Given the importance of adverse health effects teens cite in considering cessation, advice from a medical professional may be particularly effective. However, surveys in the United States suggest that only 30 to 50 percent of adolescent smokers are identified and counseled during visits to a physician [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/43,47-49\">",
"     43,47-49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is important to talk with adolescents alone and explicitly outline a policy regarding confidentiality, including the issues that will be kept confidential and in which confidentiality is conditional. The provider can talk with the adolescent about how to share such information with their parents, if appropriate, and be available to assist if needed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/47\">",
"     47",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/2/10281?source=see_link\">",
"     \"Confidentiality in adolescent health care\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Efforts at smoking cessation counseling can be successful in the medical care setting. According to a meta-analysis of counseling interventions in pediatric primary care settings, counseling doubles long-term abstinence rates as compared with no treatment, although overall abstinence rates with or without treatment are low [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/49\">",
"     49",
"    </a>",
"    ]. A variety of techniques were used successfully, ranging from one session of individual counseling with follow-up phone calls, to six or eight sessions in a group format [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/49\">",
"     49",
"    </a>",
"    ], or brief clinician counseling with a computer-based tobacco intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/41\">",
"     41",
"    </a>",
"    ]. &nbsp;There were too few studies to allow comparison of the efficacy of different counseling techniques.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Six A's",
"    </span>",
"    &nbsp;&mdash;&nbsp;Health care providers should screen for health risk behaviors, including tobacco use, at every opportunity. A simple five-step algorithm called the 5 A's has been developed to guide clinician counseling about smoking cessation. This system encourages clinicians to",
"    <strong>",
"     ask",
"    </strong>",
"    patients about their smoking status,",
"    <strong>",
"     advise",
"    </strong>",
"    smokers to quit,",
"    <strong>",
"     assess",
"    </strong>",
"    their readiness to quit,",
"    <strong>",
"     assist",
"    </strong>",
"    them with their smoking cessation effort, and to",
"    <strong>",
"     arrange",
"    </strong>",
"    for follow-up visits or contact. Assistance includes helping the patient develop a quit plan, providing practical advice to avoid relapse, and follow up counseling",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    referrals to support the patient during the quit attempt (",
"    <a class=\"graphic graphic_table graphicRef72703 \" href=\"mobipreview.htm?42/37/43612\">",
"     table 2",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?12/38/12904?source=see_link\">",
"     \"Smoking cessation counseling strategies in primary care\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For pediatric patients a sixth A is added, encouraging clinicians to",
"    <strong>",
"     anticipate",
"    </strong>",
"    the risk of tobacco use by inquiring about parental smoking and discussing the possibility of smoking initiation in pre-adolescent and adolescent children (",
"    <a class=\"graphic graphic_table graphicRef67479 \" href=\"mobipreview.htm?2/43/2749\">",
"     table 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/50,51\">",
"     50,51",
"    </a>",
"    ]. Clinicians should begin this anticipatory guidance during pediatric visits in mid-childhood.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h3\">",
"     Stages of change",
"    </span>",
"    &nbsp;&mdash;&nbsp;Health care providers can be more effective by tailoring counseling to the adolescent's concerns and levels of readiness to quit smoking. The Transtheoretical Model of Change is a theoretical construct used to describe readiness for behavior change, and has been applied to smoking cessation in both adults and teens [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/52\">",
"     52",
"    </a>",
"    ]. According to this model, smokers can be classified into one of four stages of smoking cessation:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Precontemplation (not intending to quit in the foreseeable future)",
"     </li>",
"     <li>",
"      Contemplation (intending to quit in the foreseeable future)",
"     </li>",
"     <li>",
"      Preparation (intending to quit in the immediate future)",
"     </li>",
"     <li>",
"      Recent Action (cessation of smoking)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Using this model, an individual's stage of change is identified, and then counseling focuses on processes most likely to move him or her forward toward quitting. As an example, individuals in the precontemplation stage need messages to increase ambivalence about smoking and motivate them to consider quitting by shifting the",
"    <span class=\"nowrap\">",
"     pro/con",
"    </span>",
"    balance. Those in the contemplation stage need messages to build confidence and a commitment to quit. Those in preparation need to set a quit date and discuss the actions that will be required to quit and to problem-solve about barriers to quitting. Lastly, those in Recent Action need to focus on maintenance of cessation and avoidance of relapse [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/52,53\">",
"     52,53",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Adolescent smoking cessation programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are few reports describing techniques and outcomes for smoking cessation interventions in adolescents. Successful programs emphasize immediate negative health and other consequences of tobacco use, and provide instruction in coping strategies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/44\">",
"     44",
"    </a>",
"    ]. A meta-analysis of 48 controlled smoking cessation studies in adolescents, most of which were in group format, found modest effects of smoking cessation programs overall [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/54\">",
"     54",
"    </a>",
"    ]. Programs gave adolescent smokers a 2.9 percent (95% CI 1.47-4.35) advantage in quitting, increasing the probability of cessation by 46 percent as compared to a control condition [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/54\">",
"     54",
"    </a>",
"    ]. The treatment effect was seen in programs with five or more sessions, and generally continued after the end of the program, although only a few studies included follow-up data for 12 months or more.",
"   </p>",
"   <p>",
"    Efforts to reach teens who smoke in the school setting have had mixed results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/17\">",
"     17",
"    </a>",
"    ]. Programs have been offered on a voluntary basis as well as an alternative to suspension for teens caught violating school no smoking policies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One example is an educational program, the Tobacco Education Group (TEG): Intervening with Teen Tobacco Users, which is designed for adolescent smokers who were not yet thinking about quitting. The same company produced an adolescent cessation program, the Tobacco Awareness Program (TAP): Helping Teens Stop Using Tobacco, which is intended for adolescents who want to quit. Studies have shown that both programs significantly reduced tobacco use among intervention groups compared to a control group of adolescent smokers not assigned to programs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/45\">",
"     45",
"    </a>",
"    ]. The quit rate of voluntary participants in the program was 15 percent (using the conservative assumption that program drop-outs were still smoking); self-reported tobacco use was validated biochemically.",
"   </p>",
"   <p>",
"    Not On Tobacco (N-O-T) is another smoking cessation program for adolescents, and is sponsored by the American Lung Association [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/55-58\">",
"     55-58",
"    </a>",
"    ]. N-O-T uses a gender-sensitive, 10-session curriculum that includes booster sessions. The sessions are facilitated in schools and other community settings by teachers, school nurses, counselors, and other staff and volunteers specially trained by the American Lung Association. The program is designed as a voluntary, non-punitive program for teens. An Alternative-to-Suspension program is also included to address student violation of a school tobacco policy.",
"   </p>",
"   <p>",
"    Outcomes studies of N-O-T suggest that the program has modest effects on smoking cessation rates, but the analysis is hampered by high program attrition rates. One study reported a quit rate of 21 percent five months after completion of the program, as compared with 13 percent in a control group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/56\">",
"     56",
"    </a>",
"    ]. However, this was based on a liberal definition of quitting (not smoking in the previous 24 hours and breath CO levels &lt;9 ppm), and fewer than half of the participants were available for follow-up (the results were imputed by assuming equal quit rates in study dropouts). In two other studies, quit rates among program participants were higher than controls at the end of the program, but not 6 or 12 months later [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/57,58\">",
"     57,58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A different school-based clinic tobacco use cessation program, known as Project EX, reported that 17 percent of adolescent smokers had not smoked for at least the previous 30 days at the three month follow-up point, compared to 8 percent of controls [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/43\">",
"     43",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Web-based and self-help programs",
"    </span>",
"    &nbsp;&mdash;&nbsp;Smoking cessation websites can be helpful to an adolescent who is motivated to quit smoking. However, many teens do not discover these programs spontaneously. A telephone survey of 418 adolescents, age 14 to 19 years, found that 87 percent of adolescent smokers reported a desire to quit smoking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/42\">",
"     42",
"    </a>",
"    ]. One in four had visited a website for cessation assistance.",
"   </p>",
"   <p>",
"    Adolescent and adult smokers can access free proactive telephone counseling or referrals to local services throughout the United States by calling a toll-free number (1-800-QUITNOW). Specialized materials are available for adolescents.",
"   </p>",
"   <p>",
"    Many websites are available to help adolescents stop smoking, including the following [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/59-61\">",
"     59-61",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      <a class=\"external\" href=\"file://1800quitnow.cancer.gov/\">",
"       1800quitnow.cancer.gov/",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.youngwomenshealth.org/smokeinfo.html\">",
"       www.youngwomenshealth.org/smokeinfo.html",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.notobacco.org/\">",
"       www.notobacco.org/",
"      </a>",
"     </li>",
"     <li>",
"      <a class=\"external\" href=\"file://www.tobaccofree.org/children.htm\">",
"       www.tobaccofree.org/children.htm",
"      </a>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PHARMACOTHERAPY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of pharmacotherapies are available to assist with smoking cessation. In adults, combination therapy with behavioral support and pharmacotherapy is generally recommended for smoking cessation, although observational studies have suggested that nicotine replacement therapy may not reduce relapse rates. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?23/3/23609?source=see_link\">",
"     \"Overview of smoking cessation management in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/13/17626?source=see_link\">",
"     \"Pharmacotherapy for smoking cessation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In the adolescent age group, the efficacy and safety of pharmacologic intervention for smoking cessation is less well established. Some authorities suggest behavioral support (counseling) alone for this age group [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/49\">",
"     49",
"    </a>",
"    ]. However, given information regarding early nicotine dependence, the authors along with many other experts believe that there is a sound rationale for using such medications in selected adolescents.",
"   </p>",
"   <p>",
"    In our practice, we suggest nicotine replacement therapy to support smoking cessation for adolescents with symptoms of nicotine dependence, given in combination with behavioral support. Further study is required to determine optimal patient selection and potential risks and benefits of pharmacotherapy in this age group.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Nicotine replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;The mainstays of smoking cessation pharmacotherapy are nicotine replacement products (",
"    <a class=\"graphic graphic_table graphicRef75949 \" href=\"mobipreview.htm?9/63/10238\">",
"     table 4",
"    </a>",
"    ). Nicotine replacement can be provided by several different routes of administration. In the United States, three products are sold without prescription to adults (patch, lozenge, and gum). The other two (nasal spray and oral inhaler) are available by prescription only. The use and pharmacokinetics of these products in adults are described separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/13/17626?source=see_link&amp;anchor=H13311131#H13311131\">",
"     \"Pharmacotherapy for smoking cessation in adults\", section on 'Nicotine replacement therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Clinicians should inquire whether the patient has used nicotine replacement products. If the clinician determines that they are likely to be helpful to the patient (ie, because of symptoms of tobacco dependence), the clinician should provide guidance regarding appropriate use of the product and alternative forms of nicotine replacement therapy, such as gum [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/62\">",
"     62",
"    </a>",
"    ]. The dose of NRT is titrated as needed to overcome the symptoms of nicotine withdrawal.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Nicotine patch or gum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nicotine patch therapy has been shown to be safe in adolescent smokers. Based on limited data, nicotine patches may be somewhat less effective in adolescents than in adults. Nonetheless, the treatment can be useful to provide relief of acute withdrawal symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/63\">",
"     63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study of 120 adolescents who smoked daily, nicotine patch therapy significantly improved quitting rates when given in combination with a cognitive-behavioral intervention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/64\">",
"     64",
"    </a>",
"    ]. Eighteen percent of participants treated with the patch for 12 weeks were abstinent three months after treatment cessation, as compared with 2 percent of those treated with the behavioral intervention and placebo. By contrast, in another study of 101 adolescents who smoked daily, nicotine patch therapy was not effective when combined with minimal behavioral counseling [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/65\">",
"     65",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the United States, a prescription is required to allow patients under 18 years to purchase nicotine patches or gum, but these products are available without prescription for adults. One study showed somewhat higher compliance with patch therapy than with gum, but this varies with patient preference [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The proper use of nicotine patches or gum is described in a separate topic review. Similar guidance can be given to adolescent smokers; lower starting doses are advised for smaller patients (those who weigh less than 45 kg) or those who smoke less than",
"    <span class=\"nowrap\">",
"     1/2",
"    </span>",
"    pack a day (",
"    <a class=\"graphic graphic_table graphicRef75949 \" href=\"mobipreview.htm?9/63/10238\">",
"     table 4",
"    </a>",
"    ). Users of gum should be reminded to \"chew and park\" the gum, rather than chew continuously, for maximum benefit. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/13/17626?source=see_link&amp;anchor=H13311131#H13311131\">",
"     \"Pharmacotherapy for smoking cessation in adults\", section on 'Nicotine replacement therapy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h3\">",
"     Nicotine nasal spray",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nicotine nasal spray does not appear to be well tolerated by adolescents. In a randomized open-label trial in 40 adolescent smokers, 57 percent of participants assigned to use the nasal spray stopped treatment after only one week [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/66\">",
"     66",
"    </a>",
"    ]. The most commonly reported adverse effect was nasal irritation and burning (34.8 percent), followed by complaints about the taste and smell (13 percent). Those assigned to use nasal spray showed no difference in cessation rates, the numbers of cigarettes smoked per day, or cotinine levels at 12 weeks as compared with counseling alone.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Other drugs",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?38/11/39096?source=see_link\">",
"     Bupropion",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/2/15398?source=see_link\">",
"     varenicline",
"    </a>",
"    are moderately effective in increasing quit rates in adults, and are considered appropriate first-line agents for assisting smoking cessation in adults (as is nicotine replacement therapy). The choice between these agents depends on patient preference and individual medical considerations, which include possible increased risks of neuropsychiatric symptoms, including suicidal behavior among individuals treated with bupropion or varenicline. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/13/17626?source=see_link\">",
"     \"Pharmacotherapy for smoking cessation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Few studies address",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?38/11/39096?source=see_link\">",
"     bupropion",
"    </a>",
"    for smoking cessation in adolescents. One study found no significant effect of combination therapy with bupropion and nicotine patch therapy as compared with nicotine patch therapy alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/67\">",
"     67",
"    </a>",
"    ]. Another study suggested that the combination of sustained-release bupropion hydrochloride (300",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    and short-term counseling had short-term efficacy as compared with counseling alone [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/68\">",
"     68",
"    </a>",
"    ]. However, abstinence rates were lower than those reported for adults, and there was rapid relapse after the medication was discontinued.",
"   </p>",
"   <p>",
"    Based on this limited data, we do not recommend",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?38/11/39096?source=see_link\">",
"     bupropion",
"    </a>",
"    as a first-line pharmacologic intervention for adolescent smoking cessation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/49\">",
"     49",
"    </a>",
"    ]. We also do not recommend",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?15/2/15398?source=see_link\">",
"     varenicline",
"    </a>",
"    for adolescents because of the lack of clinical trial data in this age group, as well as the safety concerns raised by postmarketing studies in adults.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     SMOKING CESSATION IN THE SETTING OF OTHER RISKY BEHAVIORS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Teen pregnancy",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the United States between 20 and 50 percent of pregnant teenagers smoke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/69,70\">",
"     69,70",
"    </a>",
"    ]. Pregnant adolescents who smoke can cause adverse outcomes for their infants. Smokers are 3.1 times more likely to have small-for-gestational-age (SGA) infants compared to nonsmokers. In utero exposure to maternal smoking has been associated with an increased incidence of wheezing in infants and of physician-diagnosed asthma in children [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/31/10744?source=see_link&amp;anchor=H10#H10\">",
"     \"Pregnancy in adolescents\", section on 'Pregnancy counseling'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/53/27482?source=see_link&amp;anchor=H7#H7\">",
"     \"Smoking and pregnancy\", section on 'Adverse effects'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Early pregnancy may be an opportune time to intervene among pregnant smokers. If a teenager stops smoking early in pregnancy, small-for-gestational age births could be reduced up to 40 percent, and infant low birth weight reduced by as much as 14.5 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Extrapolation from studies in adult populations suggests that intervention during pregnancy can enhance quitting rates. Brief cessation counseling sessions significantly increase rates of cessation among adult pregnant smokers. Among women who successfully stopped smoking during pregnancy, there is a substantial risk of relapse postpartum. Special considerations relevant to supporting smoking cessation during pregnancy are discussed in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?26/53/27482?source=see_link\">",
"     \"Smoking and pregnancy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Drug and alcohol use",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tobacco has been described as a gateway drug. Adolescents who smoke are three times as likely to abuse alcohol and eight times as likely to use marijuana as compared with peers who do not smoke [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/51\">",
"     51",
"    </a>",
"    ]. There is a high rate of smoking among adolescent substance abusers. When any patient discloses use of alcohol, tobacco, or drugs, it is particularly important to inquire about concomitant use of other substances. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?18/35/19000?source=see_link&amp;anchor=H4#H4\">",
"     \"Guidelines for adolescent preventive services\", section on 'Screening'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21783?source=see_link\">",
"     \"Cannabis use disorders: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Addressing problems with each substance is important for success. A study of teens who started smoking by age 15 years found that by 28 years, cessation rates were lower among those who consumed more alcohol [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some teens enrolled in drug rehabilitation programs that have no smoking policies may face the challenge of nicotine withdrawal during the rehabilitation program, in addition to their dependence on other drugs. Despite their use of other drugs, such teens may indicate an interest in quitting smoking [",
"    <a class=\"abstract\" href=\"mobipreview.htm?40/33/41497/abstract/74\">",
"     74",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31103382\">",
"    <span class=\"h1\">",
"     SMOKELESS TOBACCO AND ALTERNATIVE NICOTINE SOURCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to smoking cigarettes, many teens use smokeless tobacco, including chewing tobacco (dip) and snuff, as well as alternative forms of inhaled tobacco, such as bidis, kreteks, snus, hookahs, and electronic cigarettes (e-cigarettes) (",
"    <a class=\"graphic graphic_table graphicRef50718 \" href=\"mobipreview.htm?2/25/2461\">",
"     table 5",
"    </a>",
"    ). It is important to ask specifically about all forms of tobacco use, because teens may fail to mention smokeless tobacco when asked about smoking. Health concerns about e-cigarettes and other nicotine sources are discussed in more detail in a separate topic review. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/34997?source=see_link&amp;anchor=H279603278#H279603278\">",
"     \"Patterns of tobacco use\", section on 'Nicotine sources'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The prevalence of tobacco smoking among adolescents in the United States has gradually declined since the late 1990s. In 2008, 20 percent of 12th grade students reported smoking in the past 30 days (",
"      <a class=\"graphic graphic_figure graphicRef79503 \" href=\"mobipreview.htm?18/63/19454\">",
"       figure 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The majority of adolescents who smoke report that they would like to quit, suggesting readiness for intervention. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Readiness to quit'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adolescents who smoke frequently cite concerns about future and current health, physical appearance, cost of cigarettes, and athletic performance. Discussing these incentives and barriers to quitting is a valuable first step in counseling. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Fostering motivation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adolescents who are not interested in quitting should be given serial brief interventions with messages to increase ambivalence about smoking and motivate them to consider quitting by shifting the",
"      <span class=\"nowrap\">",
"       pro/con",
"      </span>",
"      balance. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Stages of change'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We recommend that clinicians initiate behavioral support for smoking cessation for all adolescents who smoke (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). This may include a brief intervention by the clinician to discuss the potential advantages of quitting and to problem-solve about how to overcome barriers to quitting. We use the maximal frequency and intensity of intervention that is acceptable to the patient; referral to a teen smoking cessation program",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      to self-help interventions may be helpful. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Interventions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For adolescents with symptoms of nicotine dependence, we suggest nicotine patch or gum therapy in conjunction with a counseling intervention&nbsp;(",
"      <a class=\"graphic graphic_table graphicRef72703 \" href=\"mobipreview.htm?42/37/43612\">",
"       table 2",
"      </a>",
"      and",
"      <a class=\"graphic graphic_table graphicRef75949 \" href=\"mobipreview.htm?9/63/10238\">",
"       table 4",
"      </a>",
"      ) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H26\">",
"       'Nicotine replacement'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Smoking and Tobacco Use. Fact Sheet. Centers for Disease Control and Prevention www.cdc.gov/tobacco/data_statistics/fact_sheets/health_effects/effects_cig_smoking/index.htm (Accessed on August 05, 2009).",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention. Trends in current cigarette smoking among high school students and adults, United States, 1965-2007 www.cdc.gov/tobacco/data_statistics/tables/trends/cig_smoking (Accessed on August 06, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/3\">",
"      Centers for Disease Control and Prevention (CDC). Current tobacco use among middle and high school students--United States, 2011. MMWR Morb Mortal Wkly Rep 2012; 61:581.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/4\">",
"      Centers for Disease Control and Prevention (CDC). Cigarette use among high school students--United States, 1991-2005. MMWR Morb Mortal Wkly Rep 2006; 55:724.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/5\">",
"      Johnson JL, Eaton DK, Pederson LL, Lowry R. Associations of trying to lose weight, weight control behaviors, and current cigarette use among US high school students. J Sch Health 2009; 79:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/6\">",
"      Kim DS, Kim HS. Early initiation of alcohol drinking, cigarette smoking, and sexual intercourse linked to suicidal ideation and attempts: findings from the 2006 Korean Youth Risk Behavior Survey. Yonsei Med J 2010; 51:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/7\">",
"      Johansen A, Rasmussen S, Madsen M. Health behaviour among adolescents in Denmark: influence of school class and individual risk factors. Scand J Public Health 2006; 34:32.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/8\">",
"      Eaton DK, Kann L, Kinchen S, et al. Youth risk behavior surveillance - United States, 2011. MMWR Surveill Summ 2012; 61:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/9\">",
"      Centers for Disease Control and Prevention (CDC). High school students who tried to quit smoking cigarettes--United States, 2007. MMWR Morb Mortal Wkly Rep 2009; 58:428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/10\">",
"      Costello DM, Dierker LC, Jones BL, Rose JS. Trajectories of smoking from adolescence to early adulthood and their psychosocial risk factors. Health Psychol 2008; 27:811.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/11\">",
"      Paavola M, Vartiainen E, Puska P. Smoking cessation between teenage years and adulthood. Health Educ Res 2001; 16:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/12\">",
"      Karp I, O'Loughlin J, Paradis G, et al. Smoking trajectories of adolescent novice smokers in a longitudinal study of tobacco use. Ann Epidemiol 2005; 15:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/13\">",
"      Riedel BW, Robinson LA, Klesges RC, McLain-Allen B. Characteristics of adolescents caught with cigarettes at school: implications for developing smoking cessation programs. Nicotine Tob Res 2002; 4:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/14\">",
"      Myers MG, MacPherson L. Adolescent reasons for quitting smoking: initial psychometric evaluation. Psychol Addict Behav 2008; 22:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/15\">",
"      Riedel BW, Robinson LA, Klesges RC, McLain-Allen B. What motivates adolescent smokers to make a quit attempt? Drug Alcohol Depend 2002; 68:167.",
"     </a>",
"    </li>",
"    <li>",
"     Centers for Disease Control and Prevention (CDC). Economic Facts About U.S. Tobacco Production and Use. Available at: file://www.cdc.gov/tobacco/data_statistics/fact_sheets/economics/econ_facts/index.htm (Accessed on March 21, 2012).",
"    </li>",
"    <li>",
"     2012 US Surgeon General's Report: Preventing Tobacco Use Among Youth and Young Adults. Available at: file://www.surgeongeneral.gov/library/reports/preventing-youth-tobacco-use/ (Accessed on August 22, 2012).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/18\">",
"      Bailey SR, Harrison CT, Jeffery CJ, et al. Withdrawal symptoms over time among adolescents in a smoking cessation intervention: do symptoms vary by level of nicotine dependence? Addict Behav 2009; 34:1017.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/19\">",
"      DiFranza JR, Rigotti NA, McNeill AD, et al. Initial symptoms of nicotine dependence in adolescents. Tob Control 2000; 9:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/20\">",
"      DiFranza JR, Sweet M, Savageau J, Ursprung WW. An evaluation of a clinical approach to staging tobacco addiction. J Pediatr 2011; 159:999.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/21\">",
"      Dierker L, Mermelstein R. Early emerging nicotine-dependence symptoms: a signal of propensity for chronic smoking behavior in adolescents. J Pediatr 2010; 156:818.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/22\">",
"      O'Loughlin J, DiFranza J, Tyndale RF, et al. Nicotine-dependence symptoms are associated with smoking frequency in adolescents. Am J Prev Med 2003; 25:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/23\">",
"      Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet 2010; 42:441.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/24\">",
"      Prokhorov AV, Pallonen UE, Fava JL, et al. Measuring nicotine dependence among high-risk adolescent smokers. Addict Behav 1996; 21:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/25\">",
"      Prokhorov AV, Hudmon KS, de Moor CA, et al. Nicotine dependence, withdrawal symptoms, and adolescents' readiness to quit smoking. Nicotine Tob Res 2001; 3:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/26\">",
"      Tomeo CA, Field AE, Berkey CS, et al. Weight concerns, weight control behaviors, and smoking initiation. Pediatrics 1999; 104:918.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/27\">",
"      Austin SB, Gortmaker SL. Dieting and smoking initiation in early adolescent girls and boys: a prospective study. Am J Public Health 2001; 91:446.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/28\">",
"      Parsons AC, Shraim M, Inglis J, et al. Interventions for preventing weight gain after smoking cessation. Cochrane Database Syst Rev 2009; :CD006219.",
"     </a>",
"    </li>",
"    <li>",
"     American Heart Association monograph, \"How to avoid weight gain when quitting smoking\" file://www.americanheart.org/presenter.jhtml?identifier=3011 (Accessed on October 19, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/30\">",
"      Escobedo LG, Reddy M, Giovino GA. The relationship between depressive symptoms and cigarette smoking in US adolescents. Addiction 1998; 93:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/31\">",
"      Siqueira LM, Rolnitzky LM, Rickert VI. Smoking cessation in adolescents: the role of nicotine dependence, stress, and coping methods. Arch Pediatr Adolesc Med 2001; 155:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/32\">",
"      Kim MJ, Fleming CB, Catalano RF. Individual and social influences on progression to daily smoking during adolescence. Pediatrics 2009; 124:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/33\">",
"      Vitaro F, Wanner B, Brendgen M, et al. Differential contribution of parents and friends to smoking trajectories during adolescence. Addict Behav 2004; 29:831.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/34\">",
"      Thomas JL, Gerber TA, Brockman TA, et al. Willingness among college students to help a smoker quit. J Am Coll Health 2008; 57:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/35\">",
"      Males M. The influence of parental smoking on youth smoking: is the recent downplaying justified? J Sch Health 1995; 65:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/36\">",
"      Farkas AJ, Distefan JM, Choi WS, et al. Does parental smoking cessation discourage adolescent smoking? Prev Med 1999; 28:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/37\">",
"      Wakefield MA, Chaloupka FJ, Kaufman NJ, et al. Effect of restrictions on smoking at home, at school, and in public places on teenage smoking: cross sectional study. BMJ 2000; 321:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/38\">",
"      Andersen MR, Leroux BG, Bricker JB, et al. Antismoking parenting practices are associated with reduced rates of adolescent smoking. Arch Pediatr Adolesc Med 2004; 158:348.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/39\">",
"      Farkas AJ, Gilpin EA, White MM, Pierce JP. Association between household and workplace smoking restrictions and adolescent smoking. JAMA 2000; 284:717.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/40\">",
"      Prokhorov AV, Hudmon KS, Stancic N. Adolescent smoking: epidemiology and approaches for achieving cessation. Paediatr Drugs 2003; 5:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/41\">",
"      Hollis JF, Polen MR, Whitlock EP, et al. Teen reach: outcomes from a randomized, controlled trial of a tobacco reduction program for teens seen in primary medical care. Pediatrics 2005; 115:981.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/42\">",
"      Klein JD, Havens CG, Carlson EJ. Evaluation of an adolescent smoking-cessation media campaign: GottaQuit.com. Pediatrics 2005; 116:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/43\">",
"      Sussman S, Dent CW, Lichtman KL. Project EX: outcomes of a teen smoking cessation program. Addict Behav 2001; 26:425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/44\">",
"      Sussman S, Lichtman K, Ritt A, Pallonen UE. Effects of thirty-four adolescent tobacco use cessation and prevention trials on regular users of tobacco products. Subst Use Misuse 1999; 34:1469.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/45\">",
"      Coleman-Wallace D, Lee JW, Montgomery S, et al. Evaluation of developmentally appropriate programs for adolescent tobacco cessation. J Sch Health 1999; 69:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/46\">",
"      Tuakli N, Smith MA, Heaton C. Smoking in adolescence: methods for health education and smoking cessation. A MIRNET study. J Fam Pract 1990; 31:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/47\">",
"      Alfano CM, Zbikowski SM, Robinson LA, et al. Adolescent reports of physician counseling for smoking. Pediatrics 2002; 109:E47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/48\">",
"      Shelley D, Cantrell J, Faulkner D, et al. Physician and dentist tobacco use counseling and adolescent smoking behavior: results from the 2000 National Youth Tobacco Survey. Pediatrics 2005; 115:719.",
"     </a>",
"    </li>",
"    <li>",
"     Agency for healthcare research and quality clinical practice guideline. Treating tobacco use and dependence: 2008 update. Chapter 7, Specific populations and other topics file://www.surgeongeneral.gov/tobacco/ (Accessed on January 25, 2010).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/50\">",
"      Epps RP, Manley MW. A physicians's guide to preventing tobacco use during childhood and adolescence. Pediatrics 1991; 88:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/51\">",
"      Sims TH, Committee on Substance Abuse. From the American Academy of Pediatrics: Technical report--Tobacco as a substance of abuse. Pediatrics 2009; 124:e1045.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/52\">",
"      Prokhorov AV. Theoretically sound approaches to prevention and cessation of cigarette smoking among youths. Pediatr Pulmonol 2001; Suppl 23:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/53\">",
"      Armitage CJ, Arden MA. How useful are the stages of change for targeting interventions? Randomized test of a brief intervention to reduce smoking. Health Psychol 2008; 27:789.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/54\">",
"      Sussman S, Sun P, Dent CW. A meta-analysis of teen cigarette smoking cessation. Health Psychol 2006; 25:549.",
"     </a>",
"    </li>",
"    <li>",
"     American Lung Association Not-On-Tobacco (N-O-T) website file://www.notontobacco.com (Accessed on October 27, 2009).",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/56\">",
"      Dino G, Horn K, Goldcamp J, et al. A 2-year efficacy study of Not On Tobacco in Florida: an overview of program successes in changing teen smoking behavior. Prev Med 2001; 33:600.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/57\">",
"      Joffe A, McNeely C, Colantuoni E, et al. Evaluation of school-based smoking-cessation interventions for self-described adolescent smokers. Pediatrics 2009; 124:e187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/58\">",
"      Kohler CL, Schoenberger YM, Beasley TM, Phillips MM. Effectiveness evaluation of the N-O-T smoking cessation program for adolescents. Am J Health Behav 2008; 32:368.",
"     </a>",
"    </li>",
"    <li>",
"     www.youngwomenshealth.org/smokeinfo.html (Accessed on February 20, 2009).",
"    </li>",
"    <li>",
"     www.notobacco.org/ (Accessed on February 20, 2009).",
"    </li>",
"    <li>",
"     www.quitsmokingsupport.com/teens.htm (Accessed on February 20, 2009).",
"    </li>",
"    <li>",
"     Jarvik ME, Henningfield JE. Pharmacological Adjuncts for the treatment of Tobacco Dependence. In: Nicotine Addiction: Principles and Management, Oxford University Press, New York 1993. p.245.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/63\">",
"      Smith TA, House RF Jr, Croghan IT, et al. Nicotine patch therapy in adolescent smokers. Pediatrics 1996; 98:659.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/64\">",
"      Moolchan ET, Robinson ML, Ernst M, et al. Safety and efficacy of the nicotine patch and gum for the treatment of adolescent tobacco addiction. Pediatrics 2005; 115:e407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/65\">",
"      Hurt RD, Croghan GA, Beede SD, et al. Nicotine patch therapy in 101 adolescent smokers: efficacy, withdrawal symptom relief, and carbon monoxide and plasma cotinine levels. Arch Pediatr Adolesc Med 2000; 154:31.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/66\">",
"      Rubinstein ML, Benowitz NL, Auerback GM, Moscicki AB. A randomized trial of nicotine nasal spray in adolescent smokers. Pediatrics 2008; 122:e595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/67\">",
"      Killen JD, Robinson TN, Ammerman S, et al. Randomized clinical trial of the efficacy of bupropion combined with nicotine patch in the treatment of adolescent smokers. J Consult Clin Psychol 2004; 72:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/68\">",
"      Muramoto ML, Leischow SJ, Sherrill D, et al. Randomized, double-blind, placebo-controlled trial of 2 dosages of sustained-release bupropion for adolescent smoking cessation. Arch Pediatr Adolesc Med 2007; 161:1068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/69\">",
"      Albrecht SA, Cornelius MD, Braxter B, et al. An assessment of nicotine dependence among pregnant adolescents. J Subst Abuse Treat 1999; 16:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/70\">",
"      Cornelius MD, Goldschmidt L, DeGenna N, Day NL. Smoking during teenage pregnancies: effects on behavioral problems in offspring. Nicotine Tob Res 2007; 9:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/71\">",
"      Gilliland FD, Li YF, Peters JM. Effects of maternal smoking during pregnancy and environmental tobacco smoke on asthma and wheezing in children. Am J Respir Crit Care Med 2001; 163:429.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/72\">",
"      Wang C, Salam MT, Islam T, et al. Effects of in utero and childhood tobacco smoke exposure and beta2-adrenergic receptor genotype on childhood asthma and wheezing. Pediatrics 2008; 122:e107.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/73\">",
"      Scholl TO, Salmon RW, Miller LK. Smoking and adolescent pregnancy outcome. J Adolesc Health Care 1986; 7:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?40/33/41497/abstract/74\">",
"      Campbell BK, Wander N, Stark MJ, Holbert T. Treating cigarette smoking in drug-abusing clients. J Subst Abuse Treat 1995; 12:89.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6359 Version 13.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-201.65.114.212-CC23815824-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41497=[""].join("\n");
var outline_f40_33_41497=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATTERNS OF SMOKING CESSATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      READINESS TO QUIT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      ESTABLISHED INTERVENTIONS FOR ADULTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      FOSTERING MOTIVATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Incentives to quit",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Adverse health effects",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Monetary costs",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Athletic performance",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Barriers to quitting",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Nicotine dependence",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Weight control",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Depression",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Stress and coping behavior",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      OTHER INFLUENCES ON SMOKING BEHAVIOR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Peer/social influences",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Parental smoking and cessation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Smoking bans",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      INTERVENTIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Health care provider interventions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Six A's",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      - Stages of change",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Adolescent smoking cessation programs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Web-based and self-help programs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PHARMACOTHERAPY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Nicotine replacement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Nicotine patch or gum",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      - Nicotine nasal spray",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Other drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      SMOKING CESSATION IN THE SETTING OF OTHER RISKY BEHAVIORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Teen pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Drug and alcohol use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31103382\">",
"      SMOKELESS TOBACCO AND ALTERNATIVE NICOTINE SOURCES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/6359\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6359|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?18/63/19454\" title=\"figure 1\">",
"      Trends in smoking rates among US youth and adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?12/42/12975\" title=\"figure 2\">",
"      Smoking trajectories",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/6359|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?0/41/668\" title=\"table 1\">",
"      Tobacco associated cancers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?42/37/43612\" title=\"table 2\">",
"      Strategies for assisting adolescents with smoking cessation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/43/2749\" title=\"table 3\">",
"      6As for smoking prevention and cessation in children",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/63/10238\" title=\"table 4\">",
"      Nicotine replacement therapy relevant to adolescents",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?2/25/2461\" title=\"table 5\">",
"      Alternate forms of tobacco",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?16/24/16778?source=related_link\">",
"      Adolescent eating habits",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/17/21783?source=related_link\">",
"      Cannabis use disorders: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/0/12298?source=related_link\">",
"      Cigarette smoking and other risk factors for lung cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/2/10281?source=related_link\">",
"      Confidentiality in adolescent health care",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?18/35/19000?source=related_link\">",
"      Guidelines for adolescent preventive services",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?23/3/23609?source=related_link\">",
"      Overview of smoking cessation management in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/11/34997?source=related_link\">",
"      Patterns of tobacco use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/13/17626?source=related_link\">",
"      Pharmacotherapy for smoking cessation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/31/10744?source=related_link\">",
"      Pregnancy in adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/13/37081?source=related_link\">",
"      Prevention of smoking initiation in children and adolescents",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/52/30538?source=related_link\">",
"      Psychopharmacological treatment for adolescent depression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/53/27482?source=related_link\">",
"      Smoking and pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?12/38/12904?source=related_link\">",
"      Smoking cessation counseling strategies in primary care",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f40_33_41498="Primary biliary cirrhosis I";
var content_f40_33_41498=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F54128%7EGAST%2F66904%7EGAST%2F81040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F54128%7EGAST%2F66904%7EGAST%2F81040&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary biliary cirrhosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 283px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Low power view of liver biopsy in primary biliary cirrhosis. A damaged bile duct is visible in the center of an intense inflammatory cell reaction in an enlarged portal triad. The bile duct appears to be the target of this inflammatory reaction.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sanjiv Chopra, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary biliary cirrhosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 279px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    High power view of liver biopsy in primary biliary cirrhosis in the same patient showing a marked mononuclear cell infiltrate surrounding and destroying a bile duct.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Sanjiv Chopra, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Primary sclerosing cholangitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 351px; height: 239px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCADvAV8DASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDzfTwxs5m8xpUlJGCT8oyQSAenBzjmmLtaxuSrs8ODbrF1w/zcgHAHBHPP0rWSzt4LOG7z5twg5QsDtzwV9M/j2qrLcFbjzIljiUqpbaTvyecdSOP69xRe+x9LypqyKmnWNzBcW7xz72hUoElB+XOOuCQT9DV/UbgeXFAoEsgb5UPGSQTyenQGlG37Gl2QqNu/dqV2pyeDgc4PB/Gq6Wgu7uWe9McULNhj5jRkkKMYyRjvQn1Yr6WQs7pOBYur21ztQObcABAWGec+/OOxq5YWbwMsNqXnd2JMkr/d46ZxnH4UR3dvdsI0iRWB8yJthw6jowPI9R2OB071mTPa21+xmed45AcLEcgkH3/HGKN1ZDUla9yW51B3lMMELwxRP5TGLG0nIwAMjHbnHfoKUwDyriJZUiWIkMyg/MP0x93rg/SkWOKHdPDbtEkxOPMRtyc4GNuQoPHXB61eluZotMGmG4xaN86ow+Y4GAQVGTwKe2xKlLoZ2l2Esiov2l12T70CnG8E8A+oPHXFSyWtwbXfe3kMag7VVg+70GCN3NRSBp7L7BFbyloyWV1BXKsOxJGTnt1q5fpcNZWk1o4+0Qb5SIXK7V6Yc8DJB7HB+btUta7hzOK0JYpHQCOeJDcPA+xpIwxJyANrbuG6YJxVZ2nt9sMdu0zmMo0kkg5XJHXrnIHtVSylmt3uEkks4ZGblC+UI2jjGTyavXUcbeatysjKXIzHux6hiRwT0HGfpmq5VFiuV2RSiLEtu0Ibjzo/vHB4AGeOp5xyPelt4J476KS1nkW52jFs5woUZCkkHGSuCcenboKYs/KuGj1G1jVAo8qJQ7RnB6nqc/M3ep5LVInvpBdOsaMyFZHZiBjCsrAFQck9xjHQUm7MiT12LqtPc6iZo0CIQElE53x9Tu+Uc4wffvx62xbiE3zQpuCqEkjjICEFdylAcdfM7+nPrWdpyyW0ohnRUtA+8s0hcgAYJPJwenseetP1C38xjJazbZgw8tRLsjkUkEZxgZKnvjrQ1qXdrUva3qEWraK+nfagLhHWcNGXDOqhuCSuOQw71X0+R2t49kVs81vD5QdlIcdxludx4HpVGzwscAWM7nbZKJY2JjHP3BjjJx7dM9quWxSGORAgYtKYyFjwxBzgtwOPekoJKyCEEtWLdXD6gstvJ5RCggyRoVcEjsST2asuL7NDJgM01smcSSruwxxwB9Pb1rbS0srJsQoqyIMLk5ZV9M9axrCZ7e7ln1O3SSMjIjcYWToPUHjFVHRaI1Uepb8QWaarfpMHdJZiiMgOUG0ZJx/wH171FpdveaZMFs5cCSR33tlsrgYVhleO+OxAqS6vDPDHLh3kMTAzuDyhZsLuHPGQB6ACi11C+k0pAsYkuInV0SdVYEFSDy3GPTJ9aT2tYHCPY3HjO2eZEtkkkfeRFHsjBz0C9QMY71X03SA9surRXIWGZ8pvJHIJxtABxyO+OtVbeRpXksbtohJ5jbAuNrL1BP8AeIx+OOc1WijuYE8hPJ+xwjMDPtG4Ajknp+IxU8rSsn/wwO+iRqm2azniuppwodn3OCfm+cnHTPTufyqrrCiS2guXcKkcplAZeevA4zx/hTHa5utPjD7SEcthNrA8nGAcjOP51bt5A9qGE8wmRwzvIBjO7odwxjtx+dOzWoXlazIrSyu45o381Xt0yoNwTIxyQSB0x09+1Up5vs+r+Wshw2C+WPQ+gx9O9XrqdobzCzQMrJ8wZwuPpnHOP60pktVn2rNDd7CFLHb5o5xnBAP3jjIGOaE7PXqLn6XMm5sIo9sRklZFGJJBgYHZW7nkA8DrVy01CO7j8qALE4+WMMu5Tt9hj+lWntI3lWeOcKFBw0RBxnHXII/zxUlgZHuLgeSDswIChXMjEHcWUHk9O3rVOWmpOiM3UmmuYrSGW3iidyFQOd2ScAdPcirWm2CW+y0tikly7MxVVwzSfxKCcDaMcZ96R7+W4V7e1a+iQwsguD8nzZXoep+6AcD7rN60zRftWnme5Km4JQqXyctjcOeR61Du1oCbbuuiNO/0qPTbeKWSSZ4IYypLYAfgcnGc5x3A6546VkwSxX16bmBskKEWMjbuTPrz/EGGP8lXM0l3JICsTy8ySlfLkLZGAONvXgcdMVQjt/8AQYYJoo1vYpvMkeY7WCj+L5Tg43DBOe4qop21epneWxchu/JkaANGkiIZW3IWJKtt+Zgefu9MfjV/wvFPdxzQK7yztIGV5Dxnb0XnjgfrWXNNvtVtBMkpIDzNMxRWxyQSMcYAz07966jwwRYahfzW5HkQxqUyxYhmKg8nnuP1qajcYuy1CUnvuzqoGh1C3S3t5jtRQh4I4X5T+NbihVUBFVVHAAGAKzdFtorWxM7qsbSZlc8KFU8/gMAH8653XddF83lWUjpZAfvHYbBKc8AE/wAJ/DOQOeleV7N1Z8sdked7N1Z8sdkWvF/iO3t7ebTY1lkuZo2XK8BfUZPtXFwX7JMlsYlN3t3xxr8oQ7c/O/8AF1HQVptLbQRhpniVM5Ck4zz2A6896zrm6iS5lEbLNdAnCK4LE9RgKcdPX+delRpRhHlSPQpUo01yxY+b7Z57ulvDPNJEN8Zb5Nw6Yzjk5PJqeztkS7gt7aCKKSULGNigNyByT/nrVT5jciSa3aN3hVwVYBnPAIZc9uOcd+tW9JbUUvblo0hgZNql7lwhCMCHAOc5OeM+1XLROxUrRVzR1nw9MYnnF0pLYkYwsUYKDtAXI6ZJJGepzXNzzR2+svb3ELuZOHaNgqhiu7AUg+nXNa+oXqR6ZJHayQSxHBk8twznngHBxjJ7Vk3tzqaX0j6faW08Bf5AVHpznJGecjn2pU1K1pO+/l2FBNLuVE+ytG8E4MdjErYK8FhzwMk5IGe/X9ILiNLzT4HVQ9jbS4ijlJUOOcEkcg4GOpqM6WbZluZC7XOGO0y7l2qD/s8HGO55qzd3Mw0aI3AjNt5of7u5QQgIBUkc4bGR2UdOlaLcG1b9ClG0cKWgtmYiFisTou9YsnOOvJyABn0rX1DRZCscWpJNHJAxb5YyofcB0z6cUzQL1p9c0+RYoMW+LhrdcgA7RxjGMZOR6YFaN5ey6pqLCSVYriGNWkkkLfdyQowNxPLnv2/OG5c2uwOavaK0M61gjtreMQbja52hCclM9d3oeoxn0rNg1O4MpubuGWRlxDu4ztGSFAAAPJJz1rVju5pNPW4u7m3kkOQsMCPlMEjJZsDg56A8YxWdAbgWk0d7MzQSOH8y4G84/hwAx49vpWis9wbejiRTrLqF3Ck88dy0h2wsVxHgMT1U9jnPXpWmbma1v47X7aJrdSrySKi7RJ8yD8MM3U96rmKw+wtduswkjkGxYY1RVGEyQcnDc8gAgkdechbdPOnt1EM08cjLMgkCZbbz90tggg92H6cy2mrGabd3YdfTRS/ML608yKR5VSVgp3AkArg88jvn6dqlsTIsdtMjZuLg/PExHIAPC8Z3Hg4IPQ1JdpBNeubW3sJZ/s/2byLmD5AxZjnjIByQuASMDrTJofKvJ3v7GCGxkeNz5cahQx5YAAk/eOAcfWpu9gVSSd/6+ZY0+3utRnmnstRCqg2t5oT5R1wSB369q0NJni1C+mtLi7WxMMJkZoyrKxwOQzf72cY6D8a5/V7ibKWVtcIJwwIOGjzntxn1HpVuxvJ7yyMkkZw+YyIpMNvHQgnoOBx9eaThdadf6+ZrJuS3KJgMdlPaW6q8MrLiFlOyU8k/MDuyNoPH40+a1urex+wrBsbmKREYnATG0qCpJXHqQeG5OM1Z0WQ2sx1CytxNNkhyZsbTgDg7QTxjPT8cVeu76LxAizNa+aIzuVNqlssclSzHG3jpj15OaqTlzarT9SW237vUydMgTTM3JEo3QhFQ4+8SDgZHPQflWhAzfZLqWPess7LKyxrksVA28HODx27YPeoWneATzzvHHbeUI0gi3AZLDgjGOAMcdsilN5K1uHaKNYjGvzxuUaNckKduDu6eo+gqnd7o0TXUuzAkxFiscbsDMW/u4JwPfP0qMiEwvDp1zsWUs3zqNwbJUnGTkdKclti8lnkaUmcK4G4FYyMHgdQfp71LcGNpdzj/AFSZLhAWPtnPTjOMd6k01vcpCBIbWXN1AklwxDyA5UcYxgn/AGR361Kwa303bZqtxIjYVA2DknkcA9uayrie3luHS3kZ5h84i27UJPQZ+pBrXt/L8m6tJL6409jtklurfKmJQcAcZLBiwBHHIB7U5NpalSfLFuJViu4bS1WI728uMLtYAYGcY684J9qjtrPT/s91IJJIM4YtM6gHJ5x+OPWr5M0mktCfKW2Q+bG0KEO8YOQuCQBn9PSqoFy0BWzstsjnbtd1JIXkkYwMZK9SD7cUJ/IFZrXcqust2higSGO0ZnSYxFnBJONyk9MjGQSe+MdoLuKR7+3SRjILg7mKjhOAQD+JH1xVrT7cpaNJIvkyjOxYjgM33sk+uGXP8zUUVwbjR4YbeWaO68vccnLFQRk54BPI7jqaqwua2t/67GjDItlCY9zzGAZKIoyp5PrUd4sN5bGJjKsRJk2AD97tOeO/vx2qpbXZSSDz7WS4liXlmKgLyMHBJ9OcGtImVwZ54UeJPmVEwWHY5J4PPTpSs0Dd15GXdWkGszA3ksyiBciUqBv78dBgf5xjmeCwMAFxNMH8iMozouSw+8NnIHcdQelLby20d7udlVp3VEeNThz0GOMjHTmsyeN23yy3DtawyGSSEOWyQcbsEAHqBjrgU7PboZOy17m3Ff2l/b3MEzxtBN8kkBcBiqsrdQc7t2zPbANZFzYwyR296ysJocSEAHBxIwLAZ5+6fTgDpk1LFb2llDPBLEHM7GVZAozsyvT0B9K1NIvLi2trOxKhniX5pA52xDHy5HVs4wcEY9+lK7S90mVO6u0Vlnlnit7+5vPPaNkjIwvyhuMcAf3jV3Vkt5rS3WW5j8nfuaI8yMAVI2DIycjv6fWlnM5vGto188uPlLHnO4ZySeSAM54rQgtLT+yLm5mmBubaTZNE8Wdp+UDB9cHOf8KhtRsOXupRMC4jS4kimhJuTHgiWIbhDnHzNg4wuOc9x9addwXqztdyWczxhTA07xsDtIBO3A2noevcHn0WazWO2ea2eQpA2ZMPgt83O7jkAg8c5xUtrrCTPK32kr56mELHuaMEgcDOCPy9auz3RL08jT1uGx05Vt4WM0KQ5EnVcsxOMhupLZx71b0mS3tneGQMIZU2bicEMDu5P0BrO0+B9O0x4b9VfycqU+/nAHGTgEVWmVJbY2kkCxyRKJWjiI3AlsDBxjpmslFNct7+f6js+WzOk8QeIY7tv7IsijxNhJpt45UAkgYz7DPrkcda5rVreOzF5sgjRpis74kbDvlsM+ei9emOT7YOlo4tJNsETgFmOVWPGW28kn1x3/Sq934hi066uEurKR1dirSPtOcHpjJyKVOPJ7sF/wAHzM1TjD3Ujk7O1bUrtoVeCKLOHn3EhSSW2p2OGJHJ713sViryWrxRr9ntoyBINxyOMfNnHJUdu31znf29ayxGMW9zBZyKGl+zbIwuehIyd3Yjjis26uzfSzCxmaaUyb1SMFEwCSGdmIJ6DgL3b8dGpzd3oPysdDJaac97HJqDiFTkB/MCkkkcDPB6Ht2qlaWFlp1zNqNkzC8uiybz8xA5VflzjoR+VZt293dae1jPNFbyRp5jOpYhi27K8fhz7H2qXT0ljkjhuY7e0tbMiRXiYkTEo2Q4C8gE4HHelyNLf5eQnvqJ4d0SPR4nkmeBJLgeWwhcsFUHP8XcnH5Vo3W1hI8rN5BAAXgAHjnP04qG5mJuDPeW8USxphHQ5VcnnjGR26etYn2mSS5ktbNgxlzIx3FMHdzjg8cVUYuT5mbxSiki3d3lxJvkjiYRlwY0SJlwuf4yOgA64NNgk1BIFNiYXmlZhK+792FLNhQWPJHpyc560y0s3vGW2WUWfl8yoy5MvORtBOeOpIz2zU2o7Vn+ywTI7wQhmWT1Ax04IJx1JI9qWl7IzbbdjWe302zuJ5PtSyylBvMKfMTgcsdoOB7c9KwJtInk0hkRYTdyYYtNvEbfNjBB+fIA44xU1nILpRb3TpGI4gkUZ+VxtA3qQTk4KgZwOla2myMLhLp7cSq5KvFJOpDDHUOu0ZzjpmkrxV/6/QyS6XepFrmnWVjYW0mm6Va3tzGiJK9zHICxwc7OVHXGB160QaHb38UdtbiUXceZVikKxMU4G0cAMqnHr1PJpHi1XSrAxh86MzmJnZVXbG/Byx7ZJ5rN89GWWS8lSSGI4iaOFxvQkD1OQOMkf3l6ZGZipW0l89/69CYxUVpuSazpl/HqcH2yyfyUGAbiASHAH97BXr1wetVoHjjurxbeciVRKEAkTzFkIPBI+bZuCZA5OOldJFe3d74cewcuowIfLVAU2IRwzY+UgZPJB5Fc99sa3mkNzIsexW82GN1OXH3QH5CjdxyD1Gc5FVByknF20/r+vzLlzNPntfyJbSacWitq7Rvp8ZLeZsctvCqW5YcAEv1wOlR2stvc3s4WJ/Ito1W5UyH5CVGR87cKMPnH90dalt9T+0wf6PH5VtJMizF5VkbdghuQF3HA4VQOnc1OtxqDrI8xkuIIwDHH5B3RDHJwvJHc5HYdO71XkTFNq9yustlYxTRXVvPb7m8yNWRgCQMDA6Zzn24596qubAwQp5gDSAKXcPHvJJKrtJO3OfzIPPFQyXLzypOIUuIrdvMRwGGMYJbIOMDjtStPEttbG2SH7NgJCBcqPmyfl5OT39/eqUblqXVE7xXVhZ2ziEPqm5gJIizBR7knPQ45zVvRY59ZhkOqRIJ4mCxyxwlFI6gkkc47Y5qTT9ZlgmHkSxxkwlhyoz8+Dy3Hp/k1Ol7/AGes3nFyI/3jSGMhTu5JzjGOtKXNfbUrqQWz29uk5urqSG4hlEciKoOGJ77VIOSpGTU3mQs5uLSV5ZWQ4i3YdiMjgcdwenpRNqUa3EIiv9yl1ieIIHznOFyBkd6u3DRmFEgtzE6KzFyGJYk7hgHp+vWk7316jV09zLaSRGljuvLghEZLHcd3bPJJ4xuqvaSRrHdSW4iMB+WOQPkOuM8nPqWqZ4rkyANKkrxsoEap/q1PUtg8ZHQnFOvIIxAYUVpBvDlVycMQT26Dk/41d0bp31RiR/aQZJoI4JIzEUlJOVMueRjPTAHXmtRtQnkud11cSC4KsBKmdoHy8BehHX+E8mpbOxRdE+03bwwyrKSG3jywfXOcZ68Zqy1hc3Wlz6jo8yiGLCq0qDEmWAI5K4x+tS5Rb1E5xhHV6jWTfbwTQpcPcMF3uX6AjBAUnAx9OnvVeS6xMwmKRzsSkbTlBvUcn7n0B554qjZavLcOlkYDcqxwWRxnBPsPTml0WzSG+aVoTHDjEe1vMyT3OOnGetVy8urEnfYt3V3bokMduruViYxsxO3cQeME+w7cZqkjrdTyxobcpsKKEO0qMYI4xxnHIrSuB5mB5Mrl5HyucbSMdeO/BH14pNGiji1QRXKy2qttjj+UvlOMqRjI/hOTjp3zSvZXLuormWxSe1liSFEsIRGI9jTse2TnBDc/UjtVy31CxluGsnup4Z9ozGhCCM5G0cc85xjnrWtNp1tCbqMAzRTMeuRuBJ/oarQLpsl4Nk+bm3ZWZDIMxnII4xxnHfNS58yuZt6aGfeZhnEiSyPbRYZ5tx3jHJw3TOPX2qG2jtLqU3M8csbmT928aYk3dQ24Aj8zjPbpXQ22JJXjjiLKFJkZG3YPGMgdBjP5VlQSxSukelzl48kShAHCDJJJ44IOOvHbHNO/QTs9BsNpa3Gmf6b9q3qFU4dSQQOuOfU+9OE1pFcRJJbzXcDxLIJRGrlgu4jJ6k8DFVdTElrK97d4MqOHiQEfdbcOgycc8H/I1dJgabRspGYoZJWwhB3L8qE8n3z2olort7he++xTP224S4kkEEZjnIjeMMF2gjOc98dD0pUVLh4bq9e2nhtgzbyNxQrk56Y4wv5cU/xCVstOWeHy2lZREqseiN1xzycAn3xVfTbcpayy2kDea0aMHbLKWK/3ePyz3p3uroE1qma0FjbwW7C2hURuQ5Ug4IJ3Zx+NQ6msTi1tYAUuGJeQpDhBzgDO3BGDz1pbV7lHfzLnzY1dQuFVduT+nPTPpjmtHVoksbeM2fm3MjuBluCOvzdMDGO4rK7UlfUl2TSaOd1K4h01ZraK7Ju5v3jbz9/PHzMAOOAcZ6gVqaVZxa5cSW0cc32ADzJ5IoyWZ+AoG8FccenapR9mEf70tNcA7GflQc+nY9QOKwtaltbS5jlktjO8iZO6baVwcYCgZx71duZWWj/r0CSut7DtWstRtXu7W2FtHp8fSAgAleOo6Z/+tWpuvPs+y5geMOu0BkVlPHTjIA+tRaLfAPLLbvhV3KqDBHTI6jP/AOv1q9NrNpdWd6NQmC4t/wDRXQ8b8MewPonB9aJya3jf8wleC11MtEtY51ge1hkuB+8zEigI3Vc9CM4HOPxp9ne3sc4jMO10UmTyogIy3BG0+3NVNJ1ieGCVZ5m2HlSFH7xRkjt/LFaMuqws2yVJFhQNIHIJZgo5GAOCfXH4U2ns0GiVx0V5M8TyX93GoRnkYvyUUHA6AngD8/wrJXULuRrqMzWVz5EiuqwSEEISSGJJAPG09f8ACor29e8Yy2MSeWVJ/eE5EfQnnHOR6fhWnbwxmFiLeTMkXy4bJYAc9uB7mnyqOtikmmmnoLqN05SGJYxPO43BWUkFMn8Oqn8qxWfU7qDMblTvwVgkRlAAxhck9+1WpZg+mS20pVG4Qlvk2qGDAYPXksc+9RWbyR6MJWntY3knLvIzqUAIwADuxnp3zVKNkNS6NGjBfx2qG8ZAYQnz+U5VEUsNrBSuTnjjjqacZJNRuRdWKCWCMbZEKBGGQrjq2DkH8Px4W8kSCGEFI4LYyj5WLoyDBPQHqTjrkcnNQ28NzBcRzlp3tXdikPy8gkENxgEYzjnOMcVjZbo5mzSsdN1eQH7O1pIyIRGs0RXDH7zHDnAyDjHPI9xU0vkabeKb18yWsm5reHPJZCAMkYxg5/KuV+16hmaN5hPs5dVQ9dp+VWwOD2wc8DmkFvLNKDJcOwYHZLZzAtjjI3H5sgr09G/IdNp+89CWzqL/AE+WSxh1RJitq0YdII/lBQ5I46Ac9PWsjXLO8u5YIDaG1cKZW2yK0rAcYyCFxk+v4d6bDfRS2lqjteSRrktHGVKAhiqgHO9T93GCMHGMCpJnkttUaW7uYBZ+WSq3cqDILdYyMA/w8Mc4ycdDSV47vuJT094rrppn0+Z9Rdvt9skUWWUNkySFMlsn5j03D0XPpTPs7WFzcvf3Kqd5G2SI4QA5fZtZsYH54Ax3BuWW6jgdpW2gJ+/RWIySOGAwrcYGCM4Xr1KK7/a4xpq77FP3QkVmd423LlQckrlAQM46npgkWuZbvQVrbEurTQ29tpxsVSNrqVWW68v5ps9MEEEY7bgOSear2V3cTeIrrM801uIz5tmDiJAQFBClsHGcn8cZq8t2DYXYs1mk1NTLCMYaVQSdrcHPBAG4c8DvVG2klurpUaGGF4QdsKiZcsBjbk/dII4AIGQM5pdLW/r+v6QW1JVuYTaeZeW9rDDJGRGY7QPGXYsBxvB52NzgdD6g0kEkV3JcWoup4b7DIYQxw7gZYgYwOAQMt2H0qq92zxqJoUF1HKqu5zHEiEZyQSDnpyBnANVZYnt7ie2EyMpLAsYlZlcru2M+3Zw5G7njBquW2lwk+jNKWaKa7itpcJHNl4E2YEhAw3QnH44+6Oe1XLuZEvbzS723ii1H/V5Rd00Z29Afutxz99cbj1xzlNdzeV9oZbURtgM0LjySee0Tbi3C9On51ot5b+US0k9q7uxjzHvLrySmcEAfL1OeDSt/X9fl1NE2/QshLq3g2MV3+Tx53zY44JAP3s+5+pqnZ36WqyeYCtywkcOxymIwWY8DIGdxA55NW9O1K6jWS2gW1FnKN8Us0ZySOVAYcZwBwOueKgv4rp2ZrOaSKUYecRA7Zi3HQAtkYIA4xx709dmi5StqkdXd6BNdaf8Ab3lhgi8oT7hktt25ycD0/niuOutQtPNSGLy7p1cbnZSDgEjcMj68V20PiQX2im2UxrKFEEu1lIBJ24+8cE471zyxadJdJEbKQtG53umQM7uQ2DyuSecY681jQlNJ+06BTnVs+YZqNpbvpZjuFW2VONqLvUY5yBxWbIkmkQXtpc313cwQ7GnjnX5VJIwcB2B6r0yfyroLixjt82xEsNvDOYisw4YYOFDEHIJII5yao3H2aOWa1kOy3G3bseQFe/zHOR7VpCV7W1RV7tNFGaMCxUxxQReS8ayvCnlsMleM88bWGetT2eo2dzOVtUiRQwiZyCCzYY9NvcKScnsKsT6fDqllKEk2qOCUmTqBkEgEkY46jPAqSc/ZFEl81usKuWUlArdMBf3YGRyT3NVdPTqV1umO+zyfZLpZUBdgQixYVZBzjg98YzkjmqkLSQRzxX5T7NCrO3y5O3k+pzjjsPpUNrqlvEWcNPO4c75JCEXAA5K5Xjr0GePWpYNQjbUJba5uFLqvmDyR+7UDBIORnBB7+9LlY00loGhXcU929pYSrM8j+YgnZlAQ4wFwp9R1x1pEjm1JJ7WaIukYaRZUcAvtPoenbv8AlVmQSuJJ9MmhgMvyHy0GJExjkEHnIPpUkB8t4ba2WWGFGEc/mIFWRcHheORkDOfah73QlfZjrbSUJa2M0rsg88RKBtGOMDJA5zUEmmRQRXEscrpiMp5iAeZggHjpg85HP+NaF3Y2d1EsFw804hbIZmyRnqCe46cVRs71Y7S5QG2STzmEURYBgg4AxnrwefbrSUpPqF/xIhNaLZveNbiVYflll2KWwSo5zgnkjjmtCC7CaJcXch2WiSMwGOcZGeO30qpZXVtD5hQQsxJc+SqqTnjnOPm/Ws1o757SSzuIWktpUDKqEF2IyeQTjIwucDGKpx7hK7ZIL61Sd1mSJJnlFsVJLtG3O3YdoAOd2DnAq4InKxvayTOYy3mFpdpbn+Lg7sdB7AVWlaxCGV7U5VA0kkKAhzkDZ7nJzz0znNQW2paZb3MarY+ZtO+UFc7N3PduDjsO9O3VINELFc+ZNEF8oNKz4hCFlfDbjkHaM4U4+prT1PWIrGCKSWxcq7HcrSKGRR1YYBBPtkVmWsjT3t3LayuVjbzYrdXwyrycMv09e+Oat2dwkspup7eNiYs+a5RgpDN8pO7GcAHHXBonFXE3db2Zct7pLhJJLUQNKRliUI4479fTPHc1TmVpbd47mUSB+T5SlAuCOxJ9anmummsI54zbW8k2GCzuBgE8DgnnGPX3rHA8m5UTwx29uxJd5CeMDj5skZJOMH0oiluUmrlp7aayWzmMUQjdFw7IDI4PGSQetZNzc2eprPLayzuiKUxKuCrE9ep/yK07x5Y3kNldItuVJCqQ21geTnBGMDHB6mrV1bQLZSm0gLOq4aSddxZj1Iz16Zp32uTKMmZejqwTZIBvjKv9V7foK0rBbOeea4Rt42s0m8fMvB+XoeDjHU1SsPMWV2meKSOFUZpAAPLHO5eg6Yq8bmGJTLGZi6szbQwYsASDnnkZIxj2ptPYpK2wyMRXLNcWcCjKOm18KpCNg8gHv047mmXFxtitoY3BSZdoEYIYDg53HHt2/CpZrizuFt3v7ieGOXIEcETmXORwcqVC9e+cmqFzJL5bNYm4VWICvcPn5R1PynC5GeeO1Jauw46b6lSMTRLLuvZ7cjktbOd8gOOp49B19PpRqFxFc6UsjKhtC2cYxIW3HknBB/z+NiydbG6Cb/PifmLpvxj5s5wDz2rQuvPgslW1wiZGWdGdifXgH29qpPXUqcY2uizqEUN1dCy0+RytttE9wuHBVgG44x1HXJ6VkDZa3lxEPtDRI5Y7V8sOcANkspyMKpO0j73GK35Suob5p4pjPHAYp4lKkESqNnzE8dFGcHG7oRmuXm8y5M6L5sC2avlhLlowuFClsDI/dnoO3HasKe1n/X/D/qcDb26mvNOj2Vxm6YWt4yxtC7ou0Lkd1DA57H19q5OS5n0eQGW1jRlBBt/NDLz0yQSe5PUfoasLDHcOIor+8meI/wCvBwu3qSMncwIGRkKeORk4C6Om6ZlRH/s9SRIxIBJIBAx35A/StUkkO90rFm+mhXw9YpYxSyPCzbpEfOwDzAQflIOPUdajiYQKzaelzG0rkSoF3AsOSy5XODxjk8A9eSMkomV8u5njhZiCHkLovyknGACGHUfKRkZzzgXdCtpWDjSEk1CXcZWdtsWzcMHhm5PA5z0JpWUb3Ii22dB9nihs1szf2r2Ubq6sIyd4ZgwfcHwDn+H/AGQMc1l2moG+sJLW2iLJGDBH9ocOZI98QABQIBn5Tnnofwrpd3SB7mG4ljacF/sszlw7KNwZduAOCDzzkVpSzpY3aTXkEdpf3BFyrKBJCgGWI2jDAnB6E8KOvFSk15jtoU4ZLoXtpFcWG6BZxCzh8+WvyhioHJ2gLycjscmrcErm2nVnWBHDjyLtCc5yCEcFN5OTgDJ7cnmoiVur6O7tLi4S7uH/AHShBHEzE/eyGLFWYcghTx1PWluoopN9rIsoisrlTcyxqqvJljhSdx3ZG45/2exIFG/X+v8AhxX00ZNY28NnA0q6f9uXzGt5Yp5TH5SFUZmJGCcAjGPU9e0FwrQWSzNbrI1rJgfMRIcE/vFOdpAzkHaV471oPHHZXFzaxLtliUidzGMiMqpJbB+bqMYJ4HQ1n2riJfLknlt5bgmIvOSXJZ92BsyOvTLcfhy1rqXfsWdHtLa9vcXc88quN4eLBIUgg4wpDYKIDgfxfm+8t/sF9LaadNPFbIjLEPL85i3zcnAyMHHB/wAat6bFHcXMss1pLPDLhWkljjGzaCdrDexPqMZ69qL6OOC7nRZo40dvPjTLKw5zjcFIx8voOc9M0ou7sWk9x6LczXJtbSfyomZ5yS8e0McZUZGeigAZyd3tUd1pM8kcNrhUTc8kmGXMpJB3AE9iOQP0qxcahaJawy5jlSMhg5hJUMOQMHBJ4Jzx0qaPWomge5gjhdQo8yTyzGVPcMuTuHPGGo99fCixbfck80hTZb3SoZQn7xv3eArcZPPXbjv7GmW5t7jUp1t4rguYyj3M527lJB2iLapA5PzZ7e9S6frO7w42lrEzWkUZZp5JMSBVb5ywAIOCT061LZ3Ec6RizaF7dAqhnVgS2AQDx0wR+fas7PXT+u//AABRu9/+HKz28Om6flZEZI3VIkzgsnHOcnvn8vxrQ1+O602yhnhvrTaxOVwAMdPvFiOtZmuWa6nrEt8bqNfJQr5aRNtAUHnk++cVBpOkWtpexnUrtp4pYy/nTx74wMlR8vLZyG/L6ZqyspSfyt+H9blc1rNuw/7b9sspoLhlCCANLIDuAJI+UY78jv0OarZg1ZzLe3LQi1AUJjADHIxnHOOatWd1PAjpcWrIlpneVKg7gmOSCdwJI6AcnPblLuyt7+MKtvGBIC0MUTBDICVO8kqQDgD161adtlYfNfYivPCmoW11ZTSWzS225pHuGdflBwcEKQOenTPNW5ggs5JQ+JArKsuMnuMAdMjA456VdvtekNiNILgTzKE2Rg8McEAMTjuKy0Eca221Y5JJIjCsrr99goyzL3+7/eqYOcl7/wDSCHNZ33H26Xs1vbvEG81lKF3AztBGHxxzyeP0qBpIobQqkkcd6jL5iNIuQS2SuTx2P5VPYapPY6kcXUiw+ZEpjRSELKOVVd3AbOc/zrHv9Z02+1XUr2OJfMwAxIztLDAJG0Z6etXFScrW0/rQrmadpDVttPlhMJhKTFw7w3G9M4GAdx29m6f4VYs9duGma3lsFjWWTEr4cjdnGPbgCptJgmsFZIfLnikUZRWKg5J5ORz6dO5p2pakz6gYZVWCV49jwgZ4OeQRxnpVS1dnqC913W5Hd28FppV3DHF58rSBio3Ann9eh6elLpct1Dpt0ZIWZbcnZGq9SeTg89M+/Sq66zJJA6RRReZu8tDIDhccnGO3ArW0pEhhvLK5ZJCjYYbSVkDDPQ/XvS5ny6/1sCld3Kl+0lvZm8g2FtzPuYYA3YHTOc4LcfSqdnb2upyQ3NyJUViRIyA4d1Ge4PfA4q5e3Vi0FxaeVDsTEkgVcYGcZ+71pohtjHDNAks8RVFBiYKIwvbDAHuc4qldLsJrUqWlwun+JVFiHVJlMczMOFVgPmII4x/n0qe+u3s/MCMkpZ1UfKdjgg5IwcrjABJJH0onvfIkm8yABJlK/PhjKCpI2/3c9Tn2q7Cxe0Mz2cdqNrDqCUHfAX6Z61Mt7scY9bmGdPMi5E6xyODDNDIQrR+pwSCf/r1eis2u4YoGLm3DNIgZCp34AJJ44x0HHI71ZcfYbS0t3WOVH2qJpOZMEEg9Pb9aivYZrmWIwiLykJyrZHbrj64/P2p8zerKURg060MCxSSstyGCMYx6ndtGcjoa0JgsF9KZ723dlJUAMuI0B+bkHBwAfrjjk1nLZ3cTQYuldlO0koeevJ+bk89ahuDNPePkQGVfllMTMmxATkkleT16egpO76lctrPYle6kWa4itHjnt5nDwyFgN/TcV9gQeuelWYT9qtozcBRlhwrgZIPTP1FRQGK1WNnm8wSlvKcgnbxjnuefp68dBMZY9Otx5EkZlfJ3yIcAdScDvyO9DvskNKNt7kE013BclWWOODaWXPzdD0yD1xg/j3oWAyxybp41llUMyvCxBGM4GGGPXr271YtFmmC3FrGswcky+XhSx4y3zEf160ybVLlROs9uIUR1Q7mB5JwAACf8Ker0W4uboWRFALhZIfnZl2b1bsOeB+PfPSqrXbQajIbwFLULsiXcASeOc4PoeMVfvl8+RZvMVTkZ2g44BH1/i/QVn6ldSwIbpxIlrIwijZWG08bg2M5yQD2qY6g5dxLLVpLjQbFXFv59vFKzh0yXUHbgk5yChPJ9V5AzWJqtyt8UMwMSAKyohWNEUZAICnBPX1J4zmnAm3WOASRq3kmKRxt3c7Sy7ecHgj8CaoeVBczmOe5EADBFONysvQZ9D17j8KIwUdUcco8pEYooXWS/e4kZWVZYxKUMan+6HKnpjGfbNaYs9MvjFHYRaz/Fg3ilkxxkZTJzkZ/KsaIFxPLqA826BXYs77fNwcHJJx0x16Vrpsiu2JvjbwyKGRVuGURkZB4DgjP9Pejle9zGMbskfTnBeaNbqaVlKHejCIljnC8AAAHJAwfvY7VWMlyYRdXkcE+FC+UVB2ocEMcYAORjg568Yp1rcxG+WC81C8FkF3CSCeT5T0BIy38PHQdaS7Nwn7qMxTSAJC8e5Y1YLvJzzjIIX5u+cU1vYLpLUs3MNnDpqvHPNJvX91bygDk4BVyoGwjjcNwyc9c8yWVi1yUcwXlruQtiVpERZNuFKYPTcwxnsDjmr0s0MU1tEkNtJpt1dOZbiSMDj5Bkbvu8gjjr15rXu3MskVrAJZctkeZ8nkhFdlG0BdwyP/HRjpU3aRcYq+pgTWlw0lnFqO+NBIBI6OI96jA3A8EnGeW+YnPantZ2E0kSzfaZHTMc0bOS0RCkArg46KQRyTnoT0vTQ3GopuE1tJcRyGEQnrsAGWCl85B4ycnn0Iqveae1vsuEhnmvLm4XKi58sO3JwD05x9T2PXLVh8trsttZ/Z7sQwWski20e6Ke4I3qCck4yAeem5ex7UfZJ3gNpNcQmB3WVo1dvMkOAMtkYwcAnHUn1JrfNsNWIMpu7PDYWVIGBlAx+7OV5Uk9Pb61HFa2knlSwu28YV5CRyo7AMOR0OR+dYKemu/9f16ladjlpo3kknnkudNjA2+ZIk0qpnoPucdCB9RWro6RT2l5dX1wzqFVN9vKxSRcfeHbPPXjkeoo1yKwsrPy7RUeXI3wtGuJB2yNvsSP932NO02OW60OW2kEelWUhKG3t7bfIVDdQ53MMjBAGP1rSUrx02/r+v8AIbXYrXk9lcWtm9tcRNdwS+dc20jKgTAHQPjqcggntjgnlfNk1G8NwyWVthUjiFuyAnOVLMASCff270XenaejRtBbGRjtWVST5rvuGVyfvY6nCkH2pl5JNYJbJaaOys6O/mEb/LKyOQpGO67T7bsDGOGrWVvxGpWZebTJVdDpdslzGiPLMGYyFfTbk4DEk0WJ81ZrOO3YXRVnlikckhSSCG+YgD7vBOAGH4WrG3aAXn2Se+WKeNS0Yc7ovl3Fd2M/e47YrPur67srgSaXaEzhAkkjorGXIBKszLkj5QCc445qFzS0X9epSvrYmsoSbMab9vt5LgoTIInjdzhcEBmBOMDOAfrzmqjW1wkKwLZROlwF2YjETcFywwu3ABAPA/i79qlnJMtyJvsCwL5BLXkWSRL0IHUFepzjHvWhe6jqMsUMvkQwXEeVVE+cLnr8wODx2HTjNacrT0EtbE8N7apNIkJigmSLA37QzdMMP4iCcYPeqq3M93FHcR7Gk8x/KYlhmMhcHr97k5B/Ic1WjiaC4uYJ7cXTRgRRT4CsUV1CsGwTjA6En0Oai1QGyOdPSeWFCPLWFiwjLZ3bgM9lQDOMZNUki4t9S3bWdzM0l3fTMixuW8uVsbUyfvADB4FJZrEtrCZppDOhWR455CA/pnnkZIxk+lTwSXF9bB5swrLCvmRmMsZMgjOQRj6AVDapZ3dwXkuVZjGUaLGCo42nB5H3Ril3uataFaedvtU1wbqDCYYRxAkqvOSQB90YAz+pomEMIkS3eeSO5HlS+WseSx/Drnd16e2OBNLsZZpSt1LFIZGhwHzuB7Njquc/Kas6cJWe4eeKFV3vs2hRv+8ucdVPOc9c96rRbE+817xFPbxQjaXuljlOVDyNkAcEkDhefpVKSb7T5wvHeQohWMMo3H06DOcE1tJZLe20ZE5dgCp/eBgQT6g/Tv3qleWENrfG4D7kXDcsGHXaR7nrRdbdRqCbSRlW9l9sje2hFwCVVsOAVX2PB59q27G3lsLRLeSWF7mWTeS7chfl6Dg9j2qjFJLaSGRWk/fjJkC5C9xwBVyRUR7e6u50e4ibbs3r83OCCB9T0ot06A6diG/ltUniHlxhijNIwRQpyp5yeedp/Coo/s1w6ReYVKoGWOOQpwck4weRgetFnPd3N2PtVlGVCHDGBSHUgjGMdeT06bqbcfZLa783OyVAAQoAMY/ubcEDg45HemuxTi7dBr6gjW+xlRogzqRGCfl5C7fc8Dn1qpbiRLSKG3tfKLM3MkYLIvGQ2M8Z57itCa3RpJ7eOBLTZ80GQPnyQcc9QOP06VKE+ywzxKJHlYbhJI3zMMEHjsBgfnQ32QkrtXZlWKwy2mJ3uIWTnZnYqknONv48d+lXvsUr2u1pvtB3kqscztngckk5OOe/cVn38KMqywzN5kzZ2Mw2J8pOc8Z6Z61t6KGW2muJgAWfCCM7lK4AJBBIHPGPY1Lb3LfJF2sTRSwJGg2xpMrMJFXDFFAJ5xnHQHHoR0rN0+e4SZXOnzLHIBz5Y+X8jyOR1z3960b2KBpmS0Rma8XEhRSrIGHL5xkcADqOOKigv0kdla4RRCrIVRcfQ+2MHnp61KIi3K+pNLaWlzp9/cSWup/a0TCruKxnqAQMj61WWdpbCW1e0HnDEonaLcRJncMbckjkgjBHAqSyvZSZU+0u9qC2X3iUYxnJI4AGcY4Hy1RuJ7hrSK4gvYbefLZiXaQcNwSSeRtBOKag9mRp1JtDup7PVGn82LzcKHCkKgIbrsOCDxzx2NbE7s19dXnmvJLdMpKlmZEAHOB/Dx+tZGnR2t0xF1JCZ3j3M8PDMc8nAJ9atwGSGztkHG8KkhLZK5HTJPJzxRJK9+pUYJtO2osJDTSM13H5DrvAkzlsELhOMD1Ofwp80spVPsm1gW+83K4wf/rdqq6K3nx/ZpLcr5efmBEigHnrgtn2DY9quxpDa20cDTKv8IkkOCSPy7CpvZjTOMuNQiu5LhHleRIpQ0RfLB8tu2gH7qnA9e3A7Lcuby3ggj8pNrs5gXISPhRuUYxuIwSc9SaWV7KWSIXsV55LyZuJdpTAY/LhnwByQPm4xUTNBb3N5bQPH9leIiIyyJIxB4GShI6d+1UmuY4W79SvHaSzum6RcjdL8pOeOrD6Z6cZ7VJK9nJLaR300MJIbdO6M6FeccAFjzx061NBPbxWErXDyNcM6FE3FsxMxJIU99u08epontkmMr2wmfDbx56KhdcKoPzAKcEMM/T2q79NhP4XruXtXupINLksluIpolBQwzwsrhNxIAIZl2A4IHUEA7eKZokkFvqKQwu9mZkOGUfMGHJKbenHHJHBP0qS0MNvY2H2pbuF5HjQyWaKqyRbuocDO/cCcZwcdCTzq2UlmbS3itIrz7SIkE0ktqAiYHVdq52kkjLDPQHBNY6JNWEknqyK/FtYxQWkVxfTrex+cu9VKFMfNk7gTkAkDb19c8dHdQG0nQxzSw20NqV2ocjyzwGK8DgA4wTjJ45qG1NpY2yrHqU8E8u0pAFXbKMAbTlM+vQgfNxUuizave3lxFqNvbNuG+DywclM8bucf16+hxnJu13su5abXxEWlTwTiZbaSMRwuG3GMjzmYZJZe/Cr1PPtUkNw7yXCDUZrgxYkmWV3CwocnKDB7Hp+tT39xYW+RNcJ9qUtHHbW7lnD8ffC5KgHA5IA3c1LCwUqghMcbNldofPGSWYjgZ6596i6etik+xi2OgtI0stmzW1u4yGiYIzqODkgeueMds0anPdQhJY5LO2CoFEhDs6qpx94AZ5HTArb1HRbPUJXeS0MpCgeXMGKIOecDpnv9Kl0vS9GtY0EzXNqEBCpbMFhI9SO56+1N1k9Xr5CTtuclpWh6bNHvOpGeFhlpJomkkPOBjIGOnvW3py29lFbQQPuto8RoSmC4wACw6f5PSrWr2Vm84g0q4m+2IPM8qV1xsPG4lRkHOR1FLbWqw6WqX2ZpVwSQCQeQc4x1+gpupzq93r0KTTKyaL9untFbDxJMDv4DFgynDA5yMDPXtVXxBMsOtx6XPGrxzHyQ5QZWPgOUGTztJ646DrV/TbmO6MUxVvIVSzMCCF4BHc8/Sq8li2pa0N81olvIGVUnkAlmGD/AKsd+MZ6H8MU4tqXvPRIJPld29DM0zT57Nrm4jeOETycGUFwSWJ5C4yOoHsR70SxEXNzHO6T3GfPEpQnb8oACEnKqMD1xxjPbXu0ij2rdNd/ZASWaJ0V9mMtjcQD6fTntkZUNxZefJNbqjWsL7bYSAPOB1YseR1wcqccjv00UnJ3Klq7E/8AZl1bahPfsS65bDHGWQpwMZ4bOB1xx1qvPZy6n9rNpbSmJPLbdPMvlgjIIwASPvDkA546YqJdakvrCOaeeCRSxWSGQpsjTkcehJI6n+KrNhpVikF095aW8sZChFhiaRevuCW5zzzj2oUpWUnv/XoN8zIFgl1GNrO92yRThZgbc4ZUYBgwL/wgHG3Gavfu1tbCSD7a6oocZZV2qVwO/I56cdKhspEvPEi2tm4hiuIlT93GFYkMGbJxkDapBHt61a1C0bSropfLBbWLZNmlpD8xXPVgVxnbtpt6qP4Bza26lCSeWws4Hgt4vJlTzUd+THnkhgOo54x27ccxXVppz28wIeFpOCY0AIOePy7c1Zje3iklfUZYMlmYENh0IJwFHXhuuPcZ44nutSsFigkme48iVtqzFT5LHOOD35/Kq5mnoi011MW1tfsmJI4txm/dLJMRvcYAU8djt6E/lWq/k/YIgBwXMTAcZPzZGcckbSc9OD6iodQttK3fOtuRIqyBY0UueDhxgZP60ycs9wEuEBAkUK/k7Q5II4YgDJ7EYqvi1LT0sPhu7u3u7qBYreKIqCBFkHpyew//AFVQ0ayV7lLaJ4jblXRztIaI7iDgYwefT1qxrb2s8kSXMTCF/lVLgFcuemPXj0yKt3N5emwigtg0mJcypHEoVlwcHAA3fw+owPap1SuupXM7Xj/wTMv7G4uWW0cPI7k/M2MADnpk46Huf61FJa3dqhVQII1ZhIT14+h/xq1e276fZz3DzSsxdczEF1QHPcjC5NPS4jurC3juWmid15HIZcYPy54Ax07Zz70+Z28i/aKO+pX1eR0t4LpQ9wyqCm9vl2ZByQec8DH1qOyvYZdQikjiEdz5asRHwzkg5BOOeOnPegWa3cZ+3mV44lBCnLFjkbdueTnB98UsdzFBcRpCW2NtiCRoSVYdA3HByRx19adtLC0b1Zakt5LnTWuL2FmNpFJK0e1QpB4Kg7m6gk9O2O9aPhLVYo7xDC04gEbNLCp+Q4cYG3gZPz/Nk+mPXOkYWuitHK1y99KwXcA4UjdkgE4JHTg9h7VEGsBqkUNjE9wbgBXuIQZAgJxneM4A5yR0rKcVOLi9jnkoyTTfYvW2iK0sszxRRL5vyR7QVEYwAVA+6cfrk1ekurTT0z5Qz2iRRgdOewrnIb2QAabdT5hDlyYcqNuTwOgGBzjA6fm+6tmFhFcWiMFnlZVcZyoVRuznpyy8j1qnFt+8zaKiknIu6x+9L3EMkKJGu6QlCHHqcjr1HHr3rPgRDp13bwoiTzgS7c9RnLbjjnp75p2ny31uyw3cjNaLuHALNI5yV6dc5AP41p3k1oIhK6fZ7liCGdNm44ORz169D61Xw6EP8DEsre6jgfEUZgdSsjRHhQMjocZyKZbQ3DeUiQo1uxZoYyctja3B/hxz0yK0/tE0jxNp5tmQg78vkg8g7RnAP4Vovby2+ye7gu47FVIaecqjcjgAKQcnkYx/WiU7PXqN2te5k2Mf2RZprx0tpAufKIJCoM4Py5H4DPerpaC7gijQhZom+USR5BIyuQoPpnuP6UXtu9xAZbS0+0qiF4fP3tjvkgHOen51d3J9ltZ2hIumVfN25ByQAdwB5Az3zUtoHd6Mr6bp8Nq5tLB4lij+Z12EOSenIwP07Vctg80MjloDF5rBGG4txxyCB6GqGpatZaVeOkiukSqPM/vhj90lQeeM84Jx7ZodyrCKKSRLPGUeKF3YH0bCkdPXnOKjlctyIvp2OVkmUwrNfsJ0J4t9wVWUHndjh8ADgAY69AaeLO2Mq3cNoCm0Hy1G5VUhWGSBwPrVmZDqdotw8CK7I3zrJ9/JCjAK8YGRyeM9xVe3sMXttFdSKGLRpCNu/IJICt0wSQenHB6cZ2SS8jC3WWo/7LaNdwNNJvDKgHybVVQUGAwAHTj2qe9to/Nj817zT4ijBpJYnmSLlcRjAGSeWySRyBgEZKC2trHVrWS8y1w4kVktxiLgYI2kfnz156VFc31ndbpdQtZ4NOicBVglVJXJXpnawGCCenT3qZa7f1+hEmrMmhMqWumWk8UsUKyK8juC5UhiAFXHH8JAH860/DU9pGUjvbiUZyhYzAMSAPbJU8nByBtyOcmobiCDRJVTUWlikUjzYTgwomdwGFz8/C5wCMFsHpU9nc2mmi4tp5GeRpCDHKpdVPbb6AbGwPelZSi7dQjqbGnaXBqtvHdTOcrIwDp1i+bAAI4BBHQAD0Aq7aaag+WLULrIUK3kzkFMdixy3twVxz61zlnFqGptp8sMdnbJBJ5jBQQGJCtkAHpxznkkmuphjg0+CKC1g8tZGCRhVX5m45PQfdBP4fQHnqXWl/l2Kbl1K82n6fZSxyywt580uxZirSNJ03Ekc9QuWJPbNLY3M1zqLQyac0cCKyRT/av9YcgY8sYJz+n41es7YQSyLLI000hMjbhlUDMwVR/3yfXp9Kp61MyjypElS282NnlaQKm3cPlAAZjuJA6AHvgcjO/M+Xd/1sQ5ClriC3k+ym4YklWY3HmAcA85yWHP3AR+tZVnfamlzFFcaet5aupzdQKyiM5PVCX4H4de1bV3cW2m/Zc29mqXMnlKscZUljjnOOvsQO3NR2usW8/nR2fkSXSRiUwxoygqSoyMgDPzDv1PI601zWvy6CUkMtpoGu/PcwRNt8ppj8pI6heTkjmpJ2CvMEDmXj5WkO08dAp+73/niucu/wC1NFvER7XT5buGJpbuCEnyirMqoUBx83XOSenarlxqF0l9pdjODbpfKjQsRgtuxtHysduTwRz35xzWnKpO6LUr67F7TbWWztHONkcmCY3KFVPdQQBj0/LGO8sEMUsi3Fzb7WtnJt5ElGVGByCO2cjHt3zVieOQ3CrblRcM5wkgyrEAkoSMds4PYgHnpVa5me1uEdjCY5l2S2/zAllJB2HGAckgkjkKo460ruT03ZTZQvmXUDdLDdANAo3RvgImR/ebAAPOeemazZ7B7WCIRQiV2UupjwFAbqxYEhwCBhc4we/Wuj8iKYLMFUhgGDMOHUqeCMZ6Gq4jjhkkFnHHEWGDsXaqv24HXPJz/KtIztojRGdZ2Fna6RMpt4FYyf6iZUDsQwGdrDOMrnGDyK0r2xmljzZXT2tuzbY5olU7CBkqUOQc57gdc9s1Bp1taHxBq6X6x7HtnfZs3YVSpDA+o29MVX8KzXF1p91cTMkSskYAIJX7784B9hT6X9Px/wAhOSLmhva2XiK385AJJJ2RMxgMoZWAOQuevHPrzVjx3cJJq+lxLsnWONg0RcIQcHv7Y6e/0rGuZLm4sJ5J1it51UHfCxDqoII+bB574+nNWvEB8nSbOe9jmVnC7XDL5hcjJO7nqAaPZ/vIze+39feKUbSUipPpljeao7zzTLDG3loEQhWI+YksQQMluvv3NSxabBBYQ2txe/brK0IeK3MK55OWJIBLYJ6VrDR7q9hu5IZfLIJLjd8rZG0AjuPl6Z/iPNcvceUbS+ku0RpUXFzsQKNrZA25J6jHrVRfPpfaxSau/IfeyW8Eol3RLEZFQGSIh4o8ZCjPUjkjjj0qS4uLi3mjtAbe5lSRI1tX5liwQNxO7lsc9Aeaq7xBpdmLZbWGBFMyy3ERZtpxjlecrg9u/FalvoV7p9/JrF0iSrcM5VDg7S4OMnPIGcDjuOnNVJqPxfLzHzdFoVLm4bVEia3tI7h48hzkMEz0K9lbr79KSe+1CFYhFYpCCqr5hlUfN3X8emaltLye11g2It2gEqrsQMNqnOCeD05H5VJeeaLwriFlCo8jkENhSCzd+flp6J2toW5aWEtZDb2d9D4guo5re4l2x2jwhVIBDBtw54wQBke+axLqWGWJrvz1lG8xxKjlQqgjBBBwQc9CDj8a2Wu7a1KTzTobWVWlT923T5e3PTcOffoKy7mOPylvrUma2kBkVWQDbjlicnngjjjhcUQjZ37ii1EZDIPN8pbppPuGNsk8Ddtyc46454zuFWSFiSeZohCy4Mb5H7yY8Z29Tzs57561X1LFvd28gSJGlJePbnLYIxzjj738qmd2miUz3Ajt2A3YLFgxYqQOPUU3qjZu3wuxVjudTkvrZLi3laLJbaSHy2OnA+Xk47fzrXubW0tlItm+xqkRRGjYoG3EnGeM8j6is27MMDIZlaCAHyxjHOSOQB0K4/wqVpxpmmxadI0M8eGkLXG5jtBOTgA/3vXpScbpJGd7X6+oul2Mq3wa6jEinOGePDdPTp7cir9/9skBt4rdWtol3RwIwjJZiN3zdugP4YrJn1mCe3jFmlyZYeSuQqcA5B55H/1qvWk0X2IXAhLNKCpE+CAFbvjr1ptNO7CVpoY4K+VKsMihWIIln4i4IGemTnbg+4+tV49RfULgQXxtHe3LkrGFcn5SCCQTtJOBnrVi48lro2kMEBlkw0shTb8vByDyc52+tLJbQvYagssUPnxjbHMsY2hifmZv4i2B1Hr3qU7a2KmtFqXLS2jWFLmOIQxorsIUVTuPJyWx796ga4uLuWO1muJrsiVXNtIxxF/vH+LGe/pSaNcRzWiWSpJKBHtZjgqcZ5wSO4P5CqRcvZxwxSW7TlQwxExJ9NoOAMEjq3p+A4tvUNN7eh0DNLbyoRIYoBGVPlqxDHPTCnjGCKyL27inQJYXEzXe8faIgwYQIDywAUHHHcnGe/WruhaPqwlt1gZvOljd/MkYKfmZeAAx56c5/wDrVtd/s9ktGWO1hTezSSCIl59oyxZgOeh6jvWSs5Wjr6fMybd7lY2uqeKBJfadpFpNM2FdVdJMbeACxO3PJPTPFa0F+9pqKwahdabZReWd0Mnlny3zjkgjOQM47Z9qrrILS0+2w6fHaQNlYgIUdJDkbiUDryOmSfwouY59VjW4tdlvdFyGCR4XYMjj5uOccexovfdK35fPVEKMtkRSNBdWEe3yHEfl4VbjzGVd6g5A+Yk+44yay76xW9Mu0x21vCQxFym9eNwKqzDI3Y7dNp4HenpKSpNDJCZVijIW5Qx5MYJ4LEAE5IzntS3r3LSXMwuM2aMxRZIywdlJ4xkZzzz0rZLl0RN+ZWGRiOC2uIDNHfXG1IY3ic7bZmUgMrHHVtuenPU1s+GdFtpUkbWbi3+yg70SVVhEgOFDbsjoQwxzXOLaTR30txKslnbXJO2EYHOcjg/dI+8MjtXo1voMUmm2dhdzm4t1Dym9CiPHzYEW05OMnPXr9azqT5Vva5hJ30Ev4Li/BuLVBDneVmllyS21gpC88H5SGHGPc4qCCKR7eO1u7FcxthS8gkL4XG7Pbp65qzqVnf6dp4vV3NFwPL8wLGq9cgEk8D5QufwqHRmlhtpru+kZkyHXzB/q938P4cVnFrlunc3jZq6L1tDPaadEivFHiNikatnzZDkenGDtJ7c4GcVb0LTriF2e5uWuZ5sEk54yQcegH3vTrWfaOb//AEm3mJt4Cqqp/jBPLHPI4wRjGfftpSp/ZTXF39puHRS7De5KYLKBhRj5fQD1PNZTb+FbvyMZaIdNczpfXCQQ/u4w0YLHaokGDkkj5gN3Qbs5bjjmwj3ENpGzStdMIxlnAjGAPmbLHA/ve2KzJI2vGtTcX7QtdTrKqRoyrKox+7HOVLB1yxOTx/d4S+1OFJLyA3kDxog+0QZA8mMoflDdctkDg56ntxnyX0RCV9txbeG5tZRC13eXM8z7y8GYkAwo5IYDA6kd89Dg0kVtI0eoz37TCV2K+W6+cyIQv3QCSVOcYwMFiMZFc7bazrl5Kw0m2YoMBtqiVlT+L3B6HJz1HbFaWl62l2tvuZleWRo5neXeYWyzclcZUYUAdBkDOQK2lSnHU0cGi9NOdHmMLK1xBGgLMAJEMmT0xuwdrAdvu+9WbQQxW13DZKt1aLKoNtuG6IggsNp5ORyMcenIrKuriW0067WEnU1hCSRTxosrT7m2sTsUodvyjbt3DGela0UYgWOa33yG6/et+78lgMDGTgAk89v8KhrTz/Pr8v6RMXcoWpnV386YXzXDJJbhsq8RIckDgnkAAbtvIxwSac90lvOn2iB4Yxvd5Wl+RWUZIdc43cAYPU885qa/tpFtWli2tNHKu0xfumCA7gevUFe/uMcnMVxbpeWcDiUSgP5kqNhvOIILIcYBOVKng++atWZab6EqSRm6aCONoy4Vl5kdZOhJwV2ryegPU89KsTAqUVsZK4BJAwQenvnjj2qGeFJLi1xLIDCxGYmC8FTwwwcjgH8Ac0w3JkmkiaPe0b7Vy3K8DD5/Hp69+DStfYtOy1KU8VjeMtzLbF7tRuLMrKXAB+Xd6Z+veqmjTQ3TrFDFG2nsoMkGzKOuXx1GMhwDx6e9aMsY+zyMJJCpkEq4XAA4yF44GNzYOep45qnPaR6YsjWt0ljbeUEWR03LC28HJVjkk5Yc+tbRas116b/19xfTUI3ubnUHiWBUsQu1pN2Q+O+Mf16ChraImYmUpF5hDEEllPYAA59fyNVbC4ksy9q10khjyXV1O6TPPy88cEdM9D+Fq81NNKhluhDBKGZZPIkiOWLbucn+WOPxrSzTtErmfQ1bfWjbh3h33Ft5Q3oFOZTtIUjg55rk4YLi5ubyQ3qQxTRhI9mG2OFwzAjuMN096txJd30NxcRymO5s2aBYoEEaMOqgp0yNx7c8Uy7S2jt44o9QijiQPuaG33biWALgjJXqeCTjd7cKEVBtR3f9f1/wCFFdiPT530luQdV3r5SbwI9zZJZg3JPVRtOBkE9c1ZMUdrcmBbHBlfcgmAjTAYEYLcHGRj6dqbpVkZ4pHjDkxoy28jMCH5yGC9mJ79e1OdV1eIwTXUkN1aumJHZv3hGdyoCRnlcHaT1H0Le7f3/oFuRFWC7slmkJtph5TBTKZTgMwyCwz0AX3+lRTMbC6t7m9sXM5AkIyFV8oc4I4DHluQPStnQtDuF0u7byUvJIctLHKFTflcglmPGACOcj5ulZNxbR3s0UVzqMlzaKuRcJIFJPI29+inkjA4zgVSlFyaTGpXfL2NHfaLfW8S27SiVAYgeQRhjtzz2GfwrnNKuLxdY8rzlliuBI8lqD8qHawCk4wOg5HUY+lbEdzcRW8NxLa28XkTGNC+4bF2YB+8CepHX+tJAbe3WW5msobO93fMgY/L2J5PQEtz7deKI6XW478zXYq3mlIJALPyku2OWbGBgHk46ZyRzj8aVrdPsghM8KzxYLO4wrtvJwfxz16ZzTorhpriTEJNxGvk7zLsVicjvwCSB3649KrxWl59vcSxF4nbDxSMCD8vGG7c9xzkZzVK/VmstNEiS8tZG06OKOISzlA8mxskqEwSp6MRu6A81BEv2nTXt5mmlnijOGZCG3EsR/Tj2q/wCU8CyvLJIUCAKkcgBj6cAjn29+9W7aFykygIk23cpaMB++CQeuD0pXsg9TATTbi7utsvmeV5gLb1+TGB8pPUdfSrml6f5VxKPJQWEqAiEOXBYHBODyDwO341ozQbR5ckxTcRvcSFN5xzwDx07UwRG1maKyxISu8h5CxXkDgk8DqaTlcdrsgguLOZg1qhSfGwyFc+WoGMMD+A5HpWh5MTXOxilySrHGQQvbcQT8uRkY9/asaxWeJrmaW2jimWVlWMDd5qAA7ioPUkE/l+OrbWSWwkmnmkEkpByu5QCc/KRknHJ4yKUmujJTukMlVrQlN0otmBY+WgKoOeM5yB2HY/nTbRXkvTqDylLAKGjQw7XjAHLFsbvmxnBPetBBBLbSDzUkiIMbkk7R7E57Ek8ms0uEdtOWGVLTBAmN2HYqeQMEHPXAqbt6f1/w4Nt7f1/XmXLuafUljbTL026JlfnLbZAe/I68Hj3qpeFdPurY2phgiRmVoIv3juuMAbsZGM54Jx3xTUtT9qhSC8aCEJt2zOqBiD1UHblue2e3FUprbU2jj3vD9piPzPHEGY5B3Z+Yr+IFCS+FEr7y5h9RjEi3Ec12XLK33ii4ACnjPUMfxFVWuXvULJM32cDaFki2/N1LdOOp4pNHuJLGdfNi8qSbIEWzLqADzhQCR17D9DUem6Ve+ZJ9guVnjHBhmx1wCThmyOtaKyeuxfwtdipcQzyWEV1FZRxTRwsgCFQUIwu5myNxOCRgDBPPvRN050aBHt4JZBIRLIwzIJCW2gk+wPIzitrVTHBPeGCxuYXdSI5Uzkqo6E5BHQe5/Oo47fStUggtrjUI/P8AIEryN5haJujKfUjjvg4qOZJJnHKSiyloenPHq9pe3X2pLeMRSxDzVYTmOPdk+i/Lk5GT7Gu2vtPvNXU6Q13MlzJILgzBi6KoUjauSD2B5AHPes17Gw0aSK+sTNHCuVMsYaUOcFUdgzdz0C7h83XABN7TdWuLWd2v47qeOEBDIIRGJCcn5VHTGQM+3vWUm5e/Df8AX+vMmEOqQanFeb9MtrOW2tRDbxL9lJcMTuJ3uVG07s5yOeRx1qSXTopri3hm3Oqn7QVRhtkk2lSuCPugEnJ5yB74F8xJBILWS2curu6xbnycM3GOoBK+uR0A5EB1OcX+kzXiy2htZHDrOvMgMTAEbQeM/wCelJc3L7vn/X9altpRsjTgjebTb63eQh7q4wxHXbEwY/muf1q7qe9YbFIWGRGlpBECU858HA3c7RxnJHG0dc8ZUn7m1vrGOcwXH22cqzDjKvv79mBAz71pys1nFFMI5FZWHyhiPIQjaMgdSC56A9DWEtPeX9f1sZyWt+o+01KS3e1tHsWa5WVo3clZEjk+TrkgsBnsBnB6cVzHiuwaGHVb+6EJeYgsqpwQrqhIOenI4PIyOuDWvJd6bPrVnOkiPJFhbmYRHCqzD52ZgCAuxvoS3Qk5h1VJLpbu1kiYwxwlzcu67SzbcbPmzhixHYDI9BVUvcknt3+8UHaVzT+GgsJ4bq8sJJzIVEciOAFXk4K/XH6fSuG8VW1xovja7vlcEQyi4KpwGUkNg8/3SAfpWv4P1yPw1NNZ6tDOk8hQY37sDJOfmPP3u3NeiXtrYavpxcxw3KlN0cg4Oeoww5HWlOo6NaUpK8ZDnN06rlLVM4HwzrEEMl1exK7wbBJ5X+s5yEyhO3HuCPxq+LS4TT3Wa6WeK3PlyLKG8xFRy4dW5GSrDPHIUDA7cz4d1BYL6WGCHzMjz44gQmTjYy+nYN/wGtq3aISWd9IkFpfQRtb+XPKHkQlfly7fMNvmcggHAxg8CtasOWbt/Vtv+HKqR5JF+KKSxuNPsr2ZvLjlVra4xkzb45FCPzn+Ac8ct0qS5s2nVoxI67ZZNpjODndnH55HXpWTFo8RtGgZrtjGxkl84O2fLwARliQAzBux4PHUUyxS+0yVMSyT2iym6IRAd65zsGeVIC55xkt9TUqOvNF6jgnY35bWK8jmKSYeVGQEDBjLcce/oaguLWT7OtqJGE0EQZXzyxRcDcfQk81YRkmgU284ZfM+cx9Rtf5lIHToQfxqb7RDADEWCJuAAb+8xLbfXJ3cewqFJrYe2pWYEwSgsQw+XA6KcA8VBodhLr891I7tagkSRbDuKcBSAeODjPbk/nMbqMwYYKuxvNeQHIK4wR+fOfaobW3EalJQroDuXDEcdMH8c/nVJtRdtGU3eLtoZVu0xzJZwxS28amKMzH94xU4yx6c4I+p64q1Hbq1g0FxKLu4LZ3SLkIwxlee3XvUjWklvby2csOyMh2RSAhOWJyMe+cf4U3Rmt5g++GKa3njXzMfJvIORkAdec5+lbOWl0XfS6MSzjij0i0sxeSreyLKIFySWbJP3scYG3+nSpIbg3mlyWcQdc/PHKXyTubLY4425wPX2q1bSRW6X1mDHJv+a1WOUI8gYc7SDktxnJOenNWIRA00Ba5NxI5ETouTICcZZh0XGM5z9K0lJX1Xn/X9f8BLQz4knt4onE0s8FnIs0rKf3gVclwxJGQc9B/dHXtsanps9zD5ltbW7mXcRLHiKRAVJVixznHAxx3qHUI7ZLgpZxbZwGWE3CHDSYUbwSD0IHP49+Wm3+16VNNC0iXRCPcQSuxZWUHGEPyAlgDgYz3qHK7Ulp/X9fkJt6NGj4Fc6RBd2UkjzskQlMmfdsdfx/Kuavp2eznt4IYpopn3B2iBdWHGBlhz8vXvk9M1V08SZdvtB3earSK0rEy8YUZXdnG1uGwPmNX5r57DW4ZFs1nthLuVyFUOwJZk5HU4YZP1qvZ8s3Ldv9B8sdZLr+hUOp+V5stxaolp5YklcoOSWAyFBPJJXJPYVpxzw/2dbxGxDXl4Nz5ZfLQABju4yxILfjioPFOqzat5c5VoZ51WMEyKrBRubZkEZAyeR61T1G6S10uCwaK5+0fc83BZgu4Ak4JPIB46800uZK6s/UaukuYp3Utrd6VYi3kmVYH8uTco3K6+WfXB6Hn6+2bOm3EflXW3E4VwjmXIyCAADweM5q29yNL3W8NtK6KzkzRjcsZ2kAnPXBAJzjtms23uLG6uY2kvIhIHYNu+baSSSdp+XLEnhcnpntWl7x/r1Hez3LC20h82a1eGeG6DQhoIzGQD027jxjGMn04BrUENysSCGFEk58wl+EB78denSseG9uVFzHch4YmdkUE7TgbjtC8Y4HUcnrVyKO2vY4w0bQ+aARGWbzcAsCzMucjkfxEc84xUSurXKUrLfUo38FvHYiC+kzHKRKkyrmUgndj6Y3Dr+FOj1i2kWO1Mfk4Bc/JuPU9CCMULBLd6ipuLJW2ygyT43FguMr8oLdunTipbiHy4i4ujEByk5iJdCTggpznOOpPFXZbMd3e5X0y0tBbRXcmoztbRSqclSCuMAIevy+w9a19VkE3leWwKgouNuN5JIXJ9s5/Dt1rGEd1DcyXdsHudyYkMLtDnod2ABg8DoP61YW6sEije2igjvJ0B3mRtyOcEg7wB/wB8k+1KSvJPcSfLoS61FI8sE7rHI0MSqu5chSAB3PTgdKpaRNLfXzPaxW5tHibqm0HjAyM885P4VNqd0YVihuJypmVP3qxK6r0yckjPOScVZDLHFLOq5WJSDKwx5g7n/wAd70rPlsXda+RWvHurSzJurSMwBynnQSBWCHPygEcdD+lOtIysrtaPFGWyojYEhQDg8jGSPoKgt7g3V1HIkvk20MbTCH7wdd2WwR3J7dRVFFwzfZ5o8/MoVk2GINz87EZ7Y79afL0HGo1uaOn208nmB41e3LAv83TjgqD05BB+tOgMrXhdJirIvlsrLyDjP97k4Iq5ey2/2aOe5ieSZQQFEeQuT3BwORj8qqOIppw128UloF8uOJlCAYPYryeh/Wkm27/1/X3F8/Np1H6ha32ZUWB7xXKgsjtu2ggZxk4yOuMZ5qDSLCzWeae4tJILu1yfs+GIdc5BbjkEg8HJOcdsVpXGnNd6pNumcpLGSCi54wMgtng+nB6H0qhNdRaYzo8c8c7N5URnw6NtAUYPy4zwSBn681mndWOS0b2Z2NzotvPokVyk1xcmaIGKJI8RAjBUBAMg5AHJ6547Vn6heLBaGQW8bur4EMkgQEkdMnjOOfy/HXtfET2ml2f2qzeJ41VCtvwnI25APVRkHHHauOfTDdtHbXd1HbbkMirCMAEEg/uye4xzntWNFS1dTZP+tjKmp6qRTt7/AF2GaRZDcRxMweJpXVvM3YPDsD2LY5PT8K1byziTT7aS9Ny5u1VWWSaR2gYKWID5z6jjA496qvYahHItsupTJZjEYjgZhGhC8bRnG3IAI9Salh1TdpkUiROXgCROl184faCM54xgsex61tq2rfgUou1zegitNSDTgs052PIru2WJA+ZRxycYYc/dzgZNdNPaW+owO8UuWYrIQnP8QbH046e9cNFL9jvtlnbFrWRlb5Bt2kIvGACCOAOoxg9a6d0cyKLS7jSSaNmiSWT5w/YYHXkqDj1HtXFVi1Z3suhlUi9NSGXR1Z7hZY7eLz0kjP7gjMZwMYRlJJOTyeCW4+aof3MjNC8M0tg0Aia6DE/OGRVTCgYy2ckfdKZ4qU398+nSNc2ZuL+xd1liRGPmBRndGDk7iAo571Hd6hf2+hpFDb3FwXTe0kgbciZGfXEilwQc87Cfl7Jc39P8TPUxvEGlQvDb3ka/ai6uFuWYMRjHp1IIOPpiul+H9/BeaGLUSr9oid0eMNlgOO3tnHHHFVYv7LSxePdaabLctsELBYldmBUAL/ESFHFZV3pdw2vTzafLPFPGxfCkmESbcckYIYg9MZ5znnFau1WDpydrGjaqR5GzmtPsSuroxnEJMRJkZTtj5x1BHXPTNdZdaRBcwebLLNLfS4cIsRZbnCqThgOGxkZByfl6nrm+GreYam13qdq0MMMRR4zEUU5IwMNxnv8ASuit9Pks4QYlM6RMrQeUpLoVVflHqzEYOMelbYip7+j/AK/r/gamlSV5aEyTLcK4kOGnjkVJY0x5kRAy4yCM85/LikkjjsbNk3xyEwKsUUq/OxBJJJ4zkFT0Hp9MPT5J7eybUI2uJGlwx08yFzEWG5XC4G1Dhl6cBOp6BI9Mm8QNdPI86zyNEY1KktaA4Rth6rkoTwBxg+wx9mk9XZELXU14bO0sLu3t7SaVJlmeWVSWZWVtzHIPBI3dMnB6jjh9zFHNcyO6+aBICvGOQMBuPTpiqlzbW8y6Je2KSI+6bzRgfvMKY8sR15PU+vvWorgQSRz7dhRYwQf4mBO0Z/Hik7rW+v8AwdRp6XKX2dJJT5S5iOUKbcg9yD6VBLai5tfKnmkiLZAMUu1yAQSQRz1wKNPs/wCzb+EQTXL220xlJDhS24ksQOM470/7RFFLPFdPHDHFg+Y8oOAQME5Axk8fhV2d/dZa1WpVuEa71WIvf3KmErG0LRsQ6gfe3njqRwPSn2MUMDssWBsQBY+i4J6/htx+NPsyEd7Ha2YIdwkY5BwQq84GScg9u9OvNIjs7OGPSpbWCe4jSW5kjGNr87ipXByT68kZp8yT5WylK3uozI7HRpRZobiZL0r5qOMhrc5J2jjB4HQ9iOBnJp2lnLF4stopZzsvH/d3Ue1VZQNzEAfLzwPbJpdKtDd6gJGuJ4zK5kMcowQ2SoUnPOCvBwOCvArWNoNV0CGITLaSWjs0UlucldxbPpxjPTFbOXLdX338r3/ULNK5W1meK21gx/aN0CTxhJWYOS+MMox0HyrkDHNZdzfSxlm08LcefIq3MsV1t2gn5Ww5YAnrjHr35E9ralkmtsswtd0kTyLvaWXPLleNuTjBBJIqWCV9PuryCygs97IU2iT5nONyjYFHTBxyaastFrYq3u2IdLuYWeYXjabF8wSJYXjUuwAOepP8QGPy61JL5VykVtibzImz5e0hickbvmUkDnOfwzzWLq1vb3UM8V5/aL7PmSJ5Q7M204AJXofp6Vsapiy0hSLe4ntZEEbwEbsDbjJTGCeAMcVVrP1HrG6Ygs1vlg866EVyqcxCFGCM2CegxuG0jA7ZqOW3ge5G67U3kSjy0aRf355JyGJK49z/ACqrdRwa9LbeRI9vO6BmVHCDLAkkYySOMZ46j14pvBcT6u24ob15FJjjYqU2tjGcE9Fz0ppMI3ZOYLhbO7hgead2O0gzY3AZyctnr3wfSqc8cNrbSxixDzo0Lh4lBJchCy7sHlTxweTn6VrGyjhl8u8urWRok80JCArMVIJLAk88dfb2qprd05kghtNo+0AO7o2XjQBducd+Djp1q4u7CSW5cZLSSOwmmmeSKYb2Z3A8raME8jcSSdpOcjcar6fcytZSfZlS5nhOyEs4V5IyCx6YzhzjgenpU3hewZ1dZHkjmidWO4Y253FlHp6Gr1zAmmtE8cVxeO7gM5XOwepPt/jWbaUuXdiSTd7lbTpzbFJbmfan3ZNh3OWzgsFXJzj5sY5p11dRR2pyUuc/34jAGGRyQ3Trjnrjiq06wavpW24UWrTy/J8wyXC8NkjvjHQ+lXbDTo7ZkjDfaYZEIYuQ8YIYkcY9zznsKHvdlre6ZSut81nGYGkjYzqHiicDA75KgYXHY+1RR+TJK6ta20yIxEbcIQCQODnrjkfTiruqPDbPCoVXiEwnltoAN75zkkf3ScAkionupL9pgJNgmuDLsgYtw2SQemBwAetOLL1aK+oLYzCOOW9jZYekHylkPGV3enA6g96s2kEgjuGdg8UgKmHiRVXB5A56+3rWjJYizEZd0kldBJ5O7eFj2LgsuBgcMcdML164yre+R7mRzJHHZzMFkUrjYOgI5xj29xRzXWgQ5ZXsMsDaQs8UxggUuUyw2gKcdieg9KtyeHrO1kuxHrKXTu6qUjiDnBz8zEE9OOOAc+lDxWFqiy200kqNIXLxqrdDznB4A4HU4AqssNnbWS34SLy3IWNlKyOxOQrScDjpzk9altyd0yXbR30H68ssUG0xvKY8NuKsFOTjnZjOPc96sPblFUvFC9wrEiJ9kQPXPB4HU8Vn3t2Lpoy0zLHGxAhjj3Lkjksu4fhRqoudUvPtchSKSaMFg5O1iDjj8s96ai9EF5dDW0b+1bkXqSRm6Vc+W1uAzLliBkAA/nzgE44NJdyiOxMOoxq5WUpNEy7js56gj5Tg9f1rrPAtrDaWTlJS17KA0xJIJGWwducDg9QO/vVrxD4eh1S3laBvs12Qx3xxofNJHRwRz254PvXA8TGNVxktDh9uozcZbHFJqU0V4tskMtvZk7bcpuBXjIA4BPpwa08yiS3a9lLBSzOJId27IwPWuM+33q3YS9uAt1BIoMbrgRneueScKT6n6Driuj8JJqWuS3FrPcrA8CB98sXml8nnjcAMZX8/rXTUioLmdrHTJqOr2K1/HE91KdPQyhcPMoZh5ibcFVB6t0PYnBqvd/btPSHbFJFB5a4txiGSYcgYxzxwSQSTj05rpb7w3fadMt0Jobq3AzOIoTCyDBJcHeeAR0wevtWU92bqaN/NN1BDlfOlgJ8k9NuSPfp3z7UQqRnbl1X9f1+Q4uNRe4zMmsGFzaXlhJF9lXy2Nw0zLuXC8YYdQdwOcda27L7TcWU9vqtnHYXIUPbSzyhomU4zzjAB2jr6D3xbsUjnszH5dqI8cYiBRsfxbei8j9Paqq3V4kKpq9pb31o2EDNKFYr/AHV2t+PA4pOTlp2+/wDRepLTb0L9h5twIreeEXDwIGdIPm2oCQksZUfMAAeBzyv4R6JJeT309wL6Z7CQrGltKyhS0nACtuLKQcgZCkngVd0+YwbptLhKlYR5Ue751UdYyzfeAIHbv3qvuDWthcaalobe5dJpItjKV2/MCrBlAIOecHBx75wlrdNb/wBP08vz6nM1La2pJq819Iqx2FtFeIdjQSyAbdoLhlYbWKnceDg5BPIxguMltPfC6vrS3S1eVQhYq0q3Iwuw/wC0FDcZOQOhzTbiaDTdQa0WYwWlwFWCZ7sAsTkOiBuQR8pA65Y471MyyiyDz6Qrhrlp1AnU/MGIWYEDGSADwAecZ65labL9H+fkRfsFtcRXliZLG7QxngSqS6gg84DAfTGAO9ULnTI31Wxnt5otPuppAZRgTNceWQTjsrL82McnIJwemoYoraKaGx0+IxggRQRZjD5wWb2xjGPbNTlLOJ0upFWMQbpV8z5tpPVsnkdASO/ShVOXWP8AX9en4lXdijbSLc3l5KYooJGcQLOrb3OC3VQPl5cEKemT05qtr26301zYmRb4uJQ65/eNEVLZHOchenOM+uavWUSTYmtWRLeUtJ5oAbzWYrtce+M49SwJztArD8Vf2oZbSPRYTcTxyvJN865ijyoBbPHzlJCcj1HYVcLOfZf5dxppOxvxW7mysF5mKJnZxggrkc55xwfwrM1YXKzg21whEqhTA23AIyC2TnlTxgf3var/AJ0kMs1swCbYkS1UsVdsKFY9c4BI9OD171mIgE/2Z1O6DzJZJzJkqzMHKDdnP3unOAo455Ke93/XX8y43NONxLdqsDsLZXICE9skZ/EcZ96qTon22RntdqSKqtIeQ2MnB+nH5ipE/wBHhlklPlbJtkZX5htLAKO5zkjqaS2uY51iimlVpGVnBwRGwBAJDfdJ5A69qErarYu5U1NAsMm6VxEyojKgJCjeGyAOmMdsED6Umkz6a6MlgIi8p82Qp6nu2ehqe+j8uwkuYZEmwjNskYBSSDgEntkgVBptpZh5obK4jEpwzrDEgYrzx0zjP8vrWt04f1+JSta5mLdTG+UKZpBFKDv2cKowCSfqrflVu0uiLi7ksZcrEMhAh3LkHABUHdn8f6U2/tprDU/It0+SQndIx3AEsxIPOO/GfWpYks7WZ7qC4+zoxBlEqbFx2642kDOPz7Vo3FrRbmj2uEcbRwC4eKNZ5CzSGRihYklskYzxnGCPXitmLR7vyHvZostF5jIrAmTqei9jgduTn3rMVoNS1K1i+0r5byqqyb8hwxX7vIBPI9f1rrde1aK0tbiOFjJOMI6xhmaIEfeIUZzXPWnNNRitWYVJyVox1bOGmlitRbi88y5DsFiBXeYyT97JOR/9aqFzFawXUYMca3aKrbsbpDHnGNvUAjj6/ia0L/Tri7DMsnleUx+zsEGC21SFYE+ufTA+uTWntkuWE92vlTPKLeOTPzMpGcg9cHJx2z7iuqMl3N+plx3jWdmItmbmJU4T5sLgjcGxyMjGenIqfS0uY3t55ZElXyUYD5WZUwW+Un5mOwqcfh71bWPS5l320buFxbqxLjzFHO3LduAc/rUKrLucWsSRyw7YraNj0QKFOSTycAgHjoOve73vpYpNtkOi2MkN0tzesrFELI20klSPvMSBg89Oep/FlrDHeal5jlJ0+1M04fggKQY1A74AB49eas6pHeIVtbSQtAyKqsAHZ+cYJHIBGDnjp1rOWa5tr5Le3tlCou6Q5wzMAdxyeeSpXPPC5FVrLW+ojXnd7yaUWsczOIiUY5UQsVGOGwMk+nejSreWPSgmqxTtJExcojO+QMkHjg9celMs5b0XMENxEbe3dSjSh1YycfKwIGR69T1q9ZmS3gl+1JLG8uY0jMrSMRj1ycDOayk2lZA7GVJcRxy3OoXU0htHYRxoY1McTbV6nPB+90B4brTGWaK03+cY5wPlRFMgXJAzwPZh07+1VLaW1ubZtP1BXhfzFfYshKh9qgbsgjPbng8VqxxS2+rFAjXEcg+WRmGMY5+UYAwQB26n1q/hepV2ttiF21G8ng8gs9vJtYSI2CR1yR1HHasvR7KW3lunmm8h1UO0kmIfLYkqN24gE7iOPUVrzfaLHUjHYhvJZPuDc3lkcZBzwMKBj3pL1zLZNPrFiLedlWMrKCqyvnKkjgN89JeRTlLlLVnPcCaB3eSaYIY3lUBvNXB27dpI7n6571nT2zzy3EdlEhmwrpI23dJuGTnqwHOeh6D2qC81DUrCO2EUMcCzpiCXCgNjrsB4OCccelXIr6W1nPnxRRrBHl7kDa0hwBgegBPYHoBTSe6t/X9WEmo6ozobu5h3xXN2DJDJse3SNn6AdGC8YBx/+qiSe7vpIrdwZQOAG2su7aQdv90j5umCTVozQec98nl+XOjb2bYAGB5bOOTg8/hUmm221I2tbdpmBJMqzEc5Occ8E8n1GMd6bSWrQfHqyOwmzaSzTyySBkGSoPA3YC4XPORnp0/CobBJbqYXMJSSBd0SLChYqQx5GF9P506xAE8sXmRwSttZoUdWCjB4xyD0zmrUwnsSiaRE8GnkhvMSJmYHb0IHfoOg6Zpt2bt1ITlpctWa3NprzvfXEInZtkcUDEeUex2nleABwe9deNUntY8lZblhtymSSTjp7Z/HrXEz2CymCa0iiK7szTtImHX1BBO3HrxWjpd2tpaSC5d2iaZvLZQ0uFGB1APHB5zXHUpqdnuZSpxktTpba40bxQjIVEN8o3OmUW4XB5x1IHA7dCK5zxHor6bPIz3d60E6qIpLYYnQqfmGc453du1W2uvNSO4sjE+8Flm3gFwRx0yP1qudStbu0hjvZWuPKcsEZSCDjGR+B7etZ06coO8duxEKMls7rsbNhr1/5cf2mG0msygCyKWDtwOWzkeua4BnWG7hazXaXZxLb2snzKMZ4AAwuQByO1aLsHnuWllKxmQuioxyAMYGOM8CobaGYzoq3UggyzZZFUjIGBgMc/U4+ldFOnGnd9zaOHUNUi3bWQntGnAljWLYHhZdudxwrAc4ye/qtTadeT207QTpHeoHYFlcl1wOoYg7SOM8Hr2rGe3MV5JGt1MkEqBSGi3qD82CSTx1H5VvwS6daWqxXCfZt7B2n8krlsfM4bjrgcA96c1prrcqWis0TyTXXkSttiERYtC6xlynHSQ5Gce2K0L2Miys5JvKVN4eO7s+inByXbsOTk57Gubur57eXFtdTC2uCVjuIg0wTtuI6d88ntjmtTSLhktFUT6fc3OAsjgrDIp5PzBVxnAPBOOOtYzg0lJGU4JOyOmZj5aNKq89GkXcB+PGP/11DPDC96Ckyx3cahyltcBXkXp8w25ZecfgPSsyWaVdnlS/ZWQkyOMMrr6blyK0LK4tJSLlFgk9SjDI/EfMMcdq5nDlVzCVNrUil1NrWPF4ZrmdTjyF+Xd3ztJJIwR+VVZoYI72I3FyqxH5pUu7oLGuRhSEK888kkitC+V5An2O5WJ9+5yHM+8YI2qOe5B7dKiuNJtrkme6gidiMcRKT0xyCR+vb6VUXFK+1/69AjZFe38T2LpELaUXRDCNXjdWGcfdGD1AySM8A1dt4xOzXS2sjOSfvRZZOvA9M/rkenMJMdkAyw2yoqnD4AfPHGMYA98+2DUUUst3GyLMXJJ5WEMqAkkfoQOPSnyq146DUHuR6hdFr+4sYI5UljgkL3SdHZgANrDuu4/Qis27DWOmw7ob+5Y/u/Mh6pnczOxwedxJq9Y6NBYXkk7W8kZALysqufMP3goBwPX06VfkaGWBpWiuFVl8vZJIVDKc8bN2O3p07jir51FJLVFqKW2pl2k95MY4YLO+eLy+ZWyq5DYKkgHDZzx9KyTqQi1WcNDqNrHDt4tRhGLL17YPbPPGK3rS5nk+0GcqLVi2IzLhd6tgsRjbjcp5/SoTJCk8TpH5O5yHEX7wP8vAOPTrkj0Fawlq7orV3RUiuRHZ3KXSIVtrlgzMOAgbcuc9Ox/WtazhcTb9xXuMHaWHYA/n+GapW96v2q4t5YnjeHeGmK8OuNwx+BUY9c0kVpDIrC4hNzBJ8zeeS455GFbOBwfTr9KU/MrdaE00Fy2mMLiRvOjXMhXIJIOe/fisyG1n8Q6Pp0SszSKxuNoctGSxPJGOgDEZ7ZrVEP2c+XEoW3jGAEAA+gH+eta3gtYwb4KiIU2LtCgY+9np64zUSqckHNdNf0JnLkg5HJiyOnQXNrJbspj37XA5VmHJ6DHIGPYCsueWFrr7OtyrksYEAnDFSOpdMdCV9e9dH458u51meB5Wijjt1klkDsAByCpA4PAzye3Ssq5tre5kKw21oZ5mRYmSIF1dhlWb5eOATknj1FdFKTcVJ9dS4zvBS7j9VaHUr2J7LdIYQ8bLEgYjfsIJweF+U81Vm0+2v7gXEQiiltwsMIUgKuACB065Y4A9qsxWsf22CZUhiS3G1oVKjgsG5IPfB5qW6capdTW/kNbTtKjrKEHlg5UfK3AzjjPHenflslshrQytK1CWCyuWu0mQRybm81j5mTgDAOMr97nNaLLDMXeZoZHFysMakBmPzLuK/wCyQ3BFU74XF3p080Cxadi5EUskhUgjDEc+5B6elVIN9tcZuNt5DEzK08Q+SUqSA4Uc5JwAMZ+UfQW1zarRh1suhpCzuZI5G8y3d2yFkbO5VJGV+mCeM9cenMejqsk9xEmWntpPkLjA5GDt6kj5TzxzVZzcQxz3UnmCUSZVt7crkEINuTjg8kd+lTzaiHUPmQGSJd0EbFiuV255wcdXJwO/pQ72sUtWR6Qxh81I7u2uAi4ba+cNnGcZODkn8avbZLdYnu/sxuw2JZokJVEznGSQVHQ8kjjNRt9m1CWa1ntljjsimHJZlYgcnJAHBHqf0qFNN099Qee2Wy2xqqLbuVBL5zlT1J6Zx/eXntUt31Ytki4Vj1CMJMmJNu5ZIh93jjaexwf1rP0m0jijj3TxwWluzHMzYBLAfeHA68DnvU9lBEtvmKQSwF12so8kZGFIBU7s4B4xjt2q4fLl1KSM25eXyw5kJO084ww6Z5789PShu10i9jMuwl485LXaiJyhlLcDvn2HP5VSnuppIiskSTxW7CRoypZtuGBYD9AeOan1lgbmSO3DxxqRErMxAAC42qORyRnjnk9ecwXUpmtY7lbdbWaIFPmPmeb8uBgYIHLDg+9aRT0Hf3bWLdrdi4s3mlDx287IkMEnUbMLnHTsvTpj2qC8sJZLePfMiy5KhQpZAW4xjI6dj+lMtSt1YrJc2Cs0R2jEfXONxGB8vr2qWFkCSzWqPDajYxIjO4jr2Ge2OvGapLl2FpbUS2huI/IsfNASL958hIdufmz6AkgfhVkqQQ8JIMuYxGzYEK9jtx8o4GOfSmrMt3EZGhkiilSSOC5EuGQrgbmQH5lBOeeuCMVB55aeSRYmaFgBBOi8crlmAYAdvu98+2KlasXMtkX57ays0aC/heCNzmMKFVGOBkgkde3T1pqwXdxDDFb3DQwxgRmUud7YGR04IPBB4zxxSGOG3WSTcZDHGD5ijAO5sdu/B4GevvVzRkaGwnDlJSX3oisuQG2nkA5HXv7eorNuyuR111Nw6K/kxwwwpHb7sONo+ZDnPQjFQGxELPb+SBbRgjZjOV/vZHPr0qGGS+0+zmlnvLi8tUQkWghTOB2BABJxx159qdZXYuZbW6soLi2VwAySAKEOQfmJzj6fWuT3km27oyjzJ2ZmzTRWztYWj20UUSMUJA2oq4yDz79SeOta/gyzs7u6u47qyQPABgSyB2IbvgAEdD1znsRjFV9ZuUj8+aREuTEQzLC+c8ggcevb6VS1GaON1k0/zkvwPKC22JHA+8flbPGD1q2nOFlo31KneUOVOx3U2h6cWUSW9qsROMLFhif97Oah/wCEd0qKXzRakgZ+UyPgZ/GqNpqWpG1RLyO3niVdkxw0c545O3lc+3H4VmXsMuq3MDpbqiR7iiyzFOvvtPIA6e5rljCps5WX9ehzKFbrKyNW88M2Mt1G4ZoIUz5kRJIkHbknIxz0NJd3nhqe2NvK1jdJEdhRu2OoB6np29vUVWl8PWtqzyvGsqcMG805UHruAAx3PXp9KzLy6tdI1XTRZwyJvcN54+ZdysoKnJwNwY4Oe3SrgvaWSk3bbp/n/mUoqXxTbHw3uiXjTWFtaC3iicLG6BmAyOoBXnnPHPT3qpCLWGa4Ito4ZvNdXZgV83YWUEA8dM56jB5q14kkuIbaG5kDTre3LLH5ce4x7jnc+MYUfqPSuY1B0F5FmTy9RspYllbAKyEgAvyflUDJzjoc4rqpx5lp+d/61NouK6nUxagrRKr26QKx4Mq71PUHsB6flTreeGON7ePyxM2SJ4LdkTP1OU9ueD6VSsbhmv7q1sFRprYIXZiWRtwzgY53dKl0e1kM32iG7WUShWYLFgRnaowTk84A4x361EklcuXL0N6EPJISBHFjtAnAPtjJ/WnfaYWjL/ahsBZdzKVBK8HIPOR6VHMsUl+8s8gAwMHeFKnGOOMHPuKYIoNQVpt7eWHZcOm3DDjK4bnOB19K5kk9WY2XXYr+H5LG51S6E9zLqG8sqhkZI4cEEoExyefvEk4GPWti61Kx0o+XDaRKrZIYjYDjk5JHb3NYV5ZO4MWRFIVJ3SghAARkZ/vYPA9qiitYbOEzu8P7gAqEcl5CSc/KTg89hjA9a0cISd236DdGD1u7GqmsLq1kzNmCQH/VRgnd82AfMxt5H6NVeKSQSMk0Jy7YhVzvJ6DIIwDyOOOOfWie/db27VIRHFagMZ8na/T7ueCBzmqloba/l+2iMMpWWLcWI5LjLDBI6r/+rpQoJJu1l/Wn9ahGCS0Wg+SMPBdIkhVpN4QgLsBPoCO5yeuOabaCYXbRXMMYZgHDJjDNgggDJIIAB68jtwat2yfZngtonztwExyfb61W1OSZbkWdtcPG5jEiFVU7AGIPBByTnv2q4u75UU99BdKtUk1pbe6mDeYnmPkgZbIGB7HHSrGpQw6df21hp/mTyzQkSNLIXWPYfvH0JzjGQOOlZbTPHazWaKI9Sd1t2ul+YCJmX+E8A5Iz17/QJ4UeNo5ZnRmkgZoGA/5aH5cnHYcA/hVSi379/l+v9fMmzbu3ouhHDqlwJnSa3ItzPIJJHlUiBAAV6AZ3A8dxnvT7TX5dOmke2j+0pcEHlTGdu4Ybpk4DHjvV+5s1dHkDDP8ArNp7t3yPw/SuRiurVpdXuIFMt+hBhiHOG3hc4By2ASe3TnNaRUKien9f1+Rp7trbm7rM0t5aXFwkCM8rBXD4+dNpPOeQBnbz6Vmy3Ytrq6eWBrSMlYRc72OWI2gqB0xyMj1qbR2uGmFxcQKs06KgOGzuBOCV7cknqetaWm2Q8TRW63LNHBFiUlBgkrwAfTn/AD2qrqC12X9foXNKMfIydS8zFmLPK3MsyLcRxMp/d5Yckg8e4weR6VFpGqx3d19neIxpKnmRyiZi2RIEHB6HIzwB9PWbxBptidckt9MvpCqRec0ylGEjDH7tX5APP90np9D2iaJ4bW2uVjltpTcIVZVu856ZAwfVf51M68IxV09TKVRR97WzOIkja2sRFqFyn2d9jzRyLvw+GCsdpzzlhj1/WrdG6injS2hAtFaPMilFiOWDFhuBznd6mteNxNe2kcLw288ZJcGTcPukY5Gaqo195qtdXENw8MnmO+4IueCNuFOeRjHHPHNaqTv/AF/X4mmqdupSmuZoXnt3Zd4VzEsq84yABz1+pqKKO7NwssMUElw/lqUK5zkAEfe44J9vbrWzqVst1rzXhNpOrgFo5XYMjKXk3AKRzx3yPas3VAbhyAtvOjkqw80nYpwoIKgYx3Bz9080RnfSxa95bWZp3FvM1l5hCW7Kwa5QFSJl5ym7PGT3HPPeowbS2xHcwwQSOdsDsQHLHuM85yBz7VNftus9OiuLcLE8kbryx+dVyMnjAB69aqxXzte7US3YbWLKXIUsdgAzyc4Xp75qY3aFdu9xHiUW0f8AZ8/m20TAiJANx+f5nB6nGT+VNtpJ7y1WWCQ287EsUQhmIHG0k9eoP5CnqTbXFhG8lxLESNsUca+WhJbBZvvcDg8066s0ul8qKOKPzfkO6Q5wvzdOfUfnV7bhzORm3SbtXijSVn8ogyq8Z2lgDlyeMHHocVRnuY7yJINPMsgZ8FQDxjvkjj88Vq2DRCS7lURK8MnWSQnLBVXB6YH4VNNG+wTzOkt3BHlI4xtGAR25PU4zVqSi9St1oVNOE9ssrtkWKr+9dmDFWVcNj15HoalsiFVrW3kaWGRdvzxFQB2AJ+vQkn9aSS9uWtriZ5RDGyokkRAJTOFyOB655qBpvsdxeQmF3iVfODg4BYDcQOOTkkAZ9qV+a45R5d2Nlg+xywySzSPbyObdYfNCJES3zEMOOcZ2+59DSAXTpPawIyyRFVAXDYznhU6LnpnrVfyYJNLl1KWCaZJWLmI/Ky43dh/PPftWperNrdmBJNa20JKyOHk2MxHPz5B2gEdvxobtuZxdk9LkUW6KCS38yPzSy7X2NIjkbiVPzEZAIPX04zzWjbrOuozxSwGOB41YXKjy+AFATaee3UnPHpVa+mW+gjvNRu7mZ0JVCnliVc9fkCgY/wDrUmmyxLdxxqLrzroNIZXRdiDJ4OOh+X36/lGrTk9xKy0lobdpeFAI5JTJMpG5BknB9iPpVtHt3ld0UbtuH+UZz1A478+1UJPLt4ZbxkQSsq/PgkZ4GMdepFb/AIV0u2W0+2uzTy3f7wh8lVPT5R26VwTkorm/q5nWnGC5mYlzbWd9YOYlt4UlIbzyN+HBwC0bAKTnI6mtKxtkBW3mkhltFHCbNi5yT1UE9xxjHGe9dE9rZ+T5X2K2EWc7VjAGc57D1rA1xIrKW2nhaRYmcrJEG4bKnBBxkdKhVvae6r/15nPGtGehm2OmXNnqTXEmpzzEbgLd2OAnQL94gYI9qvTahKitHDbeTI3K3CIwBx1BwuOeDkmor4sIfOiVpZVY4QMELjnq2OnOcetJBNfJa3Dw26XEzY2Qsw2Dkf3s8gZ5BA6cVtfnXNK35GrV1tcfAiXoW8+yiQxsQkzKMj1Kk84PtVXSLCfV47YajDdW1xDKzJ9pkLMylMAZDEgA1oadc3LWcS3NolmSxDRIwKrhuOF49Pzpmi3rX1xbywyyOjyZZM4KZHTcRnAz06VLc7O3T+vQiUmUfKl0rV2t5llltncyOzn90oG0cZJGeW9P8HXFrDcRBQJo7wlXYQLNIByCRvA27emecdj3xteI7NZIGhw7pM3luwfa6Ag5YN6jPp6Vi3GZZY7aG5mtJixCmNjlwOSDjjt345pwlzpSuOk+ZXQ+xtFtx5iKHkJ27+VJHf39OvoPQVLcPNHOoSF9rEljGgPljBOeOp9hzk1fjjSILEjksASdw5/E9+3+RTIJfs0TG5kEpUEySBducDJwO3T3qea7uU5dRI7ZZpMvnkZG8AZ9+uadIY3kazKGRHB3FrbdH0PBYjHbpT5riKOTa04eMkhZTHggYB6ADuafDKkkKyxyb4mOFcDG4euDzU8z3J5nJaiQWkEMnnGzimlxhXLbWUf3Rx09ulVNRlkNxBGghtiSTgKGZgME4OOOPenz38kF/BAFLxuCWkyBtPYYx3NQ3tmNXglcXUkMsDlAsK7W5xyW/wAMdx3qo6NSlt94+Vx96RTD6tvjkRo4fLkBIQrJ5o6YyRx26e9WbI+deXEtwQZgCpL8+UGxwB2OVJBHvinnR3jhNvHcXixodwczAnnJxk/NwT69hRYaZFZCeIzztJcDLM7l2PXGCc46mrcoNO2/kiueLWhXsmji89IWUFlaVHjJZtu3acY+9znnNSSvtCR7WCAHMuSDyRxtbB7dapwQ+Vrazwp5VjFbeUHLs2SD9wLnA/3ip7+vEusiZ7eJRmMzNtMmclAMnPvzgfjVacyKjduxHaZlu7iK3jZJXJmmmK8BQRlz64UD64AqbRoVtVfdiG5n2zK6JjYpB+8MAljyMYOMHmrNon2PRbWIYk1G+VTK5GG8pjggHoBhf1NZMEpE09/I0quhEYRpC6FecDb0GMmnfnTS2/r8Bp8+i2Ls07wxiSeBfMO4uquG2kduOvPH9O1Yl3pFzHZXTyu11HI6GKB+sZBOVBJOcnHXHSujwwacSxxOxnKxttwPvcZGevNMvWeSwlVEUtt3KM45HfOaITaeg0+hylxBIkiP55jKwxfuHBCqwB44yPy/wpssF5JqF7G6zrbTGNEMaYDjGG6cgE9TU6r5zXB1TciWsXn/ACNjeOcgkZPAA5/2vatZIppDpciX+66dC01sYAEhVipGCMbsKfU10Obg/wCvX9Cm0tGYAs4YY44LbyZkhYsJBllYHkk4BwQeM9gBzzirV19is43a1WHeMxJGJihyOuF6A5U88epIp9ndabb2lxHoe67hWMtvnzkE54OQCRxWWtxayfaS8aSvN5iwhwdxZiV3qwxtyNxA7Zp6yetyYyfKpdxb6A3TW66heC9ALpJ5Azs4BGdh9R9ea7SSzlvtG+1W0u0wkfO2cNyN2fUkZ5561gTW0VmsbROkVs8e+SYQqWVsrgHIO7OTk4zT28QNEkOko5YXMfmbU+TYuPvdOfuE4yOlZz5p2cOn9MJaJW3ujP09Z4dQ2TmHynjwnmYXyyAe4BOcEj8+nGdGxkt4JJVt5Y5vNfHlglmZujAk8gZzjtjpWXaD7Xp8jRyubpLg2vmt82Uyv7zB4zyePetW3SLR5rSaOBL65zh2cBBuwACVxg4znjHT3q59fyNYtydkjLnkvvLL6h5z7wywhJEXyQPlLqNwI4IHA6kdeKlJTUpXujNLPH9oVQTnaG2jk7ypPT0z6DB5j1qQ7ALudTPKJAsccZRQ+RhVPJAz155IB9qaIJNNZLByXVpfPVgcbyAo5HPTdjqB7HrVJ3s1uZx35WaE10tihgciKBZWYAdREQSTgdMEnjPQZ74qSS0ddNdbG8drg4U3G53IG7P3eee2fSsvUWuYr61Uxx3Fq2XZmAyTl8qcknbxjH61NcyXFuyW1ojlHGPNWUoSOT0znORjPoaOXazGlfQZO6zhUkZ2l3hQFUBivmcN1Hy9Pl6+1RXUn269Z1ViELxqQx+THU9uxxiptQuoI7tSY/LQw/65MAoQ5wcYz2B/GkvbZrSyt7iG5EiXWJ1YRBDg4bn1yMdgaObY1gryRtnSba30gRyXpEl1EskaCFicjlvnGcEjA5IrlrqVmvC8cYtI1bc7yoDt+UhiVPU7j7/hmtm58Qyf2daJ/o0kkcbKcRFWA7YOcA49j0qgEa4GZXHkld6lkVi6rhnJ4z1H/wCus4cy1l/X4Fwozs3U3ILKedLiJrdmuVMoZiIvLWRAfmCqAcE8dh+tPWHzxAiRl1DMySMQeAdy5ye4AAGT1PpWlZW6tBNPFIqCJS8TKmAowD90Y68fl71zdjeznUDEiN5UTKUkV8AqOMlDkY5Axjv9a0T5r26GdT3dGatwkcrGVJjaSqMlY7h0Z+3zgYwQCMdcj0pkNvNdv532kS3yRqDG0pXgKo8xiudxPToeoOcjg1nyHtzNbBZF2Hcw3JuYMvvuzhx3xx+UlhaXAurcRRK3nW2VukYoxiDEKCu7GflHOAanpcyvd20P/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power view of a liver biopsy in primary sclerosing cholangitis showing mononuclear cell infiltration and charactertistic concentric fibrosis around a small bile duct.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Edward L Krawitt, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41498=[""].join("\n");
var outline_f40_33_41498=null;
var title_f40_33_41499="Ophthalmalogic dilating agents abusive head trauma";
var content_f40_33_41499=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F57408&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F57408&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Dilating drops recommended for fundus examination for nonaccidental head injury (shaken baby syndrome)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Name",
"      </td>",
"      <td class=\"subtitle1\">",
"       Efficacy/advantages",
"      </td>",
"      <td class=\"subtitle1\">",
"       Duration of large pupil&bull;",
"      </td>",
"      <td class=\"subtitle1\">",
"       Disadvantages",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tropicamide 1/2 or 1 percent",
"      </td>",
"      <td>",
"       Good in less pigmented eyes",
"      </td>",
"      <td>",
"       4 to 6 hours",
"      </td>",
"      <td>",
"       Works less well in brown eyes",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cyclopentolate 1/2 or 1 percent",
"      </td>",
"      <td>",
"       Good in all eyes",
"      </td>",
"      <td>",
"       1 to 2 days",
"      </td>",
"      <td>",
"       Long duration 2 percent solution can cause hallucinations",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Phenylephrine 2.5 percent",
"      </td>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Poor by itself",
"       </p>",
"       <p>",
"        Very helpful combined with tropicamide or cyclopentolate",
"       </p>",
"      </td>",
"      <td>",
"       3 to 4 hours",
"      </td>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Systemic hypertension in higher strengths",
"       </p>",
"       <p>",
"        Used alone, pupil still constricts during examination",
"       </p>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cyclomydril&reg; (0.2 percent cyclopentolate and 1 percent phenylephrine; Alcon laboratories)",
"      </td>",
"      <td colspan=\"1\" rowspan=\"1\">",
"       <p>",
"        Good in less pigmented eyes",
"       </p>",
"       <p>",
"        Commonly used for ROP examinations",
"       </p>",
"       <p>",
"        Convenient combination drop",
"       </p>",
"      </td>",
"      <td>",
"       3 to 4 hours",
"      </td>",
"      <td>",
"       Often needs to be repeated for darker eyes",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ROP: retinopathy of prematurity.",
"     <br>",
"      &bull; Repeat dosage will prolong duration by up to 50 percent.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Kivlin, JD. Ophthalmic manifestations of shaken baby syndrome. Journal of Aggression, Maltreatment &amp; Trauma 2001; 5:137. &copy;2001 The Haworth Press, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41499=[""].join("\n");
var outline_f40_33_41499=null;
var title_f40_33_41500="Five As for smoking cessation";
var content_f40_33_41500=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F74402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F74402&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Five \"A's\" for assessing for tobacco use and addressing smoking cessation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Intervention",
"       </td>",
"       <td class=\"subtitle1\">",
"        Technique",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         A",
"        </strong>",
"        sk",
"       </td>",
"       <td>",
"        Implement an officewide system that ensures that, for every patient at every clinic visit, tobacco-use status is queried and documented. Repeated assessment is not necessary in the case of the adult who has never used tobacco or has not used tobacco for many years, and for whom this information is clearly documented in the medical record.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         A",
"        </strong>",
"        dvise",
"       </td>",
"       <td>",
"        Strongly urge all tobacco users to quit in a clear, strong, personalized manner.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1_start\">",
"        Advice should be:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Clear - \"I think it is important for you to quit smoking now and I can help you.\" \"Cutting down while you are ill is not enough.\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Strong - \"As your clinician, I need you to know that quitting smoking is the most important thing you can do to protect your health now and in the future. The clinic staff and I will help you.\"",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        Personalized - Tie tobacco use to current health/illness, and/or its social and economic costs, motivation level/readiness to quit, and/or the impact of tobacco use on children and others in the household.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        <strong>",
"         A",
"        </strong>",
"        ssess",
"       </td>",
"       <td class=\"sublist1_start\">",
"        Determine the patient's willingness to quit smoking within the next 30 days:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        If the patient is willing to make a quit attempt at this time, provide assistance.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        If the patient will participate in an intensive treatment, deliver such a treatment or refer to an intensive intervention.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        If the patient clearly states he or she is unwilling to make a quit attempt at this time, provide a motivational intervention.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        If the patient is a member of a special population (eg, adolescent, pregnant smoker), provide additional information specific to that population.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         A",
"        </strong>",
"        ssist",
"       </td>",
"       <td>",
"        Provide aid for the patient to quit. These actions are summarized in the accompanying table.",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         A",
"        </strong>",
"        rrange",
"       </td>",
"       <td>",
"        Schedule follow-up contact, either in person or by telephone. Follow-up contact should occur soon after the quit date, preferably during the first week. A second follow-up contact is recommended within the first month. Schedule further follow-up contacts as indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Congratulate success during each follow-up. If tobacco use has occurred, review circumstances and elicit recommitment to total abstinence. Remind the patient that a lapse can be used as a learning experience. Identify problems already encountered and anticipate challenges in the immediate future. Assess pharmacotherapy use and problems. Consider use or referral to more intensive treatment.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from: Fiore MC, Jaen C, Baker T, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service. 2008.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41500=[""].join("\n");
var outline_f40_33_41500=null;
var title_f40_33_41501="Depression mortality after MI";
var content_f40_33_41501=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F76176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F76176&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Depression after a myocardial infarction predicts mortality",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 389px; height: 309px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In a study of 887 patients, baseline depression was measured by the Beck Depression Inventory (DBI); those with a higher level of depression (DBI &ge;10) had a higher one year mortality than those with a lower level of depression. Although the relationship between mortality and depression decreased with increasing levels of perceived social support (PSS), social support was not directly related to survival.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Data from Frasure-Smith, N, Lesperance, F, Gravel, G, et al, Circulation 2000; 101:1919.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41501=[""].join("\n");
var outline_f40_33_41501=null;
var title_f40_33_41502="Rx precocious puberty";
var content_f40_33_41502=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F62460&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F62460&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 530px\">",
"   <div class=\"ttl\">",
"    Treatment of children with precocious puberty",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 510px; height: 315px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GDPP: gonadotropin-dependent precocious puberty (central precocious puberty); GIPP: gonadotropin-independent precocious puberty; GnRH: gonadotropin-releasing hormone; GnRHa: gonadotropin-releasing hormone analogue; LH: luteinizing hormone; FSH: follicle-stimulating hormone.",
"     <br>",
"      * Preliminary data have been reported; treatment is still experimental.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41502=[""].join("\n");
var outline_f40_33_41502=null;
var title_f40_33_41503="Network meta-analysis of antihypertensive drugs";
var content_f40_33_41503=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F79458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F79458&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 617px\">",
"   <div class=\"ttl\">",
"    Network meta-analysis of antihypertensive drugs and the risk of cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 597px; height: 409px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The numbers represent the number of trial groups providing direct comparison between the drug classes.",
"    <div class=\"footnotes\">",
"     ARBs: angiotensin receptor blockers; ACEi: angiotensin converting enzyme inhibitor; CCBs: calcium channel blockers.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Bangalore S, Kumar S, Kjeldsen SE, et al. Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials. Lancet Oncol 2011; 12:65. Illustration used with the permission of Elsevier Inc. All rights reserved.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f40_33_41503=[""].join("\n");
var outline_f40_33_41503=null;
